
<!DOCTYPE html>
<html lang="en" >
    <head >

        <meta charset="UTF-8" />
        <meta http-equiv="X-UA-Compatible" content="IE=edge" />
        <meta name="HandheldFriendly" content="True" />
        <meta name="MobileOptimized" content="320" />
        <meta name="viewport" content="width=device-width, initial-scale=1.0" />

        
        

        
        
  <link rel="stylesheet" href="/static/assets/style-8258669d.css" />
<script type="module" crossorigin="" src="/static/assets/base_style-f4a99799.js"></script>

  <link rel="stylesheet" href="/static/assets/style-ef962842.css" />
<link rel="stylesheet" href="/static/assets/style-3ade8b5c.css" />
<script type="module" crossorigin="" src="/static/assets/article_style-d757a0dd.js"></script>

  
  
    <style>
  
  
  @media screen and (min-width: 64em) {
    div.pmc-wm {
      background: repeat-y;
      background-image: url("data:image/svg+xml,%3Csvg xmlns='http://www.w3.org/2000/svg' width='20' height='350' xmlns:xlink='http://www.w3.org/1999/xlink'%3E%3Cdefs%3E%3Cfilter x='-.02' y='0' width='1.05' height='1' id='c'%3E%3CfeFlood flood-color='%23FFF'/%3E%3CfeComposite in='SourceGraphic'/%3E%3C/filter%3E%3Ctext id='b' font-family='Helvetica' font-size='11pt' style='opacity:1;fill:%23005ea2;stroke:none;text-anchor:middle' x='175' y='14'%3E%3C/text%3E%3Cpath id='a' style='fill:%23005ea2' d='M0 8h350v3H0z'/%3E%3C/defs%3E%3Cuse xlink:href='%23a' transform='rotate(90 10 10)'/%3E%3Cuse xlink:href='%23b' transform='rotate(90 10 10)' filter='url(%23c)'/%3E%3C/svg%3E");
      padding-left: 3rem;
    }
  }
</style>

  



        
            <link rel="apple-touch-icon"
                  sizes="180x180"
                  href="/static/img/favicons/apple-touch-icon.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="48x48"
                  href="/static/img/favicons/favicon-48x48.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="32x32"
                  href="/static/img/favicons/favicon-32x32.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="16x16"
                  href="/static/img/favicons/favicon-16x16.png" />
            <link rel="manifest" href="/static/img/favicons/site.webmanifest" />
            <link rel="mask-icon"
                  href="/static/img/favicons/safari-pinned-tab.svg"
                  color="#0071bc" />
            <meta name="msapplication-config"
                  content="/static/img/favicons/browserconfig.xml" />
            <meta name="theme-color" content="#ffffff" />
        

        <title>
            The recent progress of tumor cell-derived exosomes in the pathogenesis, diagnosis and therapeutic strategies of tumors - PMC
        </title>

        
        
  
  <!-- Logging params: Pinger defaults -->
<meta name="ncbi_app" content="cloudpmc-viewer" />
<meta name="ncbi_db" content="pmc" />
<meta name="ncbi_phid" content="AE5344F38AF433630544F30021A52D69.m_1" />
<meta name="ncbi_pinger_stat_url" content="https://pmc.ncbi.nlm.nih.gov/stat" />
<!-- Logging params: Pinger custom -->
<meta name="ncbi_pdid" content="article" />
  
    <link rel="preconnect" href="https://www.google-analytics.com" />

    
        <link rel="preconnect" href="https://cdn.ncbi.nlm.nih.gov" />
    

    <!-- Include USWDS Init Script -->
    <script src="/static/assets/uswds-init.js"></script>


    <meta name="ncbi_domain" content="transmed">
<meta name="ncbi_type" content="fulltext">
<meta name="ncbi_pcid" content="journal">
<meta name="ncbi_feature" content="associated_data">
<link rel="canonical" href="https://pmc.ncbi.nlm.nih.gov/articles/PMC12362945/">
<meta name="robots" content="INDEX,NOFOLLOW,NOARCHIVE">
<meta name="citation_journal_title" content="Journal of Translational Medicine">
<meta name="citation_title" content="The recent progress of tumor cell-derived exosomes in the pathogenesis, diagnosis and therapeutic strategies of tumors">
<meta name="citation_author" content="Mengyue Li">
<meta name="citation_author_institution" content="Department of Hematology, Sichuan Academy of Medical Sciences &amp; Sichuan Provincial People’ S Hospital, School of Medicine, University of Electronic Science and Technology of China, No. 32, West Section 2, First Ring Road, Qingyang District, Chengdu, 610072 People’s Republic of China">
<meta name="citation_author" content="Yifan Wang">
<meta name="citation_author_institution" content="Department of Hematology, Sichuan Academy of Medical Sciences &amp; Sichuan Provincial People’ S Hospital, School of Medicine, University of Electronic Science and Technology of China, No. 32, West Section 2, First Ring Road, Qingyang District, Chengdu, 610072 People’s Republic of China">
<meta name="citation_author" content="Hu Zhang">
<meta name="citation_author_institution" content="Department of Pharmacy, Sichuan Academy of Medical Sciences &amp; Sichuan Provincial People’ S Hospital, School of Medicine, University of Electronic Science and Technology of China, No. 32, West Section 2, First Ring Road, Qingyang District, Chengdu, 610072 People’s Republic of China">
<meta name="citation_author" content="Xueqing Wang">
<meta name="citation_author_institution" content="Department of Pharmacy, Sichuan Academy of Medical Sciences &amp; Sichuan Provincial People’ S Hospital, School of Medicine, University of Electronic Science and Technology of China, No. 32, West Section 2, First Ring Road, Qingyang District, Chengdu, 610072 People’s Republic of China">
<meta name="citation_author" content="Lin He">
<meta name="citation_author_institution" content="Department of Pharmacy, Sichuan Academy of Medical Sciences &amp; Sichuan Provincial People’ S Hospital, School of Medicine, University of Electronic Science and Technology of China, No. 32, West Section 2, First Ring Road, Qingyang District, Chengdu, 610072 People’s Republic of China">
<meta name="citation_author" content="Jingying Dai">
<meta name="citation_author_institution" content="Department of Hematology, Sichuan Academy of Medical Sciences &amp; Sichuan Provincial People’ S Hospital, School of Medicine, University of Electronic Science and Technology of China, No. 32, West Section 2, First Ring Road, Qingyang District, Chengdu, 610072 People’s Republic of China">
<meta name="citation_publication_date" content="2025 Aug 18">
<meta name="citation_volume" content="23">
<meta name="citation_firstpage" content="925">
<meta name="citation_doi" content="10.1186/s12967-025-06883-8">
<meta name="citation_pmid" content="40826466">
<meta name="citation_abstract_html_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12362945/">
<meta name="citation_fulltext_html_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12362945/">
<meta name="citation_pdf_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12362945/pdf/12967_2025_Article_6883.pdf">
<meta name="description" content="Exosomes are extracellular vesicles of nanoscale, which represent the characteristics of the cells of origin. Tumor cell-derived exosomes (TEXs) obtain the characteristics of the tumor cells, which meanwhile transfer the various substances from the ...">
<meta name="og:title" content="The recent progress of tumor cell-derived exosomes in the pathogenesis, diagnosis and therapeutic strategies of tumors">
<meta name="og:type" content="article">
<meta name="og:site_name" content="PubMed Central (PMC)">
<meta name="og:description" content="Exosomes are extracellular vesicles of nanoscale, which represent the characteristics of the cells of origin. Tumor cell-derived exosomes (TEXs) obtain the characteristics of the tumor cells, which meanwhile transfer the various substances from the ...">
<meta name="og:url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12362945/">
<meta name="og:image" content="https://cdn.ncbi.nlm.nih.gov/pmc/cms/images/pmc-card-share.jpg?_=0">
<meta name="twitter:card" content="summary_large_image">
<meta name="twitter:site" content="@ncbi">
    
    

    </head>
    <body >
        
    <a class="usa-skipnav " href="#main-content">
      Skip to main content
    </a>


        
            

<section class="usa-banner " aria-label="Official website of the United States government" >
    <div class="usa-accordion">
        <header class="usa-banner__header">
            <div class="usa-banner__inner">
                <div class="grid-col-auto">
                    <img aria-hidden="true"
                         class="usa-banner__header-flag"
                         src="/static/img/us_flag.svg"
                         alt="" />
                </div>

                <div class="grid-col-fill tablet:grid-col-auto" aria-hidden="true">
                    <p class="usa-banner__header-text">
                        An official website of the United States government
                    </p>
                    <span class="usa-banner__header-action">Here's how you know</span>
                </div>

                



















    
        <button
            type="button"
        
    
    class="usa-accordion__button usa-banner__button
           

           
               
               
               
               
            

           
           
           
           "
    aria-expanded="false"
    aria-controls="gov-banner-default"
    
    data-testid="storybook-django-banner"
    
    >
    
        

        
                    <span class="usa-banner__button-text">Here's how you know</span>
                

        
    
        
            </button>
        


            </div>
        </header>

        <div class="usa-banner__content usa-accordion__content"
             id="gov-banner-default"
             hidden>
            <div class="grid-row grid-gap-lg">
                <div class="usa-banner__guidance tablet:grid-col-6">
                    <img class="usa-banner__icon usa-media-block__img"
                         src="/static/img/icon-dot-gov.svg"
                         alt=""
                         aria-hidden="true" />
                    <div class="usa-media-block__body">
                        <p>
                            <strong>Official websites use .gov</strong>
                            <br />
                            A
                            <strong>.gov</strong> website belongs to an official
                            government organization in the United States.
                        </p>
                    </div>
                </div>

                <div class="usa-banner__guidance tablet:grid-col-6">
                    <img class="usa-banner__icon usa-media-block__img"
                         src="/static/img/icon-https.svg"
                         alt=""
                         aria-hidden="true" />

                    <div class="usa-media-block__body">
                        <p>
                            <strong>Secure .gov websites use HTTPS</strong>
                            <br />
                            A <strong>lock</strong> (
                            <span class="icon-lock">
                                <svg xmlns="http://www.w3.org/2000/svg"
                                     width="52"
                                     height="64"
                                     viewBox="0 0 52 64"
                                     class="usa-banner__lock-image"
                                     role="graphics-symbol"
                                     aria-labelledby="banner-lock-description"
                                     focusable="false">
                                    <title id="banner-lock-title">Lock</title>
                                    <desc id="banner-lock-description">
                                    Locked padlock icon
                                    </desc>
                                    <path fill="#000000"
                                          fill-rule="evenodd"
                                          d="M26 0c10.493 0 19 8.507 19 19v9h3a4 4 0 0 1 4 4v28a4 4 0 0 1-4 4H4a4 4 0 0 1-4-4V32a4 4 0 0 1 4-4h3v-9C7 8.507 15.507 0 26 0zm0 8c-5.979 0-10.843 4.77-10.996 10.712L15 19v9h22v-9c0-6.075-4.925-11-11-11z" />
                                </svg>
</span>) or <strong>https://</strong> means you've safely
                                connected to the .gov website. Share sensitive
                                information only on official, secure websites.
                            </p>
                        </div>
                    </div>
                </div>
            </div>
        </div>
    </section>

        

        
    
    
    

<div class="usa-overlay">
</div>



<header class="usa-header usa-header--extended usa-header--wide" data-header data-testid="header"    >
    <div class="ncbi-header">
        <div class="ncbi-header__container">
            <a class="ncbi-header__logo-container"
               href="https://www.ncbi.nlm.nih.gov/">
                <img alt="NCBI home page"
                     class="ncbi-header__logo-image"
                     src="/static/img/ncbi-logos/nih-nlm-ncbi--white.svg"
                     width="410"
                     height="100" />
            </a>

            <!-- Mobile menu hamburger button -->
            



















    
        <button
            type="button"
        
    
    class="usa-menu-btn ncbi-header__hamburger-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    aria-label="Show menu"
    data-testid="navMenuButton"
    
    >
    
        

        
                <svg aria-hidden="true"
                     class="ncbi-hamburger-icon"
                     fill="none"
                     focusable="false"
                     height="21"
                     viewBox="0 0 31 21"
                     width="31"
                     xmlns="http://www.w3.org/2000/svg">
                    <path clip-rule="evenodd"
                          d="M0.125 20.75H30.875V17.3333H0.125V20.75ZM0.125 12.2083H30.875V8.79167H0.125V12.2083ZM0.125 0.25V3.66667H30.875V0.25H0.125Z"
                          fill="#F1F1F1"
                          fill-rule="evenodd" />
                </svg>
            

        
    
        
            </button>
        



            
                <!-- Desktop buttons-->
                <div class="ncbi-header__desktop-buttons">
                    
                        <!-- Desktop search button -->
                        



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--unstyled ncbi-header__desktop-button
           "
    aria-expanded="false"
    aria-controls="search-field-desktop-navigation"
    aria-label="Show search overlay"
    data-testid="toggleSearchPanelButton"
    data-toggle-search-panel-button
    >
    
        

        
                            



    <svg class="usa-icon " role="graphics-symbol" aria-hidden="true" >
        
        <use xlink:href="/static/img/sprite.svg#search" />
    </svg>


                            Search
                        

        
    
        
            </button>
        


                    

                    <!-- Desktop login dropdown -->
                    
                        <div class="ncbi-header__login-dropdown">
                            



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--unstyled ncbi-header__desktop-button ncbi-header__login-dropdown-button
           "
    aria-expanded="false"
    aria-controls="login-dropdown-menu"
    aria-label="Show login menu"
    data-testid="toggleLoginMenuDropdown"
    data-desktop-login-button
    >
    
        

        
                                



    <svg class="usa-icon " role="graphics-symbol" aria-hidden="true" >
        
        <use xlink:href="/static/img/sprite.svg#person" />
    </svg>



                                <span data-login-dropdown-text>Log in</span>

                                <!-- Dropdown icon pointing up -->
                                



    <svg class="usa-icon ncbi-header__login-dropdown-icon ncbi-header__login-dropdown-icon--expand-less ncbi-header__login-dropdown-icon--hidden" role="graphics-symbol" aria-hidden="true" data-login-dropdown-up-arrow>
        
        <use xlink:href="/static/img/sprite.svg#expand_less" />
    </svg>



                                <!-- Dropdown icon pointing down -->
                                



    <svg class="usa-icon ncbi-header__login-dropdown-icon ncbi-header__login-dropdown-icon--expand-more ncbi-header__login-dropdown-icon--hidden" role="graphics-symbol" aria-hidden="true" data-login-dropdown-down-arrow>
        
        <use xlink:href="/static/img/sprite.svg#expand_more" />
    </svg>


                            

        
    
        
            </button>
        



                            <!-- Login dropdown menu -->
                            <ul class="usa-nav__submenu ncbi-header__login-dropdown-menu"
                                id="login-dropdown-menu"
                                data-desktop-login-menu-dropdown
                                hidden>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/" class="usa-link  "  >
        

        
            Dashboard
        

        
    </a>


                                    </li>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/" class="usa-link  "  >
        

        
            Publications
        

        
    </a>


                                    </li>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/account/settings/" class="usa-link  "  >
        

        
            Account settings
        

        
    </a>


                                    </li>
                                
                                <li class="usa-nav__submenu-item">
                                    



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--outline ncbi-header__login-dropdown-logout-button
           "
    
    
    
    data-testid="desktopLogoutButton"
    data-desktop-logout-button
    >
    
        

        Log out

        
    
        
            </button>
        


                                </li>
                            </ul>
                        </div>
                    
                </div>
            
        </div>
    </div>

    <!-- Search panel -->
    
        <div class="ncbi-search-panel ncbi--show-only-at-desktop"
             data-header-search-panel
             hidden>
            <div class="ncbi-search-panel__container">
                <form action="https://www.ncbi.nlm.nih.gov/search/all/"
                      
                      autocomplete="off"
                      class="usa-search usa-search--big ncbi-search-panel__form"
                      data-testid="desktop-navigation-search-form"
                      method="GET"
                      role="search">
                    <label class="usa-sr-only" for="search-field-desktop-navigation">
                        Search…
                    </label>
                    <input class="usa-input"
                           id="search-field-desktop-navigation"
                           name="term"
                           
                               placeholder="Search NCBI"
                           
                           type="search"
                           value="" />
                    



















    
        <button
            type="submit"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    
    
    
    >
    
        

        
                        <span class="usa-search__submit-text">
                            Search NCBI
                        </span>
                    

        
    
        
            </button>
        


                </form>

                
            </div>
        </div>
    

    <nav aria-label="Primary navigation" class="usa-nav">
        <p class="usa-sr-only" id="primary-navigation-sr-only-title">
            Primary site navigation
        </p>

        <!-- Mobile menu close button -->
        



















    
        <button
            type="button"
        
    
    class="usa-nav__close ncbi-nav__close-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    aria-label="Close navigation menu"
    data-testid="navCloseButton"
    
    >
    
        

        
            <img src="/static/img/usa-icons/close.svg" alt="Close" />
        

        
    
        
            </button>
        



        
            <!-- Mobile search component -->
            <form class="usa-search usa-search--small ncbi--hide-at-desktop margin-top-6"
                  action="https://www.ncbi.nlm.nih.gov/search/all/"
                  
                  autocomplete="off"
                  data-testid="mobile-navigation-search-form"
                  method="GET"
                  role="search">
                <label class="usa-sr-only" for="search-field-mobile-navigation">
                    Search
                </label>

                <input class="usa-input"
                       id="search-field-mobile-navigation"
                       type="search"
                       
                           placeholder="Search NCBI"
                       
                       name="term" />

                



















    
        <button
            type="submit"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    
    
    
    >
    
        

        
                    <!-- This SVG should be kept inline and not replaced with a link to the icon as otherwise it will render in the wrong color -->
                    <img src="data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIGhlaWdodD0iMjQiIHZpZXdCb3g9IjAgMCAyNCAyNCIgd2lkdGg9IjI0Ij48cGF0aCBkPSJNMCAwaDI0djI0SDB6IiBmaWxsPSJub25lIi8+PHBhdGggZmlsbD0iI2ZmZiIgZD0iTTE1LjUgMTRoLS43OWwtLjI4LS4yN0E2LjQ3MSA2LjQ3MSAwIDAgMCAxNiA5LjUgNi41IDYuNSAwIDEgMCA5LjUgMTZjMS42MSAwIDMuMDktLjU5IDQuMjMtMS41N2wuMjcuMjh2Ljc5bDUgNC45OUwyMC40OSAxOWwtNC45OS01em0tNiAwQzcuMDEgMTQgNSAxMS45OSA1IDkuNVM3LjAxIDUgOS41IDUgMTQgNy4wMSAxNCA5LjUgMTEuOTkgMTQgOS41IDE0eiIvPjwvc3ZnPg=="
                         class="usa-search__submit-icon"
                         alt="Search" />
                

        
    
        
            </button>
        


            </form>

            
        

        <!-- Primary navigation menu items -->
        <!-- This usa-nav__inner wrapper is required to correctly style the navigation items on Desktop -->
        

        
            <div class="ncbi-nav__mobile-login-menu ncbi--hide-at-desktop"
                 data-mobile-login-menu
                 hidden>
                <p class="ncbi-nav__mobile-login-menu-status">
                    Logged in as:
                    <strong class="ncbi-nav__mobile-login-menu-email"
                            data-mobile-login-email-text></strong>
                </p>
                <ul class="usa-nav__primary usa-accordion">
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/" class="usa-link  "  >
        

        
            Dashboard
        

        
    </a>


                        </li>
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/" class="usa-link  "  >
        

        
            Publications
        

        
    </a>


                        </li>
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/account/settings/" class="usa-link  "  >
        

        
            Account settings
        

        
    </a>


                        </li>
                    
                </ul>
            </div>
        

        



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           ncbi-nav__mobile-login-button ncbi--hide-at-desktop
           "
    
    
    
    data-testid="mobileLoginButton"
    data-mobile-login-button
    >
    
        

        Log in

        
    
        
            </button>
        


    </nav>
</header>

    
    
        

<section class="pmc-header pmc-header--basic" aria-label="PMC Header with search box">
    <div class="pmc-nav-container">
        <div class="pmc-header__bar">
           <div class="pmc-header__logo">
               <a href="/" title="Home" aria-label="PMC Home"></a>
           </div>
            <button
                    type="button"
                    class="usa-button usa-button--unstyled pmc-header__search__button"
                    aria-label="Open search"
                    data-ga-category="search"
                    data-ga-action="PMC"
                    data-ga-label="pmc_search_panel_mobile"
            >
                <svg class="usa-icon width-4 height-4 pmc-icon__open" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#search"></use>
                </svg>
                <svg class="usa-icon width-4 height-4 pmc-icon__close" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#close"></use>
                </svg>
            </button>
        </div>
        <div class="pmc-header__search">
            


<form class="usa-search usa-search--extra usa-search--article-right-column  pmc-header__search__form" id="pmc-search-form" autocomplete="off" role="search">
<label class="usa-sr-only" for="pmc-search">Search PMC Full-Text Archive</label>
<span class="autoComplete_wrapper flex-1">
<input class="usa-input width-full maxw-none" required="required" placeholder="Search PMC Full-Text Archive" id="pmc-search"  type="search" name="term" data-autocomplete-url="https://pmc.ncbi.nlm.nih.gov/autocomp/search/autocomp/"/>
</span>
<button
class="usa-button"
type="submit"
formaction="https://www.ncbi.nlm.nih.gov/pmc/"
data-ga-category="search"
data-ga-action="PMC"
data-ga-label="PMC_search_button"
>
<span class="usa-search__submit-text">Search in PMC</span>
<img
src="/static/img/usa-icons-bg/search--white.svg"
class="usa-search__submit-icon"
alt="Search"
/>
</button>
</form>
            <div class="display-flex flex-column tablet:flex-row tablet:flex-justify flex-justify-center flex-align-center width-full desktop:maxw-44">
                <ul class="pmc-header__search__menu">
                    <li>
                        
                            <a class="usa-link" href="/journals/" data-ga-action="featured_link" data-ga-label="journal list">
                                Journal List
                            </a>
                        
                    </li>
                    <li>
                        
                            <a class="usa-link" href="/about/userguide/" data-ga-action="featured_link"
                            data-ga-label="user guide">
                                User Guide
                            </a>
                        
                    </li>
                </ul>
                
                    <button form="pmc-search-form" formaction="https://pmc.ncbi.nlm.nih.gov/search/" type="submit" class="usa-button usa-button--unstyled hover:text-no-underline text-no-underline width-auto margin-top-1 tablet:margin-top-0">
     <span class="bg-green-label padding-05 text-white">New</span><span class="text-underline text-primary">Try this search in PMC Beta Search</span>
</button>
                
            </div>
        </div>
    </div>
</section>

    


        
        

       
  <div class="usa-section padding-top-0 desktop:padding-top-6 pmc-article-section" data-article-db="pmc" data-article-id="12362945">

    

   



<div class="grid-container pmc-actions-bar" aria-label="Actions bar" role="complementary">
    <div class="grid-row">
        <div class="grid-col-fill display-flex">
             <div class="display-flex">
                <ul class="usa-list usa-list--unstyled usa-list--horizontal">
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex mob">
                        <button
                                type="button"
                                class="usa-button pmc-sidenav__container__open usa-button--unstyled width-auto display-flex"
                                aria-label="Open resources"
                                data-extra-class="is-visible-resources"
                                data-ga-category="resources_accordion"
                                data-ga-action="click"
                                data-ga-label="mobile_icon"
                        >
                            <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                <use xlink:href="/static/img/sprite.svg#more_vert"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex mob">
                        <a
                                href="https://doi.org/10.1186/s12967-025-06883-8"
                                class="usa-link display-flex usa-tooltip"
                                role="button"
                                target="_blank"
                                rel="noreferrer noopener"
                                title="View on publisher site"
                                data-position="bottom"
                                aria-label="View on publisher site"
                                data-ga-category="actions"
                                data-ga-action="click"
                                data-ga-label="publisher_link_mobile"
                        >
                                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                    <use xlink:href="/static/img/sprite.svg#launch"></use>
                                </svg>
                        </a>
                    </li>
                    
                    
                        <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                             <a
                                     href="pdf/12967_2025_Article_6883.pdf"
                                     class="usa-link display-flex usa-tooltip"
                                     role="button"
                                     title="Download PDF"
                                     data-position="bottom"
                                     aria-label="Download PDF"
                                     data-ga-category="actions"
                                     data-ga-action="click"
                                     data-ga-label="pdf_download_mobile"
                             >
                                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                    <use xlink:href="/static/img/sprite.svg#file_download"></use>
                                </svg>
                            </a>
                        </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                        <button
                            class="usa-button usa-button--unstyled  usa-tooltip collections-dialog-trigger collections-button display-flex collections-button-empty"
                            title="Add to Collections"
                            data-position="bottom"
                            aria-label="Save article in MyNCBI collections."
                            data-ga-category="actions"
                            data-ga-action="click"
                            data-ga-label="collections_button_mobile"
                            data-collections-open-dialog-enabled="false"
                            data-collections-open-dialog-url="https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC12362945%2F%3Freport%3Dclassic%23open-collections-dialog"
                            data-in-collections="false"
                        >
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-full" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-full.svg#icon"></use>
                            </svg>
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-empty.svg#icon"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                        <button role="button" class="usa-button usa-button--unstyled usa-tooltip citation-dialog-trigger display-flex"
                            aria-label="Open dialog with citation text in different styles"
                            title="Cite"
                            data-position="bottom"
                            data-ga-category="actions"
                            data-ga-action="open"
                            data-ga-label="cite_mobile"
                            data-all-citations-url="/resources/citations/12362945/"
                            data-citation-style="nlm"
                            data-download-format-link="/resources/citations/12362945/export/"
                        >
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/sprite.svg#format_quote"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="pmc-permalink display-flex" >
                         <button
                                 type="button"
                                 title="Permalink"
                                 data-position="bottom"
                                 class="usa-button usa-button--unstyled display-flex usa-tooltip"
                                 aria-label="Show article permalink"
                                 aria-expanded="false"
                                 aria-haspopup="true"
                                 data-ga-category="actions"
                                 data-ga-action="open"
                                 data-ga-label="permalink_mobile"
                         >
                            <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                <use xlink:href="/static/img/sprite.svg#share"></use>
                            </svg>
                        </button>
                        

<div class="pmc-permalink__dropdown" hidden>
    <div class="pmc-permalink__dropdown__container">
          <h2 class="usa-modal__heading margin-top-0 margin-bottom-2 text-uppercase font-sans-xs">PERMALINK</h2>
          <div class="pmc-permalink__dropdown__content">
              <input type="text" class="usa-input" value="https://pmc.ncbi.nlm.nih.gov/articles/PMC12362945/" aria-label="Article permalink">
              <button class="usa-button display-inline-flex pmc-permalink__dropdown__copy__btn margin-right-0" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                  <svg class="usa-icon" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#content_copy"></use>
                  </svg>
                  <span class="margin-left-1">Copy</span>
              </button>
          </div>
    </div>
</div>
                    </li>
                </ul>
            </div>
            <button
                    type="button"
                    class="usa-button pmc-sidenav__container__open usa-button--unstyled width-auto display-flex"
                    aria-label="Open article navigation"
                    data-extra-class="is-visible-in-page"
                    data-ga-category="actions"
                    data-ga-action="open"
                    data-ga-label="article_nav_mobile"
            >
                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#list"></use>
                </svg>
            </button>
        </div>
    </div>
</div>
    <div class="grid-container desktop:padding-left-6">
      <div id="article-container" class="grid-row grid-gap">
        <div class="grid-col-12 desktop:grid-col-8 order-2 pmc-layout__content">
            <div class="grid-container padding-left-0 padding-right-0">
                <div class="grid-row desktop:margin-left-neg-6">
                    <div class="grid-col-12">
                        <div class="pmc-layout__disclaimer" role="complementary" aria-label="Disclaimer note">
    As a library, NLM provides access to scientific literature. Inclusion in an NLM database does not imply endorsement of, or agreement with,
    the contents by NLM or the National Institutes of Health.<br/>
    Learn more:
    <a class="usa-link" data-ga-category="Link click" data-ga-action="Disclaimer" data-ga-label="New disclaimer box" href="/about/disclaimer/">PMC Disclaimer</a>
    |
    <a class="usa-link" data-ga-category="Link click" data-ga-action="PMC Copyright Notice" data-ga-label="New disclaimer box" href="/about/copyright/">
        PMC Copyright Notice
    </a>
</div>
                    </div>
                </div>
                <div class="grid-row pmc-wm desktop:margin-left-neg-6">
                    <!-- Main content -->
                    <main
                      id="main-content"
                      class="usa-layout-docs__main usa-layout-docs grid-col-12 pmc-layout pmc-prose padding-0"
                    >

                      
                        <section class="pmc-journal-banner text-center line-height-none" aria-label="Journal banner"><img src="https://cdn.ncbi.nlm.nih.gov/pmc/banners/logo-transmed.png" alt="Journal of Translational Medicine logo" usemap="#pmc-banner-imagemap" width="500" height="75"><map name="pmc-banner-imagemap"><area alt="Link to Journal of Translational Medicine" title="Link to Journal of Translational Medicine" shape="default" href="https://translational-medicine.biomedcentral.com/" target="_blank" rel="noopener noreferrer"></map></section><article lang="en"><section aria-label="Article citation and metadata"><section class="pmc-layout__citation font-secondary font-xs"><div>
<div class="display-inline-block"><button type="button" class="cursor-pointer text-no-underline bg-transparent border-0 padding-0 text-left margin-0 text-normal text-primary" aria-controls="journal_context_menu">J Transl Med</button></div>. 2025 Aug 18;23:925. doi: <a href="https://doi.org/10.1186/s12967-025-06883-8" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">10.1186/s12967-025-06883-8</a>
</div>
<nav id="journal_context_menu" hidden="hidden"><ul class="menu-list font-family-ui" role="menu">
<li role="presentation"><a href="https://www.ncbi.nlm.nih.gov/pmc/?term=%22J%20Transl%20Med%22%5Bjour%5D" class="usa-link" role="menuitem">Search in PMC</a></li>
<li role="presentation"><a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22J%20Transl%20Med%22%5Bjour%5D" lang="en" class="usa-link" role="menuitem">Search in PubMed</a></li>
<li role="presentation"><a href="https://www.ncbi.nlm.nih.gov/nlmcatalog?term=%22J%20Transl%20Med%22%5BTitle%20Abbreviation%5D" class="usa-link" role="menuitem">View in NLM Catalog</a></li>
<li role="presentation"><a href="?term=%22J%20Transl%20Med%22%5Bjour%5D" class="usa-link" role="menuitem" data-add-to-search="true">Add to search</a></li>
</ul></nav></section><section class="front-matter"><div class="ameta p font-secondary font-xs">
<hgroup><h1>The recent progress of tumor cell-derived exosomes in the pathogenesis, diagnosis and therapeutic strategies of tumors</h1></hgroup><div class="cg p">
<a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Li%20M%22%5BAuthor%5D" class="usa-link" aria-describedby="id1"><span class="name western">Mengyue Li</span></a><div hidden="hidden" id="id1">
<h3><span class="name western">Mengyue Li</span></h3>
<div class="p">
<sup>1</sup>Department of Hematology, Sichuan Academy of Medical Sciences &amp; Sichuan Provincial People’ S Hospital, School of Medicine, University of Electronic Science and Technology of China, No. 32, West Section 2, First Ring Road, Qingyang District, Chengdu, 610072 People’s Republic of China </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Li%20M%22%5BAuthor%5D" class="usa-link"><span class="name western">Mengyue Li</span></a>
</div>
</div>
<sup>1,</sup><sup>#</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Wang%20Y%22%5BAuthor%5D" class="usa-link" aria-describedby="id2"><span class="name western">Yifan Wang</span></a><div hidden="hidden" id="id2">
<h3><span class="name western">Yifan Wang</span></h3>
<div class="p">
<sup>1</sup>Department of Hematology, Sichuan Academy of Medical Sciences &amp; Sichuan Provincial People’ S Hospital, School of Medicine, University of Electronic Science and Technology of China, No. 32, West Section 2, First Ring Road, Qingyang District, Chengdu, 610072 People’s Republic of China </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Wang%20Y%22%5BAuthor%5D" class="usa-link"><span class="name western">Yifan Wang</span></a>
</div>
</div>
<sup>1,</sup><sup>#</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Zhang%20H%22%5BAuthor%5D" class="usa-link" aria-describedby="id3"><span class="name western">Hu Zhang</span></a><div hidden="hidden" id="id3">
<h3><span class="name western">Hu Zhang</span></h3>
<div class="p">
<sup>2</sup>Department of Pharmacy, Sichuan Academy of Medical Sciences &amp; Sichuan Provincial People’ S Hospital, School of Medicine, University of Electronic Science and Technology of China, No. 32, West Section 2, First Ring Road, Qingyang District, Chengdu, 610072 People’s Republic of China </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Zhang%20H%22%5BAuthor%5D" class="usa-link"><span class="name western">Hu Zhang</span></a>
</div>
</div>
<sup>2</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Wang%20X%22%5BAuthor%5D" class="usa-link" aria-describedby="id4"><span class="name western">Xueqing Wang</span></a><div hidden="hidden" id="id4">
<h3><span class="name western">Xueqing Wang</span></h3>
<div class="p">
<sup>2</sup>Department of Pharmacy, Sichuan Academy of Medical Sciences &amp; Sichuan Provincial People’ S Hospital, School of Medicine, University of Electronic Science and Technology of China, No. 32, West Section 2, First Ring Road, Qingyang District, Chengdu, 610072 People’s Republic of China </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Wang%20X%22%5BAuthor%5D" class="usa-link"><span class="name western">Xueqing Wang</span></a>
</div>
</div>
<sup>2</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22He%20L%22%5BAuthor%5D" class="usa-link" aria-describedby="id5"><span class="name western">Lin He</span></a><div hidden="hidden" id="id5">
<h3><span class="name western">Lin He</span></h3>
<div class="p">
<sup>2</sup>Department of Pharmacy, Sichuan Academy of Medical Sciences &amp; Sichuan Provincial People’ S Hospital, School of Medicine, University of Electronic Science and Technology of China, No. 32, West Section 2, First Ring Road, Qingyang District, Chengdu, 610072 People’s Republic of China </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22He%20L%22%5BAuthor%5D" class="usa-link"><span class="name western">Lin He</span></a>
</div>
</div>
<sup>2,</sup><sup>✉,</sup><sup>#</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Dai%20J%22%5BAuthor%5D" class="usa-link" aria-describedby="id6"><span class="name western">Jingying Dai</span></a><div hidden="hidden" id="id6">
<h3><span class="name western">Jingying Dai</span></h3>
<div class="p">
<sup>1</sup>Department of Hematology, Sichuan Academy of Medical Sciences &amp; Sichuan Provincial People’ S Hospital, School of Medicine, University of Electronic Science and Technology of China, No. 32, West Section 2, First Ring Road, Qingyang District, Chengdu, 610072 People’s Republic of China </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Dai%20J%22%5BAuthor%5D" class="usa-link"><span class="name western">Jingying Dai</span></a>
</div>
</div>
<sup>1,</sup><sup>✉,</sup><sup>#</sup>
</div>
<ul class="d-buttons inline-list">
<li><button class="d-button" aria-controls="aip_a" aria-expanded="false">Author information</button></li>
<li><button class="d-button" aria-controls="anp_a" aria-expanded="false">Article notes</button></li>
<li><button class="d-button" aria-controls="clp_a" aria-expanded="false">Copyright and License information</button></li>
</ul>
<div class="d-panels font-secondary-light">
<div id="aip_a" class="d-panel p" style="display: none">
<div class="p" id="Aff1">
<sup>1</sup>Department of Hematology, Sichuan Academy of Medical Sciences &amp; Sichuan Provincial People’ S Hospital, School of Medicine, University of Electronic Science and Technology of China, No. 32, West Section 2, First Ring Road, Qingyang District, Chengdu, 610072 People’s Republic of China </div>
<div id="Aff2">
<sup>2</sup>Department of Pharmacy, Sichuan Academy of Medical Sciences &amp; Sichuan Provincial People’ S Hospital, School of Medicine, University of Electronic Science and Technology of China, No. 32, West Section 2, First Ring Road, Qingyang District, Chengdu, 610072 People’s Republic of China </div>
<div class="author-notes p">
<div class="fn" id="_fncrsp93pmc__">
<sup>✉</sup><p class="display-inline">Corresponding author.</p>
</div>
<div class="fn" id="_eqcntrb93pmc__">
<sup>#</sup><p class="display-inline">Contributed equally.</p>
</div>
</div>
</div>
<div id="anp_a" class="d-panel p" style="display: none"><div class="notes p"><section id="historyarticle-meta1" class="history"><p>Received 2025 Apr 1; Accepted 2025 Jul 15; Collection date 2025.</p></section></div></div>
<div id="clp_a" class="d-panel p" style="display: none">
<div>© The Author(s) 2025</div>
<p><strong>Open Access</strong> This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit <a href="https://creativecommons.org/licenses/by-nc-nd/4.0/" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">http://creativecommons.org/licenses/by-nc-nd/4.0/</a>.</p>
<div class="p"><a href="/about/copyright/" class="usa-link">PMC Copyright notice</a></div>
</div>
</div>
<div>PMCID: PMC12362945  PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/40826466/" class="usa-link">40826466</a>
</div>
</div></section></section><section aria-label="Article content"><section class="body main-article-body"><section class="abstract" id="Abs1"><h2>Abstract</h2>
<p id="Par1">Exosomes are extracellular vesicles of nanoscale, which represent the characteristics of the cells of origin. Tumor cell-derived exosomes (TEXs) obtain the characteristics of the tumor cells, which meanwhile transfer the various substances from the tumor cells to regulate the other cells and microenvironments. TEXs play an important role in the pathogenesis of tumors, which can promote the progression, metastasis and recurrence of tumors. Furthermore, TEXs also facilitate chemotherapy resistance and radiotherapy resistance of tumors. TEXs can be applied as biomarkers for the diagnosis of tumors as well as the differentiation of the subtypes and stages of tumors. TEXs also can be used in the evaluation of the prognosis and chemotherapy/radiotherapy resistance of tumors. For tumor therapy, TEXs can be utilized as potential targets, delivery carriers and tumor vaccines to hinder tumor progression. This review highlights the recent advances in the research and application of TEXs, which provides new ideas for the understanding and control of tumor diseases.</p>
<section id="kwd-group1" lang="en" class="kwd-group"><p><strong>Keywords:</strong> TEXs, Pathogenesis, Diagnosis, Therapeutic strategies</p></section></section><section id="Sec1"><h2 class="pmc_sec_title">Introduction</h2>
<p id="Par79">Exosomes are a class of extracellular vesicles originating from cells with a diameter of 30–150 nm, which are the smallest extracellular vesicles [<a href="#CR1" class="usa-link" aria-describedby="CR1">1</a>]. After the formation of the endosomal system, then the formation of intraluminal vesicles (ILVs) and finally the fusion of multivesicular bodies (MVBs) with the plasma membrane, the exosomes are released from the cells to the extracellular environment [<a href="#CR2" class="usa-link" aria-describedby="CR2">2</a>, <a href="#CR3" class="usa-link" aria-describedby="CR3">3</a>]. Exosomes mainly contain proteins, lipids, DNAs and RNAs. The types of RNAs carried in exosomes include microRNAs, message RNAs, long non-coding RNAs, and circular RNAs. The microRNAs can be transported to the recipient cells and regulate the expression of the target genes. The message RNAs are transcribed into proteins, thus involving in protein synthesis. The lncRNAs can exert regulatory effects on the gene expression of the recipient cells. The circRNAs can act as miRNA sponges to adsorb miRNAs thereby relieving their inhibition on target genes. Most of the RNAs carried in exosomes are microRNAs (65%–90%). Meanwhile, RNAs carried in exosomes also include message RNAs (5%–15%), long non-coding RNAs (1%–10%), and very little circular RNAs [<a href="#CR4" class="usa-link" aria-describedby="CR4">4</a>]. Exosomal microRNAs play a very important role in regulating the pathophysiological process of cells. Exosomes with these cargos are involved in the communication between tumor cells and the tumor microenvironment (TME), which thus participate in the pathogenesis and development of tumors [<a href="#CR5" class="usa-link" aria-describedby="CR5">5</a>]. Some of the proteins, RNAs and lipid molecules in TEXs are tumor-specific, which can be used as biomarkers for disease diagnosis, monitoring and prognosis. In addition, TEXs derive from the tumor cells of the patients themselves, so they obtain good biocompatibility and meanwhile may carry tumor antigens. Therefore, they can be used as carriers for drug delivery as well as tumor vaccines for the therapy of tumors. Moreover, TEXs can deliver genetic material such as RNAs, DNAs and gene editing tools, which realize gene therapy through gene editing [<a href="#CR6" class="usa-link" aria-describedby="CR6">6</a>]. The application and research on TEXs are promising and ongoing currently, which will be systematically reviewed in the following parts.</p></section><section id="Sec2"><h2 class="pmc_sec_title">The roles of TEXs in tumor biology (Fig. <a href="#Fig1" class="usa-link">1</a>)</h2>
<figure class="fig xbox font-sm" id="Fig1"><h3 class="obj_head">Fig. 1.</h3>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12362945_12967_2025_6883_Fig1_HTML.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bc16/12362945/af4537a166a9/12967_2025_6883_Fig1_HTML.jpg" loading="lazy" id="MO1" height="371" width="742" alt="Fig. 1"></a></p>
<div class="p text-right font-secondary"><a href="figure/Fig1/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>The roles of TEXs in tumor biology. TEXs obtain the characteristics of the tumor cells, which meanwhile transfer the various substances from the tumor cells to regulate the other cells and the microenvironment. TEXs promote tumor progression and metastasis by regulating metabolism, epithelial-mesenchymal transition, angiogenesis, vascular permeability and immunosuppressive TME. Besides, TEXs facilitate chemotherapy resistance and radiotherapy resistance of tumors. In addition, TEXs promote the recurrence of tumors by remodeling the tumor cells and immunosuppressive TME. TEXs also promote the progression of tumors by inhibiting ferroptosis. (Created in BioRender)</p></figcaption></figure><section id="Sec3"><h3 class="pmc_sec_title">TEXs promote tumor progression and metastasis</h3>
<section id="Sec4"><h4 class="pmc_sec_title">TEXs regulate metabolism</h4>
<p id="Par80">Rapidly dividing cancer cells demand high levels of energy to sustain their proliferation [<a href="#CR7" class="usa-link" aria-describedby="CR7">7</a>]. TEXs elevate blood glucose levels by inhibiting insulin secretion, thereby providing adequate glucose for tumor cell proliferation. Exosomal miR-122 from breast cancer cells targets pyruvate kinase M to inhibit insulin secretion, thereby increasing blood glucose concentrations in the body [<a href="#CR8" class="usa-link" aria-describedby="CR8">8</a>]. Pancreatic cancer (PC)-derived exosomes contain adrenomedullin (AM) and CA19-9, which interact with receptors on β-cells to inhibit insulin secretion [<a href="#CR9" class="usa-link" aria-describedby="CR9">9</a>]. TEXs also promote the breakdown of adipose cells surrounding tumor cells to provide energy for tumor cell proliferation. TEXs derived from breast cancer cells carry miR-144 and miR-126 to induce beige/brown differentiation and metabolic reprogramming of adipocytes, thus promoting tumor metastasis [<a href="#CR10" class="usa-link" aria-describedby="CR10">10</a>]. AM in PC-derived exosomes interacts with receptors on adipocytes, which activates p38, extracellular signal-regulated kinase (ERK1/2) and mitogen-activated protein kinases (MAPKs) to promote lipolysis [<a href="#CR11" class="usa-link" aria-describedby="CR11">11</a>]. Furthermore, TEXs can inhibit glucose uptake by non-tumor cells at the distant site of colonization, thereby supplying energy for tumor cell metastasis. Breast cancer cell-derived exosomes carry miR-199b-5p to suppress the utilization of energy substances of neurons and astrocytes, leading to the extracellular accumulation of glutamate, glutamine and lactate. These substances are then utilized by breast cancer cells to promote their colonization in the brain [<a href="#CR12" class="usa-link" aria-describedby="CR12">12</a>].</p></section><section id="Sec5"><h4 class="pmc_sec_title">TEXs regulate epithelial-mesenchymal transition (EMT)</h4>
<p id="Par81">EMT refers to the process in which epithelial cells lose apical-basal polarity and transform into an invasive mesenchymal phenotype. This process enables cells to penetrate the basement membrane. EMT is generally characterized with the downregulation of epithelial markers (E-cadherin and keratin) and the upregulation of mesenchymal markers (N-cadherin and vimentin). This process reduces intercellular adhesion, thereby promoting cells to metastasize. EMT promotes tumor cells to detach from the primary tumor. TEXs promote EMT to facilitate tumor cell migration and invasion. TGF-β1 stimulates cervical cancer to secrete more exosomal miR-663b, which is internalized by adjacent or distant cervical cancer cells. This process inhibits the expression of MGAT3, accelerates EMT and ultimately promotes both local and distant metastasis of cervical cancer [<a href="#CR13" class="usa-link" aria-describedby="CR13">13</a>]. Exosomes from PC cells can induce EMT in adjacent human PC cells, partly through the action of TGF-β1 [<a href="#CR14" class="usa-link" aria-describedby="CR14">14</a>]. Under hypoxic conditions, paclitaxel-resistant breast cancer (PR-BC) cells secrete exosomes with overexpressed HSP gp96 and HIF-1α. Exosomes with overexpressed HSP gp96 and hypoxia-inducible factor (HIF-1) are transported to paclitaxel-sensitive breast cancer (PS-BC) cells, thus accelerating the EMT process [<a href="#CR15" class="usa-link" aria-describedby="CR15">15</a>]. Hypoxic exosomes from nasopharyngeal carcinoma (NPC) cells carry MMP-13 to significantly upregulate the expression of vimentin and reduce the level of E-cadherin in recipient NPC cells, thereby promoting EMT and enhancing their migration and invasion capabilities [<a href="#CR16" class="usa-link" aria-describedby="CR16">16</a>].</p></section><section id="Sec6"><h4 class="pmc_sec_title">TEXs regulate angiogenesis</h4>
<p id="Par82">Without angiogenesis, tumor cells can’t grow more than 2 mm in diameter. Blood vessels transport nutrients to tumor cells to power their proliferation. TEXs induce tumor angiogenesis via carrying angiogenic stimulators which include vascular endothelial growth factor (VEGF), fibroblast growth factor (FGF) and transforming growth factor-β (TGF-β) [<a href="#CR17" class="usa-link" aria-describedby="CR17">17</a>]. Under HOXD3 induction, liver cancer cell-derived exosomes promote CCR6-enhanced metastasis, invasion and angiogenesis of HCCs [<a href="#CR18" class="usa-link" aria-describedby="CR18">18</a>]. The miR-374b-3p in exosomes from glioblastoma stem cells enhances tumor angiogenesis by inducing M2 polarization of macrophages, thereby promoting the malignant progression of glioblastoma [<a href="#CR19" class="usa-link" aria-describedby="CR19">19</a>]. The miR-214-3p in gastric cancer cell-derived exosomes migrates to vascular endothelial cells and targets zinc finger protein A20 in vascular endothelial cells. This process negatively regulates ACSL4 which is a key enzyme involved in lipid peroxidation during ferroptosis, thereby inhibiting ferroptosis in vascular endothelial cells and reducing the anti-angiogenic efficiency of apatinib [<a href="#CR20" class="usa-link" aria-describedby="CR20">20</a>]. Exosomes from prostate cancer cells carry phosphoglycerate mutase 1 (PGAM1) which binds to γ-actin (ACTG1) to stimulate angiogenesis-related gene expression in human umbilical vein endothelial cells, thereby promoting neovascular sprouting [<a href="#CR21" class="usa-link" aria-describedby="CR21">21</a>].</p></section><section id="Sec7"><h4 class="pmc_sec_title">TEXs regulate vascular permeability</h4>
<p id="Par83">TEXs can increase vascular permeability, which makes tumor cells cross the endothelial barrier of blood vessels and provides opportunities for tumor cell metastasis. The circ-ZNF609 in exosomes from hypoxic esophageal squamous cell carcinoma (ESCC) cells acts as a sponge for miR-150-5p to activate VEGFA and promote angiogenesis and vascular permeability [<a href="#CR22" class="usa-link" aria-describedby="CR22">22</a>]. The miR-103 in liver cancer cell-derived exosomes targets endothelial cells to inhibit the expression of ZO-1, thereby increasing vascular permeability [<a href="#CR23" class="usa-link" aria-describedby="CR23">23</a>]. The miR-30a-5p in exosomes from intrahepatic cholangiocarcinoma (ICCA) increases vascular permeability depending on PDCD10, thus promoting the development of ICCA [<a href="#CR24" class="usa-link" aria-describedby="CR24">24</a>]. Protease 17 (ADAM17) is highly expressed in exosomes from various types of tumors, especially metastatic tumors. ADAM17 in metastatic CRC-derived exosomes disrupts VE-cadherin-mediated adhesion to vascular endothelial cells, which increases endothelial barrier permeability to enhance tumor cell metastasis. The ADAM17 inhibitors can act as a potential drug to inhibit hematogenous metastasis of CRC [<a href="#CR25" class="usa-link" aria-describedby="CR25">25</a>].</p></section><section id="Sec8"><h4 class="pmc_sec_title">TEXs create an immunosuppressive TME</h4>
<p id="Par84">TEXs allow tumor cells to evade anti-tumor immunity by creating an immunosuppressive TME. TEXs recruit immunosuppressive cells while suppress the functions of immune effector cells (Table <a href="#Tab1" class="usa-link">1</a>).
</p>
<section class="tw xbox font-sm" id="Tab1"><h5 class="obj_head">Table 1.</h5>
<div class="caption p"><p>Tumor cell-derived exosomes regulate immune cells</p></div>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<thead><tr>
<th align="left" colspan="1" rowspan="1">Cells of origin</th>
<th align="left" colspan="1" rowspan="1">Functional molecules</th>
<th align="left" colspan="1" rowspan="1">Immune cells</th>
<th align="left" colspan="1" rowspan="1">Function on the recipient cells</th>
<th align="left" colspan="1" rowspan="1">Refs.</th>
</tr></thead>
<tbody>
<tr>
<td align="left" colspan="1" rowspan="1">Prostate cancer cells</td>
<td align="left" colspan="1" rowspan="1">PGE2, TGF-β</td>
<td align="left" colspan="1" rowspan="1">DCs</td>
<td align="left" colspan="1" rowspan="1">Inhibit the differentiation and maturation of DCs</td>
<td align="left" colspan="1" rowspan="1">[<a href="#CR25" class="usa-link" aria-describedby="CR25">25</a>]</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Pancreatic cancer cells</td>
<td align="left" colspan="1" rowspan="1">miR-203</td>
<td align="left" colspan="1" rowspan="1">DCs</td>
<td align="left" colspan="1" rowspan="1">Inhibit the differentiation and maturation of DCs</td>
<td align="left" colspan="1" rowspan="1">[<a href="#CR27" class="usa-link" aria-describedby="CR27">27</a>]</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Renal cell carcinoma cells</td>
<td align="left" colspan="1" rowspan="1">HLA-G</td>
<td align="left" colspan="1" rowspan="1">DCs</td>
<td align="left" colspan="1" rowspan="1">Inhibit the differentiation and maturation of DCs</td>
<td align="left" colspan="1" rowspan="1">[<a href="#CR26" class="usa-link" aria-describedby="CR26">26</a>]</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Melanoma cells</td>
<td align="left" colspan="1" rowspan="1">S100A9</td>
<td align="left" colspan="1" rowspan="1">DCs</td>
<td align="left" colspan="1" rowspan="1">Inhibit the differentiation and maturation of DCs</td>
<td align="left" colspan="1" rowspan="1">[<a href="#CR28" class="usa-link" aria-describedby="CR28">28</a>]</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Glioblastoma multiforme cells</td>
<td align="left" colspan="1" rowspan="1">LGALS9</td>
<td align="left" colspan="1" rowspan="1">DCs</td>
<td align="left" colspan="1" rowspan="1">Inhibit the function of DCs</td>
<td align="left" colspan="1" rowspan="1">[<a href="#CR30" class="usa-link" aria-describedby="CR30">30</a>]</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Hepatocellular carcinoma cells</td>
<td align="left" colspan="1" rowspan="1">circUHRF1</td>
<td align="left" colspan="1" rowspan="1">NK cells</td>
<td align="left" colspan="1" rowspan="1">Inhibit the proliferation while promote the apoptosis of NK cells</td>
<td align="left" colspan="1" rowspan="1">[<a href="#CR32" class="usa-link" aria-describedby="CR32">32</a>]</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Cervical squamous cell carcinoma cells</td>
<td align="left" colspan="1" rowspan="1">miR-142-5p</td>
<td align="left" colspan="1" rowspan="1">T-cell</td>
<td align="left" colspan="1" rowspan="1">Inhibit T-cell proliferation while promote T-cell apoptosis</td>
<td align="left" colspan="1" rowspan="1">[<a href="#CR38" class="usa-link" aria-describedby="CR38">38</a>]</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Triple-negative breast cancer cells</td>
<td align="left" colspan="1" rowspan="1">ICAM1</td>
<td align="left" colspan="1" rowspan="1">T-cell</td>
<td align="left" colspan="1" rowspan="1">Inhibit T-cell proliferation while promote T-cell apoptosis</td>
<td align="left" colspan="1" rowspan="1">[<a href="#CR39" class="usa-link" aria-describedby="CR39">39</a>]</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Melanoma cells</td>
<td align="left" colspan="1" rowspan="1">
<p>hsa-miR-3187-3p, hsa-miR-498</p>
<p>hsa-miR-122</p>
<p>hsa-miR149</p>
<p>hsa-miR-181a/b</p>
</td>
<td align="left" colspan="1" rowspan="1">T-cell</td>
<td align="left" colspan="1" rowspan="1">Suppress T-cell activation</td>
<td align="left" colspan="1" rowspan="1">[<a href="#CR41" class="usa-link" aria-describedby="CR41">41</a>]</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Hepatocellular carcinoma cells</td>
<td align="left" colspan="1" rowspan="1">14–3-3ζ</td>
<td align="left" colspan="1" rowspan="1">T-cell</td>
<td align="left" colspan="1" rowspan="1">Induce the conversion of T-cells into regulatory T cells</td>
<td align="left" colspan="1" rowspan="1">[<a href="#CR43" class="usa-link" aria-describedby="CR43">43</a>]</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Hepatocellular carcinoma cells</td>
<td align="left" colspan="1" rowspan="1">miR-21-5p</td>
<td align="left" colspan="1" rowspan="1">Macrophages</td>
<td align="left" colspan="1" rowspan="1">Induce the M2 polarization of macrophages</td>
<td align="left" colspan="1" rowspan="1">[<a href="#CR44" class="usa-link" aria-describedby="CR44">44</a>]</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Esophageal squamous cell carcinoma cells</td>
<td align="left" colspan="1" rowspan="1">hsa-circ-0048117</td>
<td align="left" colspan="1" rowspan="1">Macrophages</td>
<td align="left" colspan="1" rowspan="1">Induce the M2 polarization of macrophages</td>
<td align="left" colspan="1" rowspan="1">[<a href="#CR45" class="usa-link" aria-describedby="CR45">45</a>]</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Mouse breast cancer cell line 4T1</td>
<td align="left" colspan="1" rowspan="1">miR-183-5p</td>
<td align="left" colspan="1" rowspan="1">Macrophages</td>
<td align="left" colspan="1" rowspan="1">Regulate the cytokine secretion of macrophages</td>
<td align="left" colspan="1" rowspan="1">[<a href="#CR46" class="usa-link" aria-describedby="CR46">46</a>]</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Pancreatic cancer cells</td>
<td align="left" colspan="1" rowspan="1">MIF</td>
<td align="left" colspan="1" rowspan="1">MDSCs</td>
<td align="left" colspan="1" rowspan="1">Promote the proliferation and activation of MDSCs</td>
<td align="left" colspan="1" rowspan="1">[<a href="#CR47" class="usa-link" aria-describedby="CR47">47</a>]</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Murine gastric cancer cell lines MFCs</td>
<td align="left" colspan="1" rowspan="1">PD-L1</td>
<td align="left" colspan="1" rowspan="1">MDSCs</td>
<td align="left" colspan="1" rowspan="1">Promote the proliferation and activation of MDSCs</td>
<td align="left" colspan="1" rowspan="1">[<a href="#CR50" class="usa-link" aria-describedby="CR50">50</a>]</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Mouse BC cell line 4T1</td>
<td align="left" colspan="1" rowspan="1">miR-200b-3p</td>
<td align="left" colspan="1" rowspan="1">MDSCs</td>
<td align="left" colspan="1" rowspan="1">Promote MDSC recruitment</td>
<td align="left" colspan="1" rowspan="1">[<a href="#CR52" class="usa-link" aria-describedby="CR52">52</a>]</td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/Tab1/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div></section><p id="Par85">TEXs can inhibit the differentiation and maturation of DCs. DCs are the important immune cells which activate the anti-tumor immune responses. DCs differentiate from both myeloid and lymphoid progenitors in the bone marrow or derive from monocytic cells. TEXs suppress the differentiation of monocytes and bone marrow progenitor cells into DCs through their biomolecules (COX-2, PGE2, IL-6, TGF-β, HSP70, and HLA-G). Prostate cancer-derived exosomes carry PGE2 and TGF-β to promote the conversion of monocytic cells into myeloid-derived suppressor cells (MDSCs) rather than DCs. MDSCs play a key role in the suppression of anti-tumor immunity. TEXs derived from 4T1 breast cancer cells or Lewis lung cancer not only inhibit the differentiation of myeloid precursor cells into CD11c + DCs but also induce apoptosis of CD11c + DC cells [<a href="#CR26" class="usa-link" aria-describedby="CR26">26</a>]. Renal cell carcinoma-derived exosomes carry HLA-G to impair the differentiation of monocytes into DCs [<a href="#CR27" class="usa-link" aria-describedby="CR27">27</a>]. Pancreatic cancer-derived exosomes deliver miR-203 to downregulate TLR4 and downstream cytokines in DCs, thus inhibiting DC maturation [<a href="#CR28" class="usa-link" aria-describedby="CR28">28</a>]. Melanoma-derived exosomes carry S100A9 to reduce the expression of four costimulatory molecules (CD83/86, IL-12/15) in DCs, thus disrupting DC maturation [<a href="#CR29" class="usa-link" aria-describedby="CR29">29</a>]. In addition, TEXs also inhibit the function of DCs. DCs are antigen-presenting cells (APCs) which recognize, process and present antigens on the cell surface to T cells. DCs activate anti-tumor specific T cells through major histocompatibility complex (MHC) molecules, costimulatory molecules and cytokines. TEXs from non-small cell lung cancer (NSCLC) can inhibit antigen presentation from DCs to T cells, thus interrupting antitumor immunity of cytotoxic T cells [<a href="#CR30" class="usa-link" aria-describedby="CR30">30</a>]. Glioblastoma multiforme (GBM) cell-derived exosomes carry LGALS9 to inhibit DCs antigen presentation, thus inhibiting cytotoxic T cell activation in the cerebrospinal fluid [<a href="#CR31" class="usa-link" aria-describedby="CR31">31</a>].</p>
<p id="Par86">TEXs inhibit the proliferation while promote the apoptosis of NK cells. Exosomes derived from MDA231 (human breast cancer), A2058 (human melanoma) and 4T1 (mouse breast cancer) cell lines suppress IL-2-induced NK cell proliferation [<a href="#CR32" class="usa-link" aria-describedby="CR32">32</a>]. Additionally, circUHRF1 in hepatocellular carcinoma (HCC)-derived exosomes downregulates miR-449c-5p while upregulates the expression of TIM-3 in NK cells, thus inducing the apoptosis of NK cells [<a href="#CR33" class="usa-link" aria-describedby="CR33">33</a>]. TEXs also inhibit NK cell activity. Exosomes from colorectal cancer cells activate the TGF-β signaling pathway in NK cells, which subsequently inhibits the viability and cytotoxicity of NK cells thereby leads to immune evasion [<a href="#CR34" class="usa-link" aria-describedby="CR34">34</a>]. Similarly, TEXs derived from pancreatic ductal adenocarcinoma (PDAC) induce the phosphorylation of Smad2/3 in NK cells, thereby suppressing their cytotoxicity [<a href="#CR35" class="usa-link" aria-describedby="CR35">35</a>]. Urinary bladder cancer-derived exosomes inhibit the expression of the important functional receptors (NKG2D, NKp30 and CD226) on NK cells as well as the secretion of perforin and granzyme-B from NK cells, which inhibits their viability and cytotoxicity [<a href="#CR36" class="usa-link" aria-describedby="CR36">36</a>].</p>
<p id="Par87">TEXs inhibit T-cell proliferation while promote T-cell apoptosis. TGF-β in TEXs inhibits CD4+ T cell proliferation and Th1 cytokines production [<a href="#CR37" class="usa-link" aria-describedby="CR37">37</a>]. The immunoinhibitory molecules, CD39 and CD73, are expressed on the surface of TEXs and can convert ATP into adenosine, which significantly suppresses CD4+ T cell proliferation [<a href="#CR38" class="usa-link" aria-describedby="CR38">38</a>]. Exosomes from cervical squamous cell carcinoma cells deliver miR-142-5p to lymphatic endothelial cells (LECs). The miR-142-5p upregulates IDO expression of LECs through the ARID2-DNMT1-IFN-γ signaling pathway, thus inducing CD8+ T cell apoptosis [<a href="#CR39" class="usa-link" aria-describedby="CR39">39</a>]. Exosomes from triple-negative breast cancer carry intercellular adhesion molecule 1 (ICAM1) to induce CD8+ T cell apoptosis thereby initiating and promoting the occurrence and progression of bone metastasis in TNBC. ICAM1 expression is higher in strong invasive phenotype cells than in weak invasive phenotype cells [<a href="#CR40" class="usa-link" aria-describedby="CR40">40</a>]. In addition, TEXs also suppress T-cell activation. Prostate cancer-derived exosomes induce CD73 expression on DCs to inhibit antigen presentation to T-cells by APCs, thereby suppressing T-cell activation [<a href="#CR41" class="usa-link" aria-describedby="CR41">41</a>]. Melanoma-derived exosomes contain specific miRNAs (hsa-miR-3187-3p, hsa-miR-498, hsa-miR-122, hsa-miR149 and hsa-miR-181a/b). These exosomes decrease T-cell receptor (TCR) signaling and diminish TNFα secretion by T cells, thus inhibiting T-cell responses and cytotoxic activity [<a href="#CR42" class="usa-link" aria-describedby="CR42">42</a>]. Gastric cancer cell-derived exosomes can be effectively uptaken by Vγ9Vδ2 T cells, suppressing their activation and inducing apoptosis [<a href="#CR43" class="usa-link" aria-describedby="CR43">43</a>]. Moreover, TEXs induce the conversion of T-cells into regulatory T cells (Treg). Treg cells primarily promote immune tolerance to suppress immune responses while Th cells secrete various cytokines to stimulate immune responses. Exosomes from nasopharyngeal carcinoma inhibit the proliferation of T-lymphocytes. These exosomes also inhibit the differentiation of T cells into Th1 and Th17 cells while promote the formation of Tregs, thus leading to immunosuppression40. Exosomes from HCC cells carry 14-3-3ζ, which can be phagocytosed by T-cells to induce the conversion of T cells into Tregs [<a href="#CR44" class="usa-link" aria-describedby="CR44">44</a>].</p>
<p id="Par88">Both M1 macrophages and M2 macrophages play important roles in immune responses. M1 macrophages mainly inhibit while M2 macrophages mainly promote the growth and progression of tumors. TEXs induce the M2 polarization of macrophages to promote tumor progression. Exosomes from small cell lung cancer (SCLC) induce the M2 polarization of macrophage via the NLRP6/NF-κB pathway, which promotes immunosuppression to facilitate SCLC metastasis [<a href="#CR45" class="usa-link" aria-describedby="CR45">45</a>]. HCC-derived exosomes carry miR-21-5p to regulate macrophage polarization by targeting RhoB, thus leading to M2 polarization of macrophages and HCC progression [<a href="#CR46" class="usa-link" aria-describedby="CR46">46</a>]. Exosomes from the esophageal squamous cell carcinoma (ESCC) cells in a hypoxic state are riched in hsa-circ-0048117. Exosomal hsa-circ-0048117 promotes M2 polarization of macrophage to enhance the invasion and migration ability of ESCC cells [<a href="#CR47" class="usa-link" aria-describedby="CR47">47</a>]. In addition, TEXs regulate the cytokine secretion of macrophages. Exosomes from the mouse breast cancer cell line 4T1 deliver miR-183-5p to macrophages, thus promoting the secretion of proinflammatory cytokines by inhibiting PPP2CA expression. Proinflammatory cytokines can remain the proinflammatory TME and promote the growth and metastasis of BC [<a href="#CR48" class="usa-link" aria-describedby="CR48">48</a>].</p>
<p id="Par89">MDSCs can induce the expansion of Treg and inhibit the function of immune cells (B cells, NK cells and DC cells) to enhance immunosuppression. TEXs promote the proliferation and activation of MDSCs to create an immunosuppressive TME. Pancreatic cancer cell-derived exosomes carry macrophage migration inhibitory factor (MIF) to induce the differentiation and activation of MDSCs, which promote pancreatic cancer progression. MIF tautomerase inhibitor IPG1576 inhibits MDSC differentiation in vitro and reduces tumor growth [<a href="#CR49" class="usa-link" aria-describedby="CR49">49</a>]. Exosomes from the murine melanoma cell line B16-F10 promote the differentiation and activation of MDSCs in vitro, which induce immunosuppression [<a href="#CR50" class="usa-link" aria-describedby="CR50">50</a>]. Exosomes from murine melanoma cell line B16-F10 enhance the proliferation and function of MDSCs via the JAK2 pathway, thus inhibiting T cell proliferation and exhibiting a significant immunomodulatory effect. JAK2 inhibitors can suppress the activation of TEXs and decrease the number of MDSCs [<a href="#CR51" class="usa-link" aria-describedby="CR51">51</a>]. Exosomes from the murine gastric cancer (GC) cell lines MFCs carry PD-L1 to stimulate MDSC proliferation by triggering the IL-6/STAT3 signaling pathway in vitro, which promotes the progression of GC [<a href="#CR52" class="usa-link" aria-describedby="CR52">52</a>]. TEXs promote MDSC recruitment to create an immunosuppressive TME. Exosomes from the murine melanoma cell line B16-F10 activate S100A10 (a plasminogen receptor) in lung fibroblasts to induce the expression of CXCL1 and CXCL8 chemokines, thus promoting MDSC recruitment. MDSCs regulate the lung immune microenvironment and promote the metastasis of melanoma to the lung [<a href="#CR53" class="usa-link" aria-describedby="CR53">53</a>]. Exosomes from the mouse BC cell line 4T1 carry miR-200b-3p to promote CCL2 expression by targeting PTEN. The high expression of CCL2 promotes the metastasis of BC to the lung by recruiting MDSCs in the lung [<a href="#CR54" class="usa-link" aria-describedby="CR54">54</a>].</p>
<p id="Par90">Furthermore, TEXs always act as a substitute for tumor cells to receive immune attacks, assisting tumor cells in the evasion of immune recognition. TEXs express tumor-specific antigens. These tumor antigens deplete antibodies that specifically target the tumor cells, thereby reducing the binding and attack of antibodies to tumor target cells. In aggressive B-cell lymphoma, exosomes that carry tumor-specific antigens are secreted into the plasma. These exosomes can release antigens that induce antibody binding. Thus these exosomes function as decoys against complement-mediated cytotoxicity, protecting tumor cells from immune attacks and complement-dependent cell lysis [<a href="#CR55" class="usa-link" aria-describedby="CR55">55</a>]. Pancreatic ductal adenocarcinoma (PDAC)-derived exosomes bind circulating antibodies in PDAC patients’ sera, thereby inhibiting complement-dependent cytotoxicity and antibody-dependent cell-mediated cytotoxicity toward PDAC tumor cells [<a href="#CR55" class="usa-link" aria-describedby="CR55">55</a>, <a href="#CR56" class="usa-link" aria-describedby="CR56">56</a>].</p>
<p id="Par91">Meanwhile, TEXs trigger inflammation and infiltrate stromal cells to create a favorable microenvironment for tumor growth and metastasis [<a href="#CR7" class="usa-link" aria-describedby="CR7">7</a>]. Rectal cancer cell-derived exosomes carry miR-21 to bind to TLR7, thus inducing the polarization of liver macrophages. Inflammatory cytokines (IL-6 and members of the S100A family) secreted by activated macrophages alter the pre-metastatic niches (PMN) to support liver tumor cell metastasis [<a href="#CR57" class="usa-link" aria-describedby="CR57">57</a>]. Additionally, TEXs can induce immune tolerance of tumor cells, increasing their resistance to immunity. Exosomes from HER2+ breast cancer (BC) cells can bind to trastuzumab and interfere with trastuzumab’s antiproliferative effect on breast cancer cell proliferation. They can also induce tumor cells to express HER2 to enhance immune tolerance and facilitate metastasis [<a href="#CR58" class="usa-link" aria-describedby="CR58">58</a>].</p></section></section><section id="Sec9"><h3 class="pmc_sec_title">TEXs promote drug resistance of tumor cells</h3>
<p id="Par92">Currently, many anti-tumor drugs exhibit poor effects. A main reason for that is tumor drug resistance. TEXs play an important role in drug resistance of tumors. TEXs facilitate drug efflux from tumor cells to promote tumor drug resistance. Exosomes from breast cancer cells treated with doxorubicin (DOX) accumulate a high level of DOX and are subsequently released from breast cancer cells, leading to the efflux of DOX [<a href="#CR59" class="usa-link" aria-describedby="CR59">59</a>]. Drug exporter pumps including P-glycoprotein (MDR1/P-gp), multidrug-resistant protein-1 (MRP-1) and breast cancer resistance protein (BCRP/ABCG2) participate in drug efflux from the tumor cells. TEXs can deliver these pumps to drug-sensitive cells, thus resulting in drug resistance. For example, exosomes from docetaxel-resistant prostate tumor cells deliver MDR-1/P-gp to drug-sensitive prostate tumor cells, which induces docetaxel resistance [<a href="#CR60" class="usa-link" aria-describedby="CR60">60</a>]. In addition, TEXs also regulate anti-tumor immune responses to promote tumor drug resistance. The lnc-TALC in GBMs-derived exosomes can bind to ENO1 in microglia, which activates the p38 MAPK pathway and induces the release of C5/C5a. Then, C5/C5a regulates the M2 polarization of microglia to promote TMZ resistance of GBM cells [<a href="#CR61" class="usa-link" aria-describedby="CR61">61</a>]. Moreover, TEXs increase the autophagy activity of tumor cells after chemotherapy to induce drug resistance of tumor cells. Resistant osteosarcoma exosomes deliver miR-331-3p to induce autophagy and confer resistance to sensitive cells. The inhibition of miR-331-3p decreased the drug resistance of osteosarcoma cells [<a href="#CR62" class="usa-link" aria-describedby="CR62">62</a>].</p></section><section id="Sec10"><h3 class="pmc_sec_title">TEXs promote tumor resistance to radiotherapy</h3>
<p id="Par93">Radiation exposure can damage the DNA of tumor cells as well as stimulate them to secrete more TEXs. These TEXs transmit radiation resistance among tumor cells through DNA repair mechanisms, ultimately weakening the effectiveness of radiotherapy. For example, HNSCC cells subjected to ionizing radiation (IR) secrete more exosomes. These exosomes not only enhance DNA repair in irradiated cells but also signal to unirradiated HNSCC cells, which reduces apoptosis and endows both irradiated and unirradiated cells with radiation-resistant phenotypes [<a href="#CR63" class="usa-link" aria-describedby="CR63">63</a>, <a href="#CR64" class="usa-link" aria-describedby="CR64">64</a>]. Similarly, Du et al. discovered that IR induces high expression of HMGB1 in exosomes derived from esophageal squamous cell carcinoma, thus activating the PI3K/AKT/FOXO3A signaling pathway to induce IR resistance. Exosomal HMGB1 can enhance DNA repair in recipient cells, thus leading to stronger radiation resistance of tumor cells [<a href="#CR65" class="usa-link" aria-describedby="CR65">65</a>]. Bladder cancer-derived exosomes activate the PI3K/Akt and MAPK/Erk pathways, which promotes the anti-apoptotic effect of tumor cells [<a href="#CR66" class="usa-link" aria-describedby="CR66">66</a>]. After exposure to 4 Gy radiation, both MDA-MB-231 (human breast cancer cells) and HeLa (cervical cancer cells) secrete more exosomes, which leads to enhanced activation of the PI3K/Akt and MAPK/Erk pathways for the inhibition of tumor cell apoptosis [<a href="#CR67" class="usa-link" aria-describedby="CR67">67</a>]. Furthermore, hypoxia is a key factor in radiation resistance. Hypoxia exosomes decrease the tumor cell apoptosis induced by IR while increase the repair of DNA damage. miR-340-5p is highly expressed in hypoxia exosomes. Hypoxia exosomes transfer miR-340-5p to normoxic OSCC cells, thereby inducing radiation resistance [<a href="#CR68" class="usa-link" aria-describedby="CR68">68</a>].</p></section><section id="Sec11"><h3 class="pmc_sec_title">TEXs promote tumor recurrence</h3>
<p id="Par94">Tumor recurrence is associated with tumor cell remodeling, immunosuppression, drug resistance and activation of cancer stem cells. The epithelial-mesenchymal transition (EMT) is an important way of the tumor cell remodeling to promote tumor recurrence. TEXs induce EMT of surrounding cells to promote tumor recurrence. For example, exosomes from highly metastatic MHCC97H cells trigger EMT in low-metastatic HCC cells through the MAPK/ERK signaling pathway, thus endowing the latter with invasiveness [<a href="#CR69" class="usa-link" aria-describedby="CR69">69</a>]. GC-derived exosomal miR-552-5p inhibits NK cell activity to promote EMT in surrounding GC via the PD-1/PD-L1 axis [<a href="#CR70" class="usa-link" aria-describedby="CR70">70</a>]. On the other hand, TEXs can modulate the immune system to promote tumor recurrence. For example, in patients with recurrent HNSCC, exosomes significantly enhance the production of 5'-AMP and adenosine in CD4+CD39+ Treg, thus leading to immunosuppression and tumor recurrence [<a href="#CR71" class="usa-link" aria-describedby="CR71">71</a>–<a href="#CR73" class="usa-link" aria-describedby="CR73">73</a>]. SERPINE1 is overexpressed in GC cells. SERPINE1 facilitates the transfer of exosomal let-7g-5p to macrophages and then induces M2 polarization, which promotes tumor recurrence [<a href="#CR74" class="usa-link" aria-describedby="CR74">74</a>]. Oral cancer stem cell-derived exosomes promote M2 macrophage polarization and suppress CD4+ T cell activity by transferring UCA1 and targeting LAMC2, which involves in tumor recurrence [<a href="#CR75" class="usa-link" aria-describedby="CR75">75</a>]. In addition, TEXs transfer drug resistance, thus promoting tumor recurrence. miR-891-5p, enriched in circulating exosomes from recurrent ovarian cancer patients, can transfer the drug-resistant phenotype to recipient cells and reduce chemotherapy sensitivity [<a href="#CR76" class="usa-link" aria-describedby="CR76">76</a>]. ABCB4 is highly expressed in glioblastoma stem cells (GSCs), which promotes the resistance of GSCs to TMZ. GSCs-derived exosomes transfer ABCB4 to glioblastoma and then induce TMZ resistance, which promotes tumor recurrence [<a href="#CR77" class="usa-link" aria-describedby="CR77">77</a>]. Moreover, exosomes from cancer stem cells facilitate tumor progression through angiogenesis and PMN formation, which is also the origin of tumor formation, metastasis and recurrence. For example, Wang et al. discovered exosomal miR-26a derived from glioma stem cells promotes angiogenesis of microvascular endothelial cells in gliomas [<a href="#CR78" class="usa-link" aria-describedby="CR78">78</a>]. The breast cancer stem cell-derived exosomes carry lnc-PDGFD to induce lung fibroblast activation through Y-box binding protein 1 (YBX1)/NF-κB signaling, thereby promoting the formation of the PMN [<a href="#CR79" class="usa-link" aria-describedby="CR79">79</a>].</p></section><section id="Sec12"><h3 class="pmc_sec_title">TEXs inhibit ferroptosis to promote the progression of tumors</h3>
<p id="Par95">Ferroptosis is a mode of cell death. TEXs confer drug resistance to tumor cells by inhibiting ferroptosis, thus protecting the tumor cells [<a href="#CR80" class="usa-link" aria-describedby="CR80">80</a>–<a href="#CR83" class="usa-link" aria-describedby="CR83">83</a>]. For example, cisplatin induces ferroptosis to inhibit tumor proliferation in NSCLC [<a href="#CR84" class="usa-link" aria-describedby="CR84">84</a>]. However, NSCLC-derived exosomes carry miR-4443 to suppress ferroptosis, thereby leading to cisplatin resistance [<a href="#CR84" class="usa-link" aria-describedby="CR84">84</a>]. Conversely, the enhanced ferroptosis can overcome tumor drug resistance. Exosomal miR-214-3p from gastric cancer inhibits ferroptosis in vascular endothelial cells to promote angiogenesis, which induces tumor progression [<a href="#CR20" class="usa-link" aria-describedby="CR20">20</a>]. Zhang et al. found that gastric cancer-derived exosomes carry lncFERO to inhibit ferroptosis, which suppresses the apoptosis of GCSC. Targeting the exo-lncFERO/hnRNPA1/SCD1 axis combined with chemotherapy may be an effective treatment strategy for gastric cancer [<a href="#CR85" class="usa-link" aria-describedby="CR85">85</a>]. Therefore, research on ferroptosis provides directions for tumor therapy.</p></section></section><section id="Sec13"><h2 class="pmc_sec_title">Research progress of TEXs in tumor diagnosis (Fig. <a href="#Fig2" class="usa-link">2</a>) (Table <a href="#Tab2" class="usa-link">2</a>)</h2>
<figure class="fig xbox font-sm" id="Fig2"><h3 class="obj_head">Fig. 2.</h3>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12362945_12967_2025_6883_Fig2_HTML.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bc16/12362945/46de7e057037/12967_2025_6883_Fig2_HTML.jpg" loading="lazy" id="MO2" height="524" width="778" alt="Fig. 2"></a></p>
<div class="p text-right font-secondary"><a href="figure/Fig2/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>The roles of TEXs in the diagnosis of tumors. The biomarkers carried in TEXs can help in the diagnosis of tumors (A). In addition, TEXs can be used to differentiate the subtypes and stages of tumors due to their ability to reflect the physiological and pathological state of their cells of origin (B). Furthermore, TEXs can be used to predict, monitor and evaluate drug resistance by detecting the relative biomarkers in exosomes (C). What’s more, TEXs can be used to evaluate the prognosis of tumors (D). (Created in BioRender)</p></figcaption></figure><section class="tw xbox font-sm" id="Tab2"><h3 class="obj_head">Table 2.</h3>
<div class="caption p"><p>Tumor cell-derived exosomes serve as biomarkers</p></div>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<thead><tr>
<th align="left" colspan="1" rowspan="1">Cells of origin</th>
<th align="left" colspan="1" rowspan="1">Biomarkers carried by TEXs</th>
<th align="left" colspan="1" rowspan="1">Expression change</th>
<th align="left" colspan="1" rowspan="1">Application</th>
<th align="left" colspan="1" rowspan="1">Refs.</th>
</tr></thead>
<tbody>
<tr>
<td align="left" colspan="1" rowspan="1">Ovarian cancer</td>
<td align="left" colspan="1" rowspan="1">CA125, HE4, C5a</td>
<td align="left" colspan="1" rowspan="1">Upregulation</td>
<td align="left" colspan="1" rowspan="1">Diagnosis</td>
<td align="left" colspan="1" rowspan="1">[<a href="#CR88" class="usa-link" aria-describedby="CR88">88</a>]</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Ovarian clear cell carcinoma</td>
<td align="left" colspan="1" rowspan="1">miR-29, miR-30, miR-21, miR-1281</td>
<td align="left" colspan="1" rowspan="1">Upregulation</td>
<td align="left" colspan="1" rowspan="1">Diagnosis</td>
<td align="left" colspan="1" rowspan="1">[<a href="#CR89" class="usa-link" aria-describedby="CR89">89</a>, <a href="#CR90" class="usa-link" aria-describedby="CR90">90</a>]</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Endometrioid carcinoma</td>
<td align="left" colspan="1" rowspan="1">miR-1281</td>
<td align="left" colspan="1" rowspan="1">Upregulation</td>
<td align="left" colspan="1" rowspan="1">Diagnosis</td>
<td align="left" colspan="1" rowspan="1">[<a href="#CR89" class="usa-link" aria-describedby="CR89">89</a>, <a href="#CR90" class="usa-link" aria-describedby="CR90">90</a>]</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Breast cancer</td>
<td align="left" colspan="1" rowspan="1">hsa-miR-21-5p</td>
<td align="left" colspan="1" rowspan="1">Upregulation</td>
<td align="left" colspan="1" rowspan="1">Diagnosis</td>
<td align="left" colspan="1" rowspan="1">[<a href="#CR91" class="usa-link" aria-describedby="CR91">91</a>]</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Gastric cancer</td>
<td align="left" colspan="1" rowspan="1">circATP8A1</td>
<td align="left" colspan="1" rowspan="1">Upregulation</td>
<td align="left" colspan="1" rowspan="1">Determination of tumor stages</td>
<td align="left" colspan="1" rowspan="1">[<a href="#CR94" class="usa-link" aria-describedby="CR94">94</a>]</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Breast cancer</td>
<td align="left" colspan="1" rowspan="1">miR-378a-3p, miR-378d</td>
<td align="left" colspan="1" rowspan="1">Upregulation</td>
<td align="left" colspan="1" rowspan="1">Evaluation of chemoresistance</td>
<td align="left" colspan="1" rowspan="1">[<a href="#CR99" class="usa-link" aria-describedby="CR99">99</a>]</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Diffuse large B-cell lymphoma</td>
<td align="left" colspan="1" rowspan="1">miR-99a-5p, miR-125b-5p</td>
<td align="left" colspan="1" rowspan="1">Upregulation</td>
<td align="left" colspan="1" rowspan="1">Evaluation of chemoresistance</td>
<td align="left" colspan="1" rowspan="1">[<a href="#CR100" class="usa-link" aria-describedby="CR100">100</a>]</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Ovarian cancer</td>
<td align="left" colspan="1" rowspan="1">miR-891-5p</td>
<td align="left" colspan="1" rowspan="1">Upregulation</td>
<td align="left" colspan="1" rowspan="1">Evaluation of chemoresistance</td>
<td align="left" colspan="1" rowspan="1">[<a href="#CR76" class="usa-link" aria-describedby="CR76">76</a>, <a href="#CR101" class="usa-link" aria-describedby="CR101">101</a>, <a href="#CR102" class="usa-link" aria-describedby="CR102">102</a>]</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Epithelial ovarian cancer</td>
<td align="left" colspan="1" rowspan="1">miR-6836</td>
<td align="left" colspan="1" rowspan="1">Upregulation</td>
<td align="left" colspan="1" rowspan="1">Evaluation of chemoresistance</td>
<td align="left" colspan="1" rowspan="1">[<a href="#CR103" class="usa-link" aria-describedby="CR103">103</a>]</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Cervical cancer</td>
<td align="left" colspan="1" rowspan="1">miR-651</td>
<td align="left" colspan="1" rowspan="1">Downregulation</td>
<td align="left" colspan="1" rowspan="1">Evaluation of chemoresistance</td>
<td align="left" colspan="1" rowspan="1">[<a href="#CR104" class="usa-link" aria-describedby="CR104">104</a>]</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Non-small cell lung cancer</td>
<td align="left" colspan="1" rowspan="1">miR-6836-5p</td>
<td align="left" colspan="1" rowspan="1">Downregulation</td>
<td align="left" colspan="1" rowspan="1">Evaluation of chemoresistance</td>
<td align="left" colspan="1" rowspan="1">[<a href="#CR105" class="usa-link" aria-describedby="CR105">105</a>]</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Nasopharyngeal carcinoma</td>
<td align="left" colspan="1" rowspan="1">MDR1</td>
<td align="left" colspan="1" rowspan="1">Upregulation</td>
<td align="left" colspan="1" rowspan="1">Evaluation of chemoresistance</td>
<td align="left" colspan="1" rowspan="1">[<a href="#CR108" class="usa-link" aria-describedby="CR108">108</a>]</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Glioblastoma</td>
<td align="left" colspan="1" rowspan="1">miR-25-3p</td>
<td align="left" colspan="1" rowspan="1">Upregulation</td>
<td align="left" colspan="1" rowspan="1">Evaluation of chemoresistance</td>
<td align="left" colspan="1" rowspan="1">[<a href="#CR109" class="usa-link" aria-describedby="CR109">109</a>]</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Breast cancer</td>
<td align="left" colspan="1" rowspan="1">HOTAIR</td>
<td align="left" colspan="1" rowspan="1">Upregulation</td>
<td align="left" colspan="1" rowspan="1">Evaluation of chemoresistance</td>
<td align="left" colspan="1" rowspan="1">[<a href="#CR110" class="usa-link" aria-describedby="CR110">110</a>]</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Hepatocellular carcinoma</td>
<td align="left" colspan="1" rowspan="1">miR-26a</td>
<td align="left" colspan="1" rowspan="1">Upregulation</td>
<td align="left" colspan="1" rowspan="1">Evaluation of tumor prognosis</td>
<td align="left" colspan="1" rowspan="1">[<a href="#CR112" class="usa-link" aria-describedby="CR112">112</a>]</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">HR+/HER2-breast cancer</td>
<td align="left" colspan="1" rowspan="1">UTEGs (PDPK1, WSB2, PIR, MTHFD2)</td>
<td align="left" colspan="1" rowspan="1">Upregulation</td>
<td align="left" colspan="1" rowspan="1">Evaluation of tumor prognosis</td>
<td align="left" colspan="1" rowspan="1">[<a href="#CR113" class="usa-link" aria-describedby="CR113">113</a>]</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Hepatocellular carcinoma</td>
<td align="left" colspan="1" rowspan="1">DEG_FTCD</td>
<td align="left" colspan="1" rowspan="1">Downregulation</td>
<td align="left" colspan="1" rowspan="1">Evaluation of tumor prognosis</td>
<td align="left" colspan="1" rowspan="1">[<a href="#CR114" class="usa-link" aria-describedby="CR114">114</a>]</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Breast cancer</td>
<td align="left" colspan="1" rowspan="1">lncRNA-MIR193BHG</td>
<td align="left" colspan="1" rowspan="1">Upregulation</td>
<td align="left" colspan="1" rowspan="1">Evaluation of tumor prognosis</td>
<td align="left" colspan="1" rowspan="1">[<a href="#CR116" class="usa-link" aria-describedby="CR116">116</a>]</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Pancreatic cancer</td>
<td align="left" colspan="1" rowspan="1">lncXIST</td>
<td align="left" colspan="1" rowspan="1">Upregulation</td>
<td align="left" colspan="1" rowspan="1">Evaluation of tumor prognosis</td>
<td align="left" colspan="1" rowspan="1">[<a href="#CR117" class="usa-link" aria-describedby="CR117">117</a>]</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Pancreatic cancer</td>
<td align="left" colspan="1" rowspan="1">miR-203a-3p</td>
<td align="left" colspan="1" rowspan="1">Upregulation</td>
<td align="left" colspan="1" rowspan="1">Evaluation of tumor prognosis</td>
<td align="left" colspan="1" rowspan="1">[<a href="#CR118" class="usa-link" aria-describedby="CR118">118</a>]</td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/Tab2/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div></section><section id="Sec14"><h3 class="pmc_sec_title">TEXs in the diagnosis of tumors</h3>
<p id="Par96">TEXs can exhibit the genetic or phenotypic alterations of cancer cells. Thus, TEXs can serve as potential biomarkers for the diagnosis of tumors [<a href="#CR86" class="usa-link" aria-describedby="CR86">86</a>]. The surface proteins of TEXs can serve as tumor markers. Specifically, proteins such as CLDN4, EPCAM, CD151, LGALS3BP, HIST2H2BE and HIST2H2BF on TEXs have been identified as markers for the diagnosis of pancreatic ductal adenocarcinoma [<a href="#CR86" class="usa-link" aria-describedby="CR86">86</a>, <a href="#CR87" class="usa-link" aria-describedby="CR87">87</a>]. In ovarian cancer, CA125, HE4 and C5a on TEXs are expressed higher in malignant cases compared to benign ones. The combination of exosomal CA125, HE4 and C5a shows enhanced sensitivity and specificity for differential diagnosis of ovarian tumors [<a href="#CR88" class="usa-link" aria-describedby="CR88">88</a>]. RNAs, the content of TEXs, can also serve as tumor markers. For example, studies have found miR-1281 is highly expressed in the exosomes derived from the cell lines of ovarian clear cell carcinoma (the HAC-2 and OVAS cell lines) as well as the cell line of endometrioid carcinoma (the TOV-112D cell line). Additionally, miR-21, miR-29 and miR-30 are overexpressed in exosomes from ovarian clear cell carcinoma, which symbolizes the development and progression of endometriosis-derived tumors [<a href="#CR89" class="usa-link" aria-describedby="CR89">89</a>, <a href="#CR90" class="usa-link" aria-describedby="CR90">90</a>]. hsa-miR-21-5p is up-regulated in BC cells and their exosomes, which can be used as a biomarker for BC diagnosis [<a href="#CR91" class="usa-link" aria-describedby="CR91">91</a>].</p></section><section id="Sec15"><h3 class="pmc_sec_title">TEXs in the determination of tumor subtypes and stages</h3>
<p id="Par97">TEXs carry representative cargos of tumors. Genomic and proteomic scanning and analysis of TEXs enable the determination of subtypes and stages of tumors. The exosome marker CD63 and the tumor marker EpCAM protein are expressed and coexist on the surface of most TEXs. A method utilizes two allosteric aptamers targeting CD63 and EpCAM to create orthogonal labeling barcodes, thus facilitating the selection of tumor cell-derived exosomes. The analysis of the miRNAs (miR-222, miR-1290, miR-182, miR-21, miR-221 and miR-10b) in tumor cell-derived exosomes can differentiate prostate cancer (PCa) and benign prostatic hyperplasia, which can also differentiate metastatic and nonmetastatic PCa [<a href="#CR92" class="usa-link" aria-describedby="CR92">92</a>]. The miR-375 in exosomes from the MCF-7 breast cancer cell line can be used to differentiate the ER-positive (ER+) luminal subtype, HER-2-positive (HER-2+) subtype and triple-negative subtype based on a newly developed electrochemical system [<a href="#CR93" class="usa-link" aria-describedby="CR93">93</a>]. Breast tumor cell-derived exosomes are enriched in sphingolipids and glycerophospholipids. Based on these relevant lipid species including PE(14:0_16:0) [M−H]−, PE(O‐18:2_22:6) [M−H]−, PE(O‐16:1/16:1) [M−H]−, PC(O‐20:0_22:2) [M+H]+ and PI(18:0_18:1) [M−H]−, we can discriminate tumors between benign tumors and malignant tumors. Advanced tumor node metastasis (TNM) stage is related to elevated levels of circATP8A1 in exosomes from gastric cancer cells [<a href="#CR94" class="usa-link" aria-describedby="CR94">94</a>]. We can also differentiate breast cancer subtypes based on the lipid composition of TEXs [<a href="#CR95" class="usa-link" aria-describedby="CR95">95</a>]. In mouse experiments, glycan analysis of CRC-derived exosomes revealed that the lectin UEA-I can serve as a biomarker for SW480 CRC subtype diagnosis and dynamic monitoring of SW480 tumor progression [<a href="#CR96" class="usa-link" aria-describedby="CR96">96</a>]. Cao et al. designed biomimetic vesicles using breast cancer cell membranes. They can fuse with breast cancer cell-derived exosomes with phenotypic homology, which enables stage-specific monitoring of breast cancer [<a href="#CR93" class="usa-link" aria-describedby="CR93">93</a>]. In conclusion, TEXs show potential in the application for the determination of tumor subtypes and stages.</p></section><section id="Sec16"><h3 class="pmc_sec_title">TEXs in the evaluation of chemoresistance</h3>
<p id="Par98">Protein and RNA profiles of TEXs can predict tumor response to treatments, reflecting drug sensitivity or resistance of tumors [<a href="#CR97" class="usa-link" aria-describedby="CR97">97</a>, <a href="#CR98" class="usa-link" aria-describedby="CR98">98</a>]. Chemotherapy promotes BC cells to secrete chemotherapy-elicited exosomes enriched in miR-378a-3p and miR-378d. These exosomes are absorbed by chemotherapy-surviving BC cells, resulting in drug resistance. Therefore, exosomal miR-378a-3p and miR-378d are potential biomarkers for chemotherapy resistance in breast cancer patients [<a href="#CR99" class="usa-link" aria-describedby="CR99">99</a>]. Exosomal miR-99a-5p and miR-125b-5p from chemotherapy-resistant calls of diffuse large B-cell lymphoma (DLBCL) are significantly higher than those from sensitive cells. Thus, these exosomal miRNAs can serve as biomarkers for evaluating chemotherapy resistance [<a href="#CR100" class="usa-link" aria-describedby="CR100">100</a>]. Similarly, high expression of miR-891-5p in exosomes from ovarian cancer cells is associated with platinum resistance and recurrence, making exosomal miR-891-5p a potential biomarker for platinum resistance [<a href="#CR76" class="usa-link" aria-describedby="CR76">76</a>, <a href="#CR101" class="usa-link" aria-describedby="CR101">101</a>, <a href="#CR102" class="usa-link" aria-describedby="CR102">102</a>]. Furthermore, overexpression of exosomal miR-6836 from epithelial ovarian cancer cells promotes cisplatin resistance, indicating exosomal miR-6836 potential as a biomarker for cisplatin resistance [<a href="#CR103" class="usa-link" aria-describedby="CR103">103</a>]. On the contrary, cervical cancer-derived exosomes carry miR-651 to target ATG3 and then inhibit cisplatin resistance. The downregulation of miR-651 expression indicates cisplatin resistance in cervical cancer [<a href="#CR104" class="usa-link" aria-describedby="CR104">104</a>]. The downregulation of miR-6836-5p expression in exosomes from NSCLC cells via the MSTRG.292666.16-miR-6836-5p-MAPK8IP3 axis promotes osimertinib resistance [<a href="#CR105" class="usa-link" aria-describedby="CR105">105</a>]. Additionally, NSCLC cell-derived exosomes carry circRNA_102481 to enhance EGFR-TKI resistance via the microRNA-30a-5p/ROR1 axis [<a href="#CR106" class="usa-link" aria-describedby="CR106">106</a>]. DDX3 regulates the secretion and the miRNA content of exosomes from HCC cells to affect the drug resistance of HCC [<a href="#CR107" class="usa-link" aria-describedby="CR107">107</a>]. Exosomes from Taxol-resistant nasopharyngeal carcinoma (NPC) can transfer DDX53 to normal NPC cells. DDX53 upregulates the expression of MDR1 in NPC cells, thus promoting paclitaxel resistance of NPC cells [<a href="#CR108" class="usa-link" aria-describedby="CR108">108</a>]. miR-25-3p is highly expressed in exosomes derived from glioblastoma (GBM) cells treated with TMZ. miR-25-3p promotes GBM cell proliferation as well as TMZ resistance by targeting FBXW7 [<a href="#CR109" class="usa-link" aria-describedby="CR109">109</a>]. Tang et al. discovered that high expression of HOTAIR in breast cancer-derived exosomes is related to poor response to neoadjuvant chemotherapy and tamoxifen [<a href="#CR110" class="usa-link" aria-describedby="CR110">110</a>]. CRC-derived exosomes carry miR-208b to promote Treg expansion by targeting PDCD4, leading to tumor growth and resistance to oxaliplatin. Thus, exosomal miR-208b can serve as an oxaliplatin treatment response indicator [<a href="#CR111" class="usa-link" aria-describedby="CR111">111</a>]. In conclusion, monitoring the molecular expression levels of TEXs helps to assess chemoresistance.</p></section><section id="Sec17"><h3 class="pmc_sec_title">TEXs in the evaluation of tumor prognosis</h3>
<p id="Par99">HCC-derived exosomes carry miR-26a to effectively inhibit the progression of HCC both in vitro and in vivo. HCC patients with high expression of miR-26a in exosomes have a favorable prognosis. Therefore, miR-26a can be a non-invasive prognostic marker for HCC patients [<a href="#CR112" class="usa-link" aria-describedby="CR112">112</a>]. Zhou et al. identified differentially expressed genes (DEGs) in HR+/HER2-breast cancer-derived exosomes. Among these, 315 upregulated tumor-derived exosome genes (UTEGs) are used to classify HR+/HER2-breast cancers into two categories, revealing a difference in survival rates between the groups. They developed a predictive model for breast cancer patients based on the expression of four UTEGs (PDPK1, WSB2, PIR, MTHFD2). The high expression of four UTEGs significantly shortens the distant relapse-free survival (DRFS), which is related to poor prognosis. This model can determine tumor subtypes, predict the efficacy of chemotherapy and endocrine therapy as well as provide prognostic insights [<a href="#CR113" class="usa-link" aria-describedby="CR113">113</a>]. Additionally, the DEG_FTCD in HCC cell-derived exosomes stimulates macrophage polarization towards the M1 phenotype, thereby inhibiting HCC cell proliferation. Low expression of FTCD is associated with a poor prognosis in HCC [<a href="#CR114" class="usa-link" aria-describedby="CR114">114</a>]. Real-time quantitative PCR results show the different expression of lncRNA in exosomes from normal ovarian epithelial cells and ovarian cancer (OC) cells. Cui et al. established an exosome-related lncRNA signature (ERLS) model for OC. Patients are stratified into high-risk and low-risk groups based on the model. The combination of the ERLS score with PDL1 or CTLA4 expression can predict prognosis. Patients with low expression of PDL1 or low expression of CTLA4 and a high ERLS score have the poorest survival rates, while those with low expression of PDL1 or high expression of CTLA4 and a low ERLS score have a better prognosis [<a href="#CR115" class="usa-link" aria-describedby="CR115">115</a>]. Thus, the ERLS model can assist in predicting the prognosis.</p>
<p id="Par100">The migratory potential of TEXs is related to metastasis and recurrence, which leads to poor prognosis. LncRNA-MIR193BHG is highly expressed in exosomes from breast cancer cells. Exosomal lncRNA-MIR193BHG is delivered to osteoclasts, thus promoting bone metastasis and recurrence of breast cancer by targeting the miR-489-3p/DNMT3A signaling axis in osteoclasts. Therefore, lncRNA-MIR193BHG is a promising biomarker for metastasis and recurrence of breast cancer [<a href="#CR116" class="usa-link" aria-describedby="CR116">116</a>]. Perineural invasion (PNI), a mode of metastasis for various malignant tumors, is related to pancreatic cancer recurrence. LncXIST is highly expressed in exosomes derived from pancreatic cancer cells. Exosomal lncXIST is delivered to neural cells and promotes their secretion of GDNF (glial cell line-derived neurotrophic factor). GDNF can promote PNI, thereby inducing metastasis and recurrence of pancreatic cancer. Therefore, lncXIST is a promising biomarker for metastasis and recurrence of pancreatic cancer [<a href="#CR117" class="usa-link" aria-describedby="CR117">117</a>]. miR-203a-3p is highly expressed in exosomes derived from pancreatic cancer cells to potentiate muscle wasting by inducing muscle ferroptosis, which leads to poor prognosis. Therefore the miR-203a-3p can be a biomarker to evaluate the prognosis of pancreatic cancer [<a href="#CR118" class="usa-link" aria-describedby="CR118">118</a>]. The TEX/total sEV ratio in plasma is proved to be the most effective biomarker for distinguishing between patients with recurrence and those who remained disease-free. In a phase I clinical trial (<a href="https://clinicaltrials.gov/ct2/show/NCT01935921" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NCT01935921</a>), the molecular profiling of sEV subsets is continuously monitored in a small group of patients with recurrent/metastatic HNSCC who are treated with cetuximab, IMRT and ipilimumab. The study reveals that patients with early recurrence have higher total sEV levels during and after immunoradiotherapy as well as a higher TEX/total sEV ratio [<a href="#CR119" class="usa-link" aria-describedby="CR119">119</a>, <a href="#CR120" class="usa-link" aria-describedby="CR120">120</a>]. Additionally, TEXs can be label-free characterized through FTIR spectroscopy to unveil changes in the cellular phenotype. This research unveils a set of effective spectral biomarkers that can monitor tumor metastasis [<a href="#CR121" class="usa-link" aria-describedby="CR121">121</a>].</p></section><section id="Sec18"><h3 class="pmc_sec_title">TEXs as predictors of targeted/immune-therapy outcomes</h3>
<p id="Par101">TEXs can serve as predictors of targeted/immune-therapy outcomes in cancer patients. A key mechanism involves the detection of specific biomarkers carried by TEXs, which correlate with treatment efficacy. TEXs carry PD-L1 on their surface, which has immunosuppressive properties by inhibiting T-cell activation, thus we can predict clinical outcomes by tracking the secretion levels of exosomal PD-L1. Immune checkpoint inhibitor (ICI) therapies designed to block checkpoint proteins (PD-L1) are an important immunotherapy. The high level of PD-L1-TEXs at initial diagnosis is associated with poor overall survival of osteosarcoma patients [<a href="#CR122" class="usa-link" aria-describedby="CR122">122</a>]. In the therapy of signet ring cell carcinoma with the ICI plus XELOX (oxaliplatin and capecitabine), the patients expressing low exosomal PD-L1 or lactate in peripheral blood plasma before treatment initiation demonstrated a significantly increased objective response rate (ORR) and prolonged progression-free survival (PFS) compared to that with high exosomal PD-L1 or lactate. Thus, the levels of exosomal PD-L1 and lactate can predict the clinical outcomes of ICI plus XELOX. In addition, the levels of PD-L1 and lactate in exosomes associate with Treg cells and CD8 T-cells, leading to different clinical outcomes of ICI plus XELOX [<a href="#CR123" class="usa-link" aria-describedby="CR123">123</a>]. Exosomal PD-L1 from NSCLC cells can be predictors for treatment response and survival in NSCLC patients undergoing treatment with ICIs [<a href="#CR124" class="usa-link" aria-describedby="CR124">124</a>]. MDA-MB-231 cells (breast cancer cells)-derived exosomes highly express PD-L1. The secretion levels of PD-L1-TEXs are positively correlated with tumor cell viability. While the ICI treatment time increases, PD-L1-TEXs decrease. Thus PD-L1-TEXs can be predictors of ICI treatment effects [<a href="#CR125" class="usa-link" aria-describedby="CR125">125</a>]. Exosomal PD-L1 from NSCLC cells show high sensitivity and specificity for identifying non-responders to ICIs in NSCLC patients [<a href="#CR126" class="usa-link" aria-describedby="CR126">126</a>]. In addition, exosomes from JeKo-1 mantle cell lymphoma cells carry DOK3, which can predict the long-term efficacy of gefitinib in lung tumors [<a href="#CR127" class="usa-link" aria-describedby="CR127">127</a>]. Exosomes from HER2+ BC cells carry HER2. Jia et al. constructed a HER2+ exosome capture detection system (HER2-MEDN) to extract and detect HER2-TEXs, which can predict treatment response [<a href="#CR128" class="usa-link" aria-describedby="CR128">128</a>].</p></section></section><section id="Sec19"><h2 class="pmc_sec_title">Application of TEXs in tumor therapy (Fig. <a href="#Fig3" class="usa-link">3</a>)</h2>
<figure class="fig xbox font-sm" id="Fig3"><h3 class="obj_head">Fig. 3.</h3>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12362945_12967_2025_6883_Fig3_HTML.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bc16/12362945/3da5615dba9b/12967_2025_6883_Fig3_HTML.jpg" loading="lazy" id="MO3" height="777" width="777" alt="Fig. 3"></a></p>
<div class="p text-right font-secondary"><a href="figure/Fig3/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Application of TEXs in tumor therapy. TEXs can serve as excellent delivery carriers to enhance the efficacy of drugs due to their good biocompatibility, low toxicity, low immunogenicity, high safety and favorable stability. In addition, TEXs and the molecules in the exosomes can be utilized as therapeutic targets to develop new low-toxicity inhibitors. What’s more, TEXs can be developed into tumor vaccines to activate anti-tumor immune efficacy and hinder tumor progression. (Created in BioRender)</p></figcaption></figure><section id="Sec20"><h3 class="pmc_sec_title">TEXs as potential targets</h3>
<p id="Par102">TEXs can promote tumor metastasis and progression. Therefore, preventing tumor metastasis and progression requires targeting TEXs through reduced biogenesis/release, clearance of circulating vesicles, blockade of cellular uptake, and suppression of drug-resistance molecules [<a href="#CR129" class="usa-link" aria-describedby="CR129">129</a>]. Currently, numerous therapeutic targets have been identified based on these mechanisms. Some exosome inhibitors based on these targets have been applied in clinical settings.</p>
<p id="Par103">Inhibiting the transfer of TEXs carrying drug resistance molecules can reverse chemotherapy resistance. For example, exosomes from CRC with multi-drug resistance (MDR), specifically exosomes with circ_0001610, fuse with chemotherapy-sensitive cells and confer the drug-resistant phenotype to the chemotherapy-sensitive cells. Inhibiting the transfer of TEXs can prevent the spread of MDR, thereby enhancing chemotherapy sensitivity [<a href="#CR130" class="usa-link" aria-describedby="CR130">130</a>]. Injecting exo-circ_0001610 inhibitors into mice makes tumors more sensitive to oxaliplatin [<a href="#CR131" class="usa-link" aria-describedby="CR131">131</a>]. Additionally, experimental evidence suggests that combining chemotherapy drugs with exosome inhibitors yields better therapeutic outcomes. For example, hsa-miR-101-3p, which shows an oncogenic nature, is expressed in exosomes from CRC cell lines. The efficacy of CRC is significantly improved when 5-FU is used synergistically with a hsa-miR-101-3p inhibitor compared to 5-FU alone [<a href="#CR132" class="usa-link" aria-describedby="CR132">132</a>]. Tian et al. analyzed exosomes from 124 early-stage hepatocellular carcinoma patients who underwent surgical treatment. They found that the levels of miR-21 and miR-10b are closely related to tumor size, cell differentiation and recurrence. Exosomal miR-21 and miR-10b derived from HCC cells promote tumor proliferation and metastasis. They developed nanoparticles (PDCM-miR-21 and PDCM-miR-10b) that target exosomal miR-21 and miR-10b. These nanoparticles significantly inhibit tumor growth and reduce the number of metastatic lung nodules [<a href="#CR133" class="usa-link" aria-describedby="CR133">133</a>]. Lin et al. found that exosomal miR-4454 promotes HCC cell progression by targeting Vps4A and Rab27A. miR-4454 inhibitor significantly inhibits HCC cell proliferation, migration, invasion and angiogenesis while accelerates cycle arrest, apoptosis and reactive oxygen species (ROS) [<a href="#CR134" class="usa-link" aria-describedby="CR134">134</a>]. The mortality of BC ranks second among female tumors. The treatment of advanced BC is prone to develop doxorubicin resistance, thus leading to a poor prognosis. miR-181b-5p is highly expressed in exosomes from drug-resistant BC cells. Exosomes with miR-181b-5p fuse with recipient cells and confer the drug-resistant phenotype. Experiments in vivo have demonstrated that inhibitors of miR-181b-5p exhibit significant tumor control effects and reverse doxorubicin resistance [<a href="#CR135" class="usa-link" aria-describedby="CR135">135</a>]. CirmiR-20a-5p in triple-negative breast cancer cell-derived exosomes can induce CD8+ T cell dysfunction, thereby promoting cancer cell growth and immunosuppression. Inhibitors of cirmiR-20a-5p may overcome anti-PD-1 immunotherapy resistance in triple-negative breast cancer [<a href="#CR136" class="usa-link" aria-describedby="CR136">136</a>].</p></section><section id="Sec21"><h3 class="pmc_sec_title">
<strong><em>TEXs as delivery carriers (</em></strong>Table <a href="#Tab3" class="usa-link">3</a><strong><em>)</em></strong>
</h3>
<section class="tw xbox font-sm" id="Tab3"><h4 class="obj_head">Table 3.</h4>
<div class="caption p"><p>Tumor cell-derived exosomes as delivery carriers</p></div>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<thead><tr>
<th align="left" colspan="1" rowspan="1">Cells of origin</th>
<th align="left" colspan="1" rowspan="1">Cargos</th>
<th align="left" colspan="1" rowspan="1">Target cells</th>
<th align="left" colspan="1" rowspan="1">Effects</th>
<th align="left" colspan="1" rowspan="1">Refs.</th>
</tr></thead>
<tbody>
<tr>
<td align="left" colspan="1" rowspan="1">
<p>Lung adenocarcinoma</p>
<p>MDA-MB-231 cells</p>
</td>
<td align="left" colspan="1" rowspan="1">Doxorubicin</td>
<td align="left" colspan="1" rowspan="1">Cancer cells</td>
<td align="left" colspan="1" rowspan="1">Reduce the toxic side effects of doxorubicin on the body</td>
<td align="left" colspan="1" rowspan="1">[<a href="#CR142" class="usa-link" aria-describedby="CR142">142</a>]</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Glioma 261 cell line</td>
<td align="left" colspan="1" rowspan="1">DHT, TMZ</td>
<td align="left" colspan="1" rowspan="1">Glioma cells</td>
<td align="left" colspan="1" rowspan="1">Reduce TMZ resistance in gliomas</td>
<td align="left" colspan="1" rowspan="1">[<a href="#CR144" class="usa-link" aria-describedby="CR144">144</a>]</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Glioblastoma</td>
<td align="left" colspan="1" rowspan="1">Bevacizumab</td>
<td align="left" colspan="1" rowspan="1">Glioblastoma cells</td>
<td align="left" colspan="1" rowspan="1">Cross the blood-brain barrier to promote the apoptosis of tumor cells</td>
<td align="left" colspan="1" rowspan="1">[<a href="#CR145" class="usa-link" aria-describedby="CR145">145</a>]</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Metastatic breast cancer 4T1 cells</td>
<td align="left" colspan="1" rowspan="1">DDL/DOX</td>
<td align="left" colspan="1" rowspan="1">Breast cancer cells</td>
<td align="left" colspan="1" rowspan="1">Prevent the elimination of DDL/DOX and enhance their therapeutic efficacy</td>
<td align="left" colspan="1" rowspan="1">[<a href="#CR146" class="usa-link" aria-describedby="CR146">146</a>]</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">CRC</td>
<td align="left" colspan="1" rowspan="1">siRNAs</td>
<td align="left" colspan="1" rowspan="1">CRC cells</td>
<td align="left" colspan="1" rowspan="1">Reverse chemoresistance and improve the chemotherapy effects</td>
<td align="left" colspan="1" rowspan="1">[<a href="#CR147" class="usa-link" aria-describedby="CR147">147</a>]</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">PDAC</td>
<td align="left" colspan="1" rowspan="1">Dasatinib</td>
<td align="left" colspan="1" rowspan="1">Tumor cells</td>
<td align="left" colspan="1" rowspan="1">Increase toxicity to tumor cells</td>
<td align="left" colspan="1" rowspan="1">[<a href="#CR151" class="usa-link" aria-describedby="CR151">151</a>]</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Ovarian cancer</td>
<td align="left" colspan="1" rowspan="1">miR497, TP</td>
<td align="left" colspan="1" rowspan="1">Ovarian cancer cells</td>
<td align="left" colspan="1" rowspan="1">Inhibit cisplatin resistance and eliminate tumor cells</td>
<td align="left" colspan="1" rowspan="1">[<a href="#CR149" class="usa-link" aria-describedby="CR149">149</a>]</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Glioblastoma</td>
<td align="left" colspan="1" rowspan="1">TMZ, siRNAs</td>
<td align="left" colspan="1" rowspan="1">Mesenchymal-glioblastoma cells</td>
<td align="left" colspan="1" rowspan="1">Reverse TMZ resistance</td>
<td align="left" colspan="1" rowspan="1">[<a href="#CR154" class="usa-link" aria-describedby="CR154">154</a>]</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Mouse colon cancer cells</td>
<td align="left" colspan="1" rowspan="1">miR-34a</td>
<td align="left" colspan="1" rowspan="1">CRC cells</td>
<td align="left" colspan="1" rowspan="1">Decrease the viability and migration while increase the apoptosis of tumor cells</td>
<td align="left" colspan="1" rowspan="1">[<a href="#CR155" class="usa-link" aria-describedby="CR155">155</a>]</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Mouse breast cancer cells</td>
<td align="left" colspan="1" rowspan="1">antilymphocyte activation gene-3 inhibitory antibody, IR806, IL-2 mRNA</td>
<td align="left" colspan="1" rowspan="1">Breast cancer cells</td>
<td align="left" colspan="1" rowspan="1">Treat the triple-negative breast cancer</td>
<td align="left" colspan="1" rowspan="1">[<a href="#CR156" class="usa-link" aria-describedby="CR156">156</a>]</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Topotecan-treated breast cancer</td>
<td align="left" colspan="1" rowspan="1">DNA fragments (&lt; 2 kbp)</td>
<td align="left" colspan="1" rowspan="1">DCs</td>
<td align="left" colspan="1" rowspan="1">Reinforce anti-tumor immunity</td>
<td align="left" colspan="1" rowspan="1">[<a href="#CR157" class="usa-link" aria-describedby="CR157">157</a>]</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Osteosarcoma</td>
<td align="left" colspan="1" rowspan="1">lncRNA MEG3</td>
<td align="left" colspan="1" rowspan="1">Osteosarcoma cells</td>
<td align="left" colspan="1" rowspan="1">Promote the apoptosis of osteosarcoma cells</td>
<td align="left" colspan="1" rowspan="1">[<a href="#CR158" class="usa-link" aria-describedby="CR158">158</a>]</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Murine melanoma</td>
<td align="left" colspan="1" rowspan="1">CRISPR/Cas9</td>
<td align="left" colspan="1" rowspan="1">Gene YTHDF1 in tumor cells</td>
<td align="left" colspan="1" rowspan="1">Restore tumor immune surveillance</td>
<td align="left" colspan="1" rowspan="1">[<a href="#CR159" class="usa-link" aria-describedby="CR159">159</a>]</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Ovarian cancer</td>
<td align="left" colspan="1" rowspan="1">CRISPR/Cas9</td>
<td align="left" colspan="1" rowspan="1">Gene PARP-1 in tumor cells</td>
<td align="left" colspan="1" rowspan="1">Induce the apoptosis of tumor cells, enhance the chemical sensitivity and synergistic cytotoxicity of cisplatin</td>
<td align="left" colspan="1" rowspan="1">[<a href="#CR160" class="usa-link" aria-describedby="CR160">160</a>]</td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/Tab3/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div></section><p id="Par104">Anti-tumor drugs generally have poor stability, low solubility and a short half-life [<a href="#CR137" class="usa-link" aria-describedby="CR137">137</a>]. Exosomes, which obtain the advantages of low toxicity, high biocompatibility, targeted delivery, high production and small particle size, are potential candidates for drug delivery [<a href="#CR138" class="usa-link" aria-describedby="CR138">138</a>, <a href="#CR139" class="usa-link" aria-describedby="CR139">139</a>]. Additionally, exosomes encapsulating anticancer drugs can effectively prevent cellular drug resistance, thereby enhancing drug efficacy. Specially, compared to exosomes derived from other types of cells, TEXs contain proteins and lipids similar to their parental cells and preferentially fuse with parental cells, resulting in higher targeting specificity and drug accumulation in tumor cells [<a href="#CR112" class="usa-link" aria-describedby="CR112">112</a>, <a href="#CR140" class="usa-link" aria-describedby="CR140">140</a>]. TEXs show significant potential in drug carriers, gene-editing tool carriers and the creation of hybrid exosomes.</p>
<section id="Sec22"><h4 class="pmc_sec_title">TEXs as drug carriers</h4>
<p id="Par105">TEXs solve the problem of poor efficacy caused by the low solubility of tumor drugs. For example, the first-line antineoplastic agent DTX exhibits poor efficacy due to low solubility in NSCLC. Wang et al. encapsulated DTX into TEXs to create EXO-DTX. It is shown that EXO-DTX significantly inhibits the proliferation of A549 cancer cells in vitro while promotes cytotoxicity in vivo. Furthermore, EXO-DTX promotes cell apoptosis, induces G2/M phase cell cycle arrest and increases ROS, thus exhibiting anti-cancer effects in vitro. Experimental results in vivo showed that EXO-DTX releases DTX more slowly than free DTX, leading to higher drug efficacy [<a href="#CR141" class="usa-link" aria-describedby="CR141">141</a>]. Drug delivery via TEXs can also reduce the toxic side effects of drugs on the body. For example, a drug-targeting delivery system based on exosomes from lung adenocarcinoma MDA-MB-231 cells and doxorubicin (DOX) has been shown to reduce DOX-induced cardiotoxicity [<a href="#CR142" class="usa-link" aria-describedby="CR142">142</a>]. The Exo-SPIONs are developed by combining superparamagnetic iron oxide nanoparticles (SPIONs) with NSCLC cell-derived exosomes, which is a “dual-targeting” anti-cancer drug delivery platform. The Exo-SPIONs encapsulated with DOX are optimal for drug delivery to tumor tissue, which promotes tumor suppression as well as reduces the toxicity of the DOX to normal tissues [<a href="#CR143" class="usa-link" aria-describedby="CR143">143</a>]. The R-EXO-T/D for glioma therapy is developed from the GL261 cell line-derived exosomes encapsulated with TMZ and dihydrotanshinone (DHT). The R-EXO-T/D addresses TMZ resistance in gliomas and shows good antitumor efficacy both in vitro and in vivo. Therefore, the R-EXO-T/D is a potential drug delivery system for glioma therapy [<a href="#CR144" class="usa-link" aria-describedby="CR144">144</a>]. The exosomes from glioblastoma deliver bevacizumab to cross the blood–brain barrier, thereby increasing the apoptosis of tumor cells and significantly prolonging the survival time of the model animals [<a href="#CR145" class="usa-link" aria-describedby="CR145">145</a>]. Exosomes derived from metastatic breast cancer 4T1 cells are used as drug carriers in animal experiments. In this study, TEXs encapsulated with DDL/DOX can prevent the elimination of therapeutic drugs, enhance the therapeutic efficacy of DDL/DOX, reduce liver injury caused by DDL and inhibit lung metastasis of BC. Furthermore, results showed this exosome drug carrier produces similar outcomes in humans [<a href="#CR146" class="usa-link" aria-describedby="CR146">146</a>]. CRC cell-derived exosomes deliver siRNAs to silence coiled-coil domain-containing protein 80 (CCDC80) which is a protein associated with drug resistance and metastasis. The results showed that these TEXs significantly reverse chemoresistance, improve the chemotherapy effect and reduce CRC liver metastasis [<a href="#CR147" class="usa-link" aria-describedby="CR147">147</a>]. Human colorectal cancer HCT116 cell-derived exosomes loaded with DOX and the photodynamic therapy agent 5-aminolevulinic acid (ALA) can pre-target PET/CT imaging to monitor drug delivery [<a href="#CR148" class="usa-link" aria-describedby="CR148">148</a>].</p></section><section id="Sec23"><h4 class="pmc_sec_title">Hybrid TEXs as drug carriers</h4>
<p id="Par106">Research on hybrid exosomes is ongoing in recent years. Hybrid exosomes are developed from the fusion of exosomes and liposomes, which deliver drugs in tumor therapy. They obtain the advantages of both liposomes and exosomes, including low toxicity, high targeting specificity, evasion from the clearance of mononuclear phagocytic system (MPS) and a long circulation half-life. Therefore, hybrid exosomes can overcome chemotherapy resistance and enhance drug delivery efficiency [<a href="#CR149" class="usa-link" aria-describedby="CR149">149</a>, <a href="#CR150" class="usa-link" aria-describedby="CR150">150</a>].</p>
<p id="Par107">Hybrid TEXs enhance the anti-tumor activity of drugs. For example, hybrid TEXs are developed from the fusion of PDAC-derived exosomes with dasatinib-loaded liposomes. The study indicated a rank of tumor cell toxicity: dasatinib hybrid exosomes &gt; dasatinib liposomes &gt; dasatinib alone. Furthermore, hybrid exosomes loaded with dasatinib also exhibit higher drug uptake-rates to parental PDAC cells [<a href="#CR151" class="usa-link" aria-describedby="CR151">151</a>]. Hybrid TEXs can overcome chemotherapy resistance. Cisplatin resistance is a big challenge for ovarian cancer (OC) therapy. The overexpression of miR497 in OC cell-derived exosomes may overcome OC chemotherapy resistance. The hybrid exosomes miR497/TP-HENPs are generated from the fusion of OC cell-derived exosomes with TP-loaded liposomes, which can co-deliver miR497 and TP. These hybrid TEXs inhibit cisplatin resistance and eliminate tumor cells by blocking the PI3K/AKT/mTOR signaling pathway in OC cells, reducing intracellular glutathione levels, increasing ROS and upregulating the M1 macrophage polarization pathway [<a href="#CR149" class="usa-link" aria-describedby="CR149">149</a>]. Additionally, hybrid TEXs can reduce the toxic side effects of drugs and tumor metastasis. Compared to free DOX, TEXs fused with long-circulating and pH-sensitive liposomes that are loaded with DOX are less toxic in animal experiments, which also reduces the number of lung metastasis lesions [<a href="#CR152" class="usa-link" aria-describedby="CR152">152</a>]. Hybrid TEXs also significantly improve drug solubility. For example, TEXs loaded with thalidomide (THD) fuse with liposomes to deliver THD. The hybrid exosomes show improved drug solubility, optimized drug targeting efficiency and inhibition of the Treg proliferation [<a href="#CR153" class="usa-link" aria-describedby="CR153">153</a>].</p></section><section id="Sec24"><h4 class="pmc_sec_title">TEXs as genetic therapy carriers</h4>
<p id="Par108">TEXs can deliver nucleic acid molecules (siRNA, miRNA, mRNA, DNA and lncRNA) for tumor therapy. VPS28G and RASGRP1 genes are related to the promotion of TMZ resistance via RAS-GDP to RAS-GTP transformation and TMZ efflux. Glioblastoma cell-derived exosomes deliver TMZ and siRNAs which target VPS28G and RASGRP1 genes to reverse TMZ resistance in the mesenchymal-glioblastoma subtype [<a href="#CR154" class="usa-link" aria-describedby="CR154">154</a>]. miR-34a is a tumor suppressor gene. TEXs from the mouse colon cancer cell line CT-26 in starved condition can deliver miR-34a to CRC cells, which decreases the viability and migration while increases the apoptosis of tumor cells [<a href="#CR155" class="usa-link" aria-describedby="CR155">155</a>]. Exosomes from the mouse breast cancer cell line EMT6 are developed as the exosome platform, which can co-deliver IL-2 mRNA, the photothermal agent IR806 and antilymphocyte activation gene-3 inhibitory antibody for the treatment of triple-negative breast cancer [<a href="#CR156" class="usa-link" aria-describedby="CR156">156</a>]. Exosomes from the topotecan-treated breast cancer cells functionally deliver DNA fragments (&lt; 2 kbp) into the cytoplasm of GM-CSF-induced DCs to activate a STING-dependent pathway, thus reinforcing anti-tumor immunity [<a href="#CR157" class="usa-link" aria-describedby="CR157">157</a>]. Long non-coding RNA maternally expressed gene 3 (lncRNA MEG3) obtains anti-tumor properties. Osteosarcoma cell-derived exosomes deliver lncRNA MEG3 to osteosarcoma cells, which inhibits proliferation and migration while promotes the apoptosis of osteosarcoma cells [<a href="#CR158" class="usa-link" aria-describedby="CR158">158</a>]. Additionally, TEXs can deliver CRISPR/Cas9 for targeted gene therapy. The CRISPR/Cas9 system is a gene-editing tool. TEXs can bypass tumor defense, which thus can be extremely effective carriers to be applied in CRISPR/Cas9-based tumor therapy. The tumor-intrinsic gene YTHDF1 promotes tumor immune evasion and resistance to immune checkpoint inhibitors. Murine melanoma B16-F10 cell-derived exosomes deliver CRISPR/Cas9 to specifically deplete YTHDF1 in vivo, thus restoring tumor immune surveillance [<a href="#CR159" class="usa-link" aria-describedby="CR159">159</a>]. Poly(ADP-ribose) polymerase-1 (PARP-1) is one of the targets for tumor therapy. Ovarian cancer cell-derived exosomes deliver CRISPR/Cas9 to inhibit the expression of human locus PARP-1, which induces the apoptosis of ovarian cancer cells as well as enhances the chemical sensitivity and synergistic cytotoxicity of cisplatin [<a href="#CR160" class="usa-link" aria-describedby="CR160">160</a>].</p></section></section><section id="Sec25"><h3 class="pmc_sec_title">
<strong><em>TEXs as tumor vaccines (</em></strong>Table <a href="#Tab4" class="usa-link">4</a><strong><em>)</em></strong>
</h3>
<section class="tw xbox font-sm" id="Tab4"><h4 class="obj_head">Table 4.</h4>
<div class="caption p"><p>Tumor cell-derived exosomes as tumor vaccines</p></div>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<thead><tr>
<th align="left" colspan="1" rowspan="1">Cells of origin</th>
<th align="left" colspan="1" rowspan="1">Cargos</th>
<th align="left" colspan="1" rowspan="1">Cancer</th>
<th align="left" colspan="1" rowspan="1">Refs.</th>
</tr></thead>
<tbody>
<tr>
<td align="left" colspan="1" rowspan="1">Breast cancer</td>
<td align="left" colspan="1" rowspan="1">ELANE, Hiltonol</td>
<td align="left" colspan="1" rowspan="1">Increase anti-tumor immunity in breast cancer</td>
<td align="left" colspan="1" rowspan="1">[<a href="#CR168" class="usa-link" aria-describedby="CR168">168</a>]</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Breast cancer 4T1/Her2 cells</td>
<td align="left" colspan="1" rowspan="1">Two potent immune adjuvants (CpG ODN, p(I:C))</td>
<td align="left" colspan="1" rowspan="1">Regress tumor growth in tumor-bearing mice</td>
<td align="left" colspan="1" rowspan="1">[<a href="#CR169" class="usa-link" aria-describedby="CR169">169</a>]</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Mouse prostate cancer cells</td>
<td align="left" colspan="1" rowspan="1">Interferon-γ</td>
<td align="left" colspan="1" rowspan="1">Inhibit tumor growth</td>
<td align="left" colspan="1" rowspan="1">[<a href="#CR170" class="usa-link" aria-describedby="CR170">170</a>]</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Murine melanoma cells</td>
<td align="left" colspan="1" rowspan="1">A natural adjuvant (Akk-OMV)</td>
<td align="left" colspan="1" rowspan="1">Promote DC maturation and activate CTL response</td>
<td align="left" colspan="1" rowspan="1">[<a href="#CR172" class="usa-link" aria-describedby="CR172">172</a>]</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Mouse breast cancer cells</td>
<td align="left" colspan="1" rowspan="1">GM-CSF</td>
<td align="left" colspan="1" rowspan="1">Elicit tumor‐specific immune responses to kill cancer cells</td>
<td align="left" colspan="1" rowspan="1">[<a href="#CR174" class="usa-link" aria-describedby="CR174">174</a>]</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Colon cancer cells</td>
<td align="left" colspan="1" rowspan="1">GM-CSF</td>
<td align="left" colspan="1" rowspan="1">Elicit tumor‐specific immune responses to kill cancer cells</td>
<td align="left" colspan="1" rowspan="1">[<a href="#CR174" class="usa-link" aria-describedby="CR174">174</a>]</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Murine colorectal carcinoma cells</td>
<td align="left" colspan="1" rowspan="1">miR-124-3p</td>
<td align="left" colspan="1" rowspan="1">Inhibit tumor growth and increase median survival time</td>
<td align="left" colspan="1" rowspan="1">[<a href="#CR165" class="usa-link" aria-describedby="CR165">165</a>]</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Mouse melanoma B16BL6 cells</td>
<td align="left" colspan="1" rowspan="1">SAV</td>
<td align="left" colspan="1" rowspan="1">Exhibit a stronger anti-tumor effect</td>
<td align="left" colspan="1" rowspan="1">[<a href="#CR176" class="usa-link" aria-describedby="CR176">176</a>]</td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/Tab4/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div></section><p id="Par109">Currently, tumor vaccines often show poor clinical benefits. One of the main reasons for that is the poor immunogenicity of tumor antigens [<a href="#CR161" class="usa-link" aria-describedby="CR161">161</a>]. Nevertheless, TEXs carry a variety of tumor antigens and possess strong immunogenicity [<a href="#CR162" class="usa-link" aria-describedby="CR162">162</a>]. TEXs present tumor antigens from malignant cells to DCs as well as facilitate DCs to mature, ultimately stimulating a tumor-specific CTL response [<a href="#CR163" class="usa-link" aria-describedby="CR163">163</a>, <a href="#CR164" class="usa-link" aria-describedby="CR164">164</a>]. Moreover, TEXs present a more complete and enriched collection of tumor antigens than tumor lysate, thus contributing to the stimulation of a larger number of T cell clones [<a href="#CR165" class="usa-link" aria-describedby="CR165">165</a>]. TEXs serve as an ideal replacement repository of tumor antigens, which are promising to be developed highly effective and personalized tumor vaccines [<a href="#CR166" class="usa-link" aria-describedby="CR166">166</a>, <a href="#CR167" class="usa-link" aria-describedby="CR167">167</a>].</p>
<p id="Par110">Breast cancer cell-derived exosomes loaded with the ELANE (an immunogenic cell death inducer) and Hiltonol (TLR3 agonist) can serve as an in situ DC-primed vaccine, which enhances the antigen cross-presentation activity of cDC1s and induce potent CD8+ T cell responses in vitro to increase anti-tumor immunity in breast cancer [<a href="#CR168" class="usa-link" aria-describedby="CR168">168</a>]. Breast cancer 4T1/Her2 cell-derived exosomes loaded with two potent immune adjuvants such as CpG ODN and p(I:C) can serve as tumor vaccines, which can induce stronger humoral and cellular anti-tumor specific immune responses to regress tumor growth in tumor-bearing mice [<a href="#CR169" class="usa-link" aria-describedby="CR169">169</a>]. Exosomes from the mouse prostate cancer cell line RM-1 are modified by interferon-γ to formulate a novel exosomal vaccine. These exosomal vaccines promote M1 macrophage differentiation to engulf RM-1 cell-derived exosomes and induce the production of antibodies against RM-1 cell-derived exosomes, thus inhibiting tumor growth [<a href="#CR170" class="usa-link" aria-describedby="CR170">170</a>]. Exosomes from renal cell carcinoma cells act as tumor vaccines to promote the proliferation and activation of CD8+ T cells, which enhances anti-tumor immunity [<a href="#CR171" class="usa-link" aria-describedby="CR171">171</a>]. The Lipo@HEV is generated from the fusion of lipids and exosomes from murine melanoma cell line B16-F10. The Lipo@HEV loaded with a natural adjuvant (outer membrane vesicle from Akkermansia muciniphila, Akk-OMV) acts as a tumor vaccine to promote synergistic tumor immunotherapy by inducing memory T cells, promoting DC maturation and activating CTL response [<a href="#CR172" class="usa-link" aria-describedby="CR172">172</a>]. A hybrid nanovaccine is developed from the fusion of TEXs and DC membrane vesicles, which can elicit a robust T‐cell response for HNSCC therapy [<a href="#CR173" class="usa-link" aria-describedby="CR173">173</a>]. Exosomes from the mouse breast cancer cell 4T1 or colon cancer cell CT26 encapsulated GM-CSF inside and incorporated Ce6 in the surface. These exosomes can be developed as hydrogel vaccines which can elicit tumor‐specific immune responses to kill cancer cells [<a href="#CR174" class="usa-link" aria-describedby="CR174">174</a>]. miRNA-124 promotes the polarization of naive CD4+ T cells into T helper 1 (Th1) cells, which also mediates the immunosuppressive state to the immunostimulatory state by regulating cytokine balance. Exosomes from the murine colorectal carcinoma cell line CT-26 are loaded with miR-124-3p, which act as tumor vaccines to inhibit tumor growth and increase median survival time in tumor-bearing mice [<a href="#CR165" class="usa-link" aria-describedby="CR165">165</a>]. Exosomes from the human hepatoma cell lines HepG2 and 97H carry tumor antigens and overexpress Rab27a. TEXs overexpressing Rab27a are loaded onto DCs to form tumor vaccines, which can promote the differentiation and maturation of DCs [<a href="#CR175" class="usa-link" aria-describedby="CR175">175</a>]. Additionally, TEXs can be modified for the codelivery of tumor antigen and adjuvant. For example, exosomes from the streptavidin (SAV)-transfected mouse melanoma B16BL6 cells carry SAV, which are combined with biotinylated CpG DNA to form CpG DNA-modified exosomes (CpG-SAV-exo). CpG-SAV-exo acts as a tumor vaccine to exhibit a stronger anti-tumor effect in tumor-bearing mice [<a href="#CR176" class="usa-link" aria-describedby="CR176">176</a>]. Although TEXs can act as tumor vaccines to promote immune activation, they also possibly induce immunosuppression. Therefore, the safety of TEX vaccines deserves careful consideration as well as confirmation by comprehensive and further research.</p></section></section><section id="Sec26"><h2 class="pmc_sec_title">Conclusions and challenges</h2>
<p id="Par111">TEXs carry various cargos including proteins, RNAs, DNAs and lipids. TEXs with these cargos are involved in regulating tumor cells and the TME by exchanging cargos among cells, which thus play important roles in the pathogenesis, development and metastasis of tumors. TEXs prevent the apoptosis of tumor cells by inhibiting ferroptosis. TEXs promote the spread of tumor cells by regulating metabolism, angiogenesis, vascular permeability, epithelial-mesenchymal transition and immunosuppressive TME. TEXs also facilitate chemotherapy resistance and radiotherapy resistance of tumors. TEXs have been studied and recognized as potential biomarkers for the diagnosis of tumors as well as the differentiation of the subtypes and stages of tumors due to their abilities to reflect the physiological and pathological state of their cells of origin. TEXs also can be used in the evaluation of the prognosis and chemotherapy/radiotherapy resistance of tumors based on components which are aberrantly expressed in TEXs. For tumor therapy, TEXs and the molecules in the exosomes can be utilized as therapeutic targets to develop new low-toxicity inhibitors. TEXs can serve as excellent delivery carriers due to their good biocompatibility, low toxicity, low immunogenicity, high safety and favorable stability. TEXs can be developed into tumor vaccines to activate anti-tumor immune efficacy and hinder tumor progression.</p>
<p id="Par112">In recent years, tumor diagnosis and therapy based on TEXs are promising due to their specific advantages. Therapeutic TEXs can maintain anti-tumor efficacy even after undergoing frozen storage for 5 months. TEXs can cross the blood-brain barrier to treat brain diseases. TEXs obtain low immunogenicity, good tolerability and favorable safety. TEXs also can prolongate the half-life of drugs in the body. However, some important questions regarding the application of TEXs need to be addressed. The isolation and purification of TEXs are complex and time-consuming, which leads to high production costs of TEXs and limits their clinical application as biomarkers for tumor diagnosis as well as drug carriers and vaccines for tumor therapy. The specificity and efficiency of exosome delivery remain to be further improved. The safety of clinical trials based on therapeutic TEXs is necessary to evaluate rigorously. Moreover, most current research on TEXs focuses on cellular and animal studies, which remain in the preclinical stage. The clinical translation trials are awaiting further exploration to confirm the efficacy and safety of TEXs-based strategies.</p></section><section id="ack1" class="ack"><h2 class="pmc_sec_title">Acknowledgements</h2>
<p>Not applicable.</p></section><section id="glossary1" class="glossary"><h2 class="pmc_sec_title">Abbreviations</h2>
<dl class="def-list">
<dt>TEXs</dt>
<dd><p id="Par2">Tumor cell-derived exosomes</p></dd>
<dt>ILVs</dt>
<dd><p id="Par3">Intraluminal vesicles</p></dd>
<dt>MVBs</dt>
<dd><p id="Par4">Multivesicular bodies</p></dd>
<dt>TME</dt>
<dd><p id="Par5">Tumor microenvironment</p></dd>
<dt>PC</dt>
<dd><p id="Par6">Pancreatic cancer</p></dd>
<dt>AM</dt>
<dd><p id="Par7">Adrenomedullin</p></dd>
<dt>ERK1/2</dt>
<dd><p id="Par8">Extracellular signal-regulated kinase1/2</p></dd>
<dt>MAPKs</dt>
<dd><p id="Par9">Mitogen-activated protein kinases</p></dd>
<dt>EMT</dt>
<dd><p id="Par10">Epithelial-mesenchymal transition</p></dd>
<dt>TGF-β</dt>
<dd><p id="Par11">Transforming growth factor-β</p></dd>
<dt>PR-BC</dt>
<dd><p id="Par12">Paclitaxel-resistant breast cancer</p></dd>
<dt>HSP</dt>
<dd><p id="Par13">Heat shock proteins</p></dd>
<dt>HIF-1</dt>
<dd><p id="Par14">Hypoxia-inducible factor-1</p></dd>
<dt>PS-BC</dt>
<dd><p id="Par15">Paclitaxel-sensitive breast cancer</p></dd>
<dt>NPC</dt>
<dd><p id="Par16">Nasopharyngeal carcinoma</p></dd>
<dt>VEGF</dt>
<dd><p id="Par17">Vascular endothelial growth factor</p></dd>
<dt>FGF</dt>
<dd><p id="Par18">Fibroblast growth factor</p></dd>
<dt>HCCs</dt>
<dd><p id="Par19">Hepatocellular carcinoma</p></dd>
<dt>PGAM1</dt>
<dd><p id="Par20">Phosphoglycerate mutase 1</p></dd>
<dt>ACTG1</dt>
<dd><p id="Par21">Actin gamma 1</p></dd>
<dt>ESCC</dt>
<dd><p id="Par22">Esophageal squamous cell carcinoma</p></dd>
<dt>ICCA</dt>
<dd><p id="Par23">Intrahepatic cholangiocarcinoma</p></dd>
<dt>CRC</dt>
<dd><p id="Par24">Colorectal cancer</p></dd>
<dt>DCs</dt>
<dd><p id="Par25">Dendritic cells</p></dd>
<dt>MDSCs</dt>
<dd><p id="Par26">Myeloid-derived suppressor cells</p></dd>
<dt>APCs</dt>
<dd><p id="Par27">Antigen-presenting cells</p></dd>
<dt>MHC</dt>
<dd><p id="Par28">Major histocompatibility complex</p></dd>
<dt>NSCLC</dt>
<dd><p id="Par29">Non-small cell lung cancer</p></dd>
<dt>GBM</dt>
<dd><p id="Par30">Glioblastoma multiforme</p></dd>
<dt>PDAC</dt>
<dd><p id="Par31">Pancreatic ductal adenocarcinoma</p></dd>
<dt>ATP</dt>
<dd><p id="Par32">Adenosine triphosphate</p></dd>
<dt>LECs</dt>
<dd><p id="Par33">Lymphatic endothelial cells</p></dd>
<dt>ICAM1</dt>
<dd><p id="Par34">Intercellular adhesion molecule 1</p></dd>
<dt>TCR</dt>
<dd><p id="Par35">T-cell receptor</p></dd>
<dt>Treg</dt>
<dd><p id="Par36">Regulatory T cells</p></dd>
<dt>SCLC</dt>
<dd><p id="Par37">Small cell lung cancer</p></dd>
<dt>MIF</dt>
<dd><p id="Par38">Migration inhibitory factor</p></dd>
<dt>GC</dt>
<dd><p id="Par39">Gastric cancer</p></dd>
<dt>BC</dt>
<dd><p id="Par40">Breast cancer</p></dd>
<dt>PMN</dt>
<dd><p id="Par41">Pre-metastatic niches</p></dd>
<dt>DOX</dt>
<dd><p id="Par42">Doxorubicin</p></dd>
<dt>MRP-1</dt>
<dd><p id="Par43">Multidrug-resistant protein-1</p></dd>
<dt>TMZ</dt>
<dd><p id="Par44">Temozolomide</p></dd>
<dt>HNSCC</dt>
<dd><p id="Par45">Head and neck squamous cell carcinoma</p></dd>
<dt>IR</dt>
<dd><p id="Par46">Ionizing radiation</p></dd>
<dt>OSCC</dt>
<dd><p id="Par47">Oral squamous cell carcinoma</p></dd>
<dt>GSCs</dt>
<dd><p id="Par48">Glioblastoma stem cells</p></dd>
<dt>YBX1</dt>
<dd><p id="Par49">Y-box binding protein 1</p></dd>
<dt>GCSC</dt>
<dd><p id="Par50">Gastric cancer stem cells</p></dd>
<dt>PCa</dt>
<dd><p id="Par51">Prostate cancer</p></dd>
<dt>TNM</dt>
<dd><p id="Par52">Tumor node metastasis</p></dd>
<dt>DLBCL</dt>
<dd><p id="Par53">Diffuse large B-cell lymphoma</p></dd>
<dt>DEGs</dt>
<dd><p id="Par54">Differentially expressed genes</p></dd>
<dt>UTEGs</dt>
<dd><p id="Par55">Upregulated tumor-derived exosome genes</p></dd>
<dt>DRFS</dt>
<dd><p id="Par56">Distant relapse-free survival</p></dd>
<dt>OC</dt>
<dd><p id="Par57">Ovarian cancer</p></dd>
<dt>ERLS</dt>
<dd><p id="Par58">Exosome-related lncRNA signature</p></dd>
<dt>PNI</dt>
<dd><p id="Par59">Perineural invasion</p></dd>
<dt>GDNF</dt>
<dd><p id="Par60">Glial cell line-derived neurotrophic factor</p></dd>
<dt>sEV</dt>
<dd><p id="Par61">Small extracellular vesicles</p></dd>
<dt>ICI</dt>
<dd><p id="Par62">Immune checkpoint inhibitor</p></dd>
<dt>XELOX</dt>
<dd><p id="Par63">Oxaliplatin and capecitabine</p></dd>
<dt>ORR</dt>
<dd><p id="Par64">Objective response rate</p></dd>
<dt>PFS</dt>
<dd><p id="Par65">Progression-free survival</p></dd>
<dt>MDR</dt>
<dd><p id="Par66">Multi-drug resistance</p></dd>
<dt>ROS</dt>
<dd><p id="Par67">Reactive oxygen species</p></dd>
<dt>DTX</dt>
<dd><p id="Par68">Docetaxel</p></dd>
<dt>SPIONs</dt>
<dd><p id="Par69">Superparamagnetic iron oxide nanoparticles</p></dd>
<dt>DHT</dt>
<dd><p id="Par70">Dihydrotanshinone</p></dd>
<dt>CCDC80</dt>
<dd><p id="Par71">Coiled-coil domain-containing protein 80</p></dd>
<dt>ALA</dt>
<dd><p id="Par72">Aminolevulinic acid</p></dd>
<dt>MPS</dt>
<dd><p id="Par73">Mononuclear phagocytic system</p></dd>
<dt>THD</dt>
<dd><p id="Par74">Thalidomide</p></dd>
<dt>LncRNA MEG3</dt>
<dd><p id="Par75">Long non-coding RNA maternally expressed gene 3</p></dd>
<dt>Akk-OMV</dt>
<dd><p id="Par76">Outer membrane vesicle from Akkermansia muciniphila</p></dd>
<dt>PARP-1</dt>
<dd><p id="Par77">Poly ADP-ribose polymerase</p></dd>
<dt>SAV</dt>
<dd><p id="Par78">Streptavidin</p></dd>
</dl></section><section id="notes1"><h2 class="pmc_sec_title">Author contributions</h2>
<p>M.L. wrote the manuscript. Y.W. designed the figures. J.D. and L.H. revised the manuscript. H.Z. and X.W. provided important advice on the manuscript. All authors have read and agreed to the published version of the manuscript.</p></section><section id="notes2"><h2 class="pmc_sec_title">Funding</h2>
<p>This work was supported by grants from the Sichuan Academy of Medical Sciences and the Sichuan Provincial People’s Hospital Clinical Study and Translational Fund (No. 2020LZ01) and Sichuan Science and Technology Program (2023YFS0159).</p></section><section id="notes3"><h2 class="pmc_sec_title">Data availability</h2>
<p>Not applicable.</p></section><section id="notes4"><h2 class="pmc_sec_title">Declarations</h2>
<section id="FPar1"><h3 class="pmc_sec_title">Ethics approval and consent to participate</h3>
<p id="Par113">Not applicable.</p></section><section id="FPar2"><h3 class="pmc_sec_title">Consent for publication</h3>
<p id="Par114">Not applicable.</p></section><section id="FPar3"><h3 class="pmc_sec_title">Competing interests</h3>
<p id="Par115">The authors report no conflicts of interest in this work.</p></section></section><section id="fn-group1" class="fn-group"><h2 class="pmc_sec_title">Footnotes</h2>
<div class="fn-group p font-secondary-light font-sm">
<div class="fn p" id="fn1">
<p><strong>Publisher's Note</strong></p>
<p>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p>
</div>
<div class="fn p" id="fn2"><p>Mengyue Li and Yifan Wang contributed equally to this work.</p></div>
<div class="fn p" id="fn3"><p>Lin He and Jingying Dai contributed equally to this work.</p></div>
</div></section><section id="_ci93_" lang="en" class="contrib-info"><h2 class="pmc_sec_title">Contributor Information</h2>
<p>Lin He, Email: helin514@126.com.</p>
<p>Jingying Dai, Email: 741107213@qq.com.</p></section><section id="Bib1" class="ref-list"><h2 class="pmc_sec_title">References</h2>
<section id="Bib1_sec2"><ul class="ref-list font-sm" style="list-style-type:none">
<li id="CR1">
<span class="label">1.</span><cite>Brennan K, Martin K, FitzGerald SP, O’Sullivan J, Wu Y, Blanco A, et al. A comparison of methods for the isolation and separation of extracellular vesicles from protein and lipid particles in human serum. Sci Rep. 2020;10:1039.
</cite> [<a href="https://doi.org/10.1038/s41598-020-57497-7" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6978318/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31974468/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Brennan%20K,%20Martin%20K,%20FitzGerald%20SP,%20O%E2%80%99Sullivan%20J,%20Wu%20Y,%20Blanco%20A,%20et%20al.%20A%20comparison%20of%20methods%20for%20the%20isolation%20and%20separation%20of%20extracellular%20vesicles%20from%20protein%20and%20lipid%20particles%20in%20human%20serum.%20Sci%20Rep.%202020;10:1039." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR2">
<span class="label">2.</span><cite>Xie S, Zhang Q, Jiang L. Current knowledge on exosome biogenesis, cargo-sorting mechanism and therapeutic implications. Membranes. 2022;12:498.
</cite> [<a href="https://doi.org/10.3390/membranes12050498" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9144303/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35629824/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Xie%20S,%20Zhang%20Q,%20Jiang%20L.%20Current%20knowledge%20on%20exosome%20biogenesis,%20cargo-sorting%20mechanism%20and%20therapeutic%20implications.%20Membranes.%202022;12:498." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR3">
<span class="label">3.</span><cite>Palomar-Alonso N, Lee M, Kim M. Exosomes: membrane-associated proteins, challenges and perspectives. Biochem Biophy Rep. 2024;37: 101599.</cite> [<a href="https://doi.org/10.1016/j.bbrep.2023.101599" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10746368/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38145105/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Palomar-Alonso%20N,%20Lee%20M,%20Kim%20M.%20Exosomes:%20membrane-associated%20proteins,%20challenges%20and%20perspectives.%20Biochem%20Biophy%20Rep.%202024;37:%20101599." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR4">
<span class="label">4.</span><cite>Huang X, Yuan T, Tschannen M, Sun Z, Jacob H, Du M, et al. Characterization of human plasma-derived exosomal RNAs by deep sequencing. BMC Genomics. 2013;14:319.
</cite> [<a href="https://doi.org/10.1186/1471-2164-14-319" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3653748/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/23663360/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Huang%20X,%20Yuan%20T,%20Tschannen%20M,%20Sun%20Z,%20Jacob%20H,%20Du%20M,%20et%20al.%20Characterization%20of%20human%20plasma-derived%20exosomal%20RNAs%20by%20deep%20sequencing.%20BMC%20Genomics.%202013;14:319." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR5">
<span class="label">5.</span><cite>Sun W, Luo J, Jiang H, Duan DD. Tumor exosomes: a double-edged sword in cancer therapy. Acta Pharmacol Sin. 2018;39:534–41.
</cite> [<a href="https://doi.org/10.1038/aps.2018.17" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5888693/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29542685/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Sun%20W,%20Luo%20J,%20Jiang%20H,%20Duan%20DD.%20Tumor%20exosomes:%20a%20double-edged%20sword%20in%20cancer%20therapy.%20Acta%20Pharmacol%20Sin.%202018;39:534%E2%80%9341." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR6">
<span class="label">6.</span><cite>Paget S. The distribution of secondary growths in cancer of the breast. 1889. Cancer Metastasis Rev. 1989;8:98–101.
</cite> [<a href="https://pubmed.ncbi.nlm.nih.gov/2673568/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Paget%20S.%20The%20distribution%20of%20secondary%20growths%20in%20cancer%20of%20the%20breast.%201889.%20Cancer%20Metastasis%20Rev.%201989;8:98%E2%80%93101." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR7">
<span class="label">7.</span><cite>Paskeh MDA, Entezari M, Mirzaei S, Zabolian A, Saleki H, Naghdi MJ, et al. Emerging role of exosomes in cancer progression and tumor microenvironment remodeling. J Hematol Oncol. 2022;15:83.
</cite> [<a href="https://doi.org/10.1186/s13045-022-01305-4" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9238168/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35765040/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Paskeh%20MDA,%20Entezari%20M,%20Mirzaei%20S,%20Zabolian%20A,%20Saleki%20H,%20Naghdi%20MJ,%20et%20al.%20Emerging%20role%20of%20exosomes%20in%20cancer%20progression%20and%20tumor%20microenvironment%20remodeling.%20J%20Hematol%20Oncol.%202022;15:83." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR8">
<span class="label">8.</span><cite>Cao M, Isaac R, Yan W, Ruan X, Jiang L, Wan Y, et al. Cancer-cell-secreted extracellular vesicles suppress insulin secretion through miR-122 to impair systemic glucose homeostasis and contribute to tumour growth. Nat Cell Biol. 2022;24:954–67.
</cite> [<a href="https://doi.org/10.1038/s41556-022-00919-7" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9233030/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35637408/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Cao%20M,%20Isaac%20R,%20Yan%20W,%20Ruan%20X,%20Jiang%20L,%20Wan%20Y,%20et%20al.%20Cancer-cell-secreted%20extracellular%20vesicles%20suppress%20insulin%20secretion%20through%20miR-122%20to%20impair%20systemic%20glucose%20homeostasis%20and%20contribute%20to%20tumour%20growth.%20Nat%20Cell%20Biol.%202022;24:954%E2%80%9367." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR9">
<span class="label">9.</span><cite>Javeed N, Sagar G, Dutta SK, Smyrk TC, Lau JS, Bhattacharya S, et al. Pancreatic cancer-derived exosomes cause paraneoplastic β-cell dysfunction. Clin Cancer Res. 2015;21:1722–33.
</cite> [<a href="https://doi.org/10.1158/1078-0432.CCR-14-2022" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4383684/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25355928/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Javeed%20N,%20Sagar%20G,%20Dutta%20SK,%20Smyrk%20TC,%20Lau%20JS,%20Bhattacharya%20S,%20et%20al.%20Pancreatic%20cancer-derived%20exosomes%20cause%20paraneoplastic%20%CE%B2-cell%20dysfunction.%20Clin%20Cancer%20Res.%202015;21:1722%E2%80%9333." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR10">
<span class="label">10.</span><cite>Xiong M, Zhang Q, Hu W, Zhao C, Lv W, Yi Y, et al. Exosomes from adipose-derived stem cells: the emerging roles and applications in tissue regeneration of plastic and cosmetic surgery. Front Cell Dev Biol. 2020;8: 574223.
</cite> [<a href="https://doi.org/10.3389/fcell.2020.574223" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7511773/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33015067/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Xiong%20M,%20Zhang%20Q,%20Hu%20W,%20Zhao%20C,%20Lv%20W,%20Yi%20Y,%20et%20al.%20Exosomes%20from%20adipose-derived%20stem%20cells:%20the%20emerging%20roles%20and%20applications%20in%20tissue%20regeneration%20of%20plastic%20and%20cosmetic%20surgery.%20Front%20Cell%20Dev%20Biol.%202020;8:%20574223." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR11">
<span class="label">11.</span><cite>Sagar G, Sah RP, Javeed N, Dutta SK, Smyrk TC, Lau JS, et al. Pathogenesis of pancreatic cancer exosome-induced lipolysis in adipose tissue. Gut. 2016;65:1165–74.
</cite> [<a href="https://doi.org/10.1136/gutjnl-2014-308350" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5323066/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26061593/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Sagar%20G,%20Sah%20RP,%20Javeed%20N,%20Dutta%20SK,%20Smyrk%20TC,%20Lau%20JS,%20et%20al.%20Pathogenesis%20of%20pancreatic%20cancer%20exosome-induced%20lipolysis%20in%20adipose%20tissue.%20Gut.%202016;65:1165%E2%80%9374." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR12">
<span class="label">12.</span><cite>Ruan X, Yan W, Cao M, Daza RAM, Fong MY, Yang K, et al. Breast cancer cell-secreted miR-199b-5p hijacks neurometabolic coupling to promote brain metastasis. Nat Commun. 2024;15:4549.
</cite> [<a href="https://doi.org/10.1038/s41467-024-48740-0" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11137082/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38811525/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Ruan%20X,%20Yan%20W,%20Cao%20M,%20Daza%20RAM,%20Fong%20MY,%20Yang%20K,%20et%20al.%20Breast%20cancer%20cell-secreted%20miR-199b-5p%20hijacks%20neurometabolic%20coupling%20to%20promote%20brain%20metastasis.%20Nat%20Commun.%202024;15:4549." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR13">
<span class="label">13.</span><cite>You X, Wang Y, Meng J, Han S, Liu L, Sun Y, et al. Exosomal miR-663b exposed to TGF-β1 promotes cervical cancer metastasis and epithelial-mesenchymal transition by targeting MGAT3. Oncol Rep. 2021;45:1–1.
</cite> [<a href="https://doi.org/10.3892/or.2021.7963" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7877003/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33649791/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?You%20X,%20Wang%20Y,%20Meng%20J,%20Han%20S,%20Liu%20L,%20Sun%20Y,%20et%20al.%20Exosomal%20miR-663b%20exposed%20to%20TGF-%CE%B21%20promotes%20cervical%20cancer%20metastasis%20and%20epithelial-mesenchymal%20transition%20by%20targeting%20MGAT3.%20Oncol%20Rep.%202021;45:1%E2%80%931." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR14">
<span class="label">14.</span><cite>Nakayama F, Miyoshi M, Kimoto A, Kawano A, Miyashita K, Kamoshida S, et al. Pancreatic cancer cell-derived exosomes induce epithelial-mesenchymal transition in human pancreatic cancer cells themselves partially via transforming growth factor β1. Med Mol Morphol. 2022;55:227.
</cite> [<a href="https://doi.org/10.1007/s00795-022-00321-0" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9043512/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35475918/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Nakayama%20F,%20Miyoshi%20M,%20Kimoto%20A,%20Kawano%20A,%20Miyashita%20K,%20Kamoshida%20S,%20et%20al.%20Pancreatic%20cancer%20cell-derived%20exosomes%20induce%20epithelial-mesenchymal%20transition%20in%20human%20pancreatic%20cancer%20cells%20themselves%20partially%20via%20transforming%20growth%20factor%20%CE%B21.%20Med%20Mol%20Morphol.%202022;55:227." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR15">
<span class="label">15.</span><cite>Tian T, Han J, Huang J, Li S, Pang H. Hypoxia-induced intracellular and extracellular heat shock protein gp96 increases paclitaxel-resistance and facilitates immune evasion in breast cancer. Front Oncol. 2021;11: 784777.
</cite> [<a href="https://doi.org/10.3389/fonc.2021.784777" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8722103/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34988020/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Tian%20T,%20Han%20J,%20Huang%20J,%20Li%20S,%20Pang%20H.%20Hypoxia-induced%20intracellular%20and%20extracellular%20heat%20shock%20protein%20gp96%20increases%20paclitaxel-resistance%20and%20facilitates%20immune%20evasion%20in%20breast%20cancer.%20Front%20Oncol.%202021;11:%20784777." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR16">
<span class="label">16.</span><cite>Shan Y, You B, Shi S, Shi W, Zhang Z, Zhang Q, et al. Hypoxia-induced matrix metalloproteinase-13 expression in exosomes from nasopharyngeal carcinoma enhances metastases. Cell Death Dis. 2018;9:382.
</cite> [<a href="https://doi.org/10.1038/s41419-018-0425-0" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5841433/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29515112/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Shan%20Y,%20You%20B,%20Shi%20S,%20Shi%20W,%20Zhang%20Z,%20Zhang%20Q,%20et%20al.%20Hypoxia-induced%20matrix%20metalloproteinase-13%20expression%20in%20exosomes%20from%20nasopharyngeal%20carcinoma%20enhances%20metastases.%20Cell%20Death%20Dis.%202018;9:382." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR17">
<span class="label">17.</span><cite>Mashouri L, Yousefi H, Aref AR, Ahadi AM, Molaei F, Alahari SK. Exosomes: composition, biogenesis, and mechanisms in cancer metastasis and drug resistance. Mol Cancer. 2019;18:75.
</cite> [<a href="https://doi.org/10.1186/s12943-019-0991-5" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6444571/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30940145/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Mashouri%20L,%20Yousefi%20H,%20Aref%20AR,%20Ahadi%20AM,%20Molaei%20F,%20Alahari%20SK.%20Exosomes:%20composition,%20biogenesis,%20and%20mechanisms%20in%20cancer%20metastasis%20and%20drug%20resistance.%20Mol%20Cancer.%202019;18:75." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR18">
<span class="label">18.</span><cite>Wang L, Qiao C, Han L, Wang X, Miao J, Cao L, et al. HOXD3 promotes the migration and angiogenesis of hepatocellular carcinoma via modifying hepatocellular carcinoma cells exosome-delivered CCR6 and regulating chromatin conformation of CCL20. Cell Death Dis. 2024;15:221.
</cite> [<a href="https://doi.org/10.1038/s41419-024-06593-x" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10944507/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38493218/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Wang%20L,%20Qiao%20C,%20Han%20L,%20Wang%20X,%20Miao%20J,%20Cao%20L,%20et%20al.%20HOXD3%20promotes%20the%20migration%20and%20angiogenesis%20of%20hepatocellular%20carcinoma%20via%20modifying%20hepatocellular%20carcinoma%20cells%20exosome-delivered%20CCR6%20and%20regulating%20chromatin%20conformation%20of%20CCL20.%20Cell%20Death%20Dis.%202024;15:221." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR19">
<span class="label">19.</span><cite>Huang S, Zhang P, Yin N, Xu Z, Liu X, Wu A, et al. Glioblastoma stem cell-derived exosomal miR-374b-3p promotes tumor angiogenesis and progression through inducing M2 macrophages polarization. iScience. 2024;27: 109270.
</cite> [<a href="https://doi.org/10.1016/j.isci.2024.109270" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10937837/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38487014/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Huang%20S,%20Zhang%20P,%20Yin%20N,%20Xu%20Z,%20Liu%20X,%20Wu%20A,%20et%20al.%20Glioblastoma%20stem%20cell-derived%20exosomal%20miR-374b-3p%20promotes%20tumor%20angiogenesis%20and%20progression%20through%20inducing%20M2%20macrophages%20polarization.%20iScience.%202024;27:%20109270." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR20">
<span class="label">20.</span><cite>Wang W, Wang T, Zhang Y, Deng T, Zhang H, Ba YI. Gastric cancer secreted miR-214-3p inhibits the anti-angiogenesis effect of apatinib by suppressing ferroptosis in vascular endothelial cells. Oncol Res. 2024;32:489–502.
</cite> [<a href="https://doi.org/10.32604/or.2023.046676" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10874472/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38370339/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Wang%20W,%20Wang%20T,%20Zhang%20Y,%20Deng%20T,%20Zhang%20H,%20Ba%20YI.%20Gastric%20cancer%20secreted%20miR-214-3p%20inhibits%20the%20anti-angiogenesis%20effect%20of%20apatinib%20by%20suppressing%20ferroptosis%20in%20vascular%20endothelial%20cells.%20Oncol%20Res.%202024;32:489%E2%80%93502." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR21">
<span class="label">21.</span><cite>Luo J-Q, Yang T-W, Wu J, Lai H-H, Zou L-B, Chen W-B, et al. Exosomal PGAM1 promotes prostate cancer angiogenesis and metastasis by interacting with ACTG1. Cell Death Dis. 2023;14:502.
</cite> [<a href="https://doi.org/10.1038/s41419-023-06007-4" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10403531/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37542027/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Luo%20J-Q,%20Yang%20T-W,%20Wu%20J,%20Lai%20H-H,%20Zou%20L-B,%20Chen%20W-B,%20et%20al.%20Exosomal%20PGAM1%20promotes%20prostate%20cancer%20angiogenesis%20and%20metastasis%20by%20interacting%20with%20ACTG1.%20Cell%20Death%20Dis.%202023;14:502." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR22">
<span class="label">22.</span><cite>Mao Y, Wang J, Wang Y, Fu Z, Dong L, Liu J. Hypoxia induced exosomal Circ-ZNF609 promotes pre-metastatic niche formation and cancer progression via miR-150-5p/VEGFA and HuR/ZO-1 axes in esophageal squamous cell carcinoma. Cell Death Discov. 2024;10:133.
</cite> [<a href="https://doi.org/10.1038/s41420-024-01905-8" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10933275/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38472174/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Mao%20Y,%20Wang%20J,%20Wang%20Y,%20Fu%20Z,%20Dong%20L,%20Liu%20J.%20Hypoxia%20induced%20exosomal%20Circ-ZNF609%20promotes%20pre-metastatic%20niche%20formation%20and%20cancer%20progression%20via%20miR-150-5p/VEGFA%20and%20HuR/ZO-1%20axes%20in%20esophageal%20squamous%20cell%20carcinoma.%20Cell%20Death%20Discov.%202024;10:133." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR23">
<span class="label">23.</span><cite>Fang J-H, Zhang Z-J, Shang L-R, Luo Y-W, Lin Y-F, Yuan Y, et al. Hepatoma cell-secreted exosomal microRNA-103 increases vascular permeability and promotes metastasis by targeting junction proteins. Hepatology. 2018;68:1459–75.
</cite> [<a href="https://doi.org/10.1002/hep.29920" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29637568/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Fang%20J-H,%20Zhang%20Z-J,%20Shang%20L-R,%20Luo%20Y-W,%20Lin%20Y-F,%20Yuan%20Y,%20et%20al.%20Hepatoma%20cell-secreted%20exosomal%20microRNA-103%20increases%20vascular%20permeability%20and%20promotes%20metastasis%20by%20targeting%20junction%20proteins.%20Hepatology.%202018;68:1459%E2%80%9375." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR24">
<span class="label">24.</span><cite>Jiang W, Shi X, Sun L, Zhang Y, Kong X, Yang X, et al. Exosomal miR-30a-5p promoted intrahepatic cholangiocarcinoma progression by increasing angiogenesis and vascular permeability in PDCD10 dependent manner. Int J Biol Sci. 2023;19:4571–87.
</cite> [<a href="https://doi.org/10.7150/ijbs.83170" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10535699/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37781039/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Jiang%20W,%20Shi%20X,%20Sun%20L,%20Zhang%20Y,%20Kong%20X,%20Yang%20X,%20et%20al.%20Exosomal%20miR-30a-5p%20promoted%20intrahepatic%20cholangiocarcinoma%20progression%20by%20increasing%20angiogenesis%20and%20vascular%20permeability%20in%20PDCD10%20dependent%20manner.%20Int%20J%20Biol%20Sci.%202023;19:4571%E2%80%9387." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR25">
<span class="label">25.</span><cite>Li K, Xue W, Lu Z, Wang S, Zheng J, Lu K, et al. Tumor-derived exosomal ADAM17 promotes pre-metastatic niche formation by enhancing vascular permeability in colorectal cancer. J Exp Clin Cancer Res. 2024;43:59.
</cite> [<a href="https://doi.org/10.1186/s13046-024-02991-3" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10898123/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38413999/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Li%20K,%20Xue%20W,%20Lu%20Z,%20Wang%20S,%20Zheng%20J,%20Lu%20K,%20et%20al.%20Tumor-derived%20exosomal%20ADAM17%20promotes%20pre-metastatic%20niche%20formation%20by%20enhancing%20vascular%20permeability%20in%20colorectal%20cancer.%20J%20Exp%20Clin%20Cancer%20Res.%202024;43:59." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR26">
<span class="label">26.</span><cite>Ning Y, Shen K, Wu Q, Sun X, Bai Y, Xie Y, et al. Tumor exosomes block dendritic cells maturation to decrease the T cell immune response. Immunol Lett. 2018;199:36–43.
</cite> [<a href="https://doi.org/10.1016/j.imlet.2018.05.002" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29800589/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Ning%20Y,%20Shen%20K,%20Wu%20Q,%20Sun%20X,%20Bai%20Y,%20Xie%20Y,%20et%20al.%20Tumor%20exosomes%20block%20dendritic%20cells%20maturation%20to%20decrease%20the%20T%20cell%20immune%20response.%20Immunol%20Lett.%202018;199:36%E2%80%9343." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR27">
<span class="label">27.</span><cite>Grange C, Tapparo M, Tritta S, Deregibus MC, Battaglia A, Gontero P, et al. Role of HLA-G and extracellular vesicles in renal cancer stem cell-induced inhibition of dendritic cell differentiation. BMC Cancer. 2015;15:1009.
</cite> [<a href="https://doi.org/10.1186/s12885-015-2025-z" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4690241/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26704308/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Grange%20C,%20Tapparo%20M,%20Tritta%20S,%20Deregibus%20MC,%20Battaglia%20A,%20Gontero%20P,%20et%20al.%20Role%20of%20HLA-G%20and%20extracellular%20vesicles%20in%20renal%20cancer%20stem%20cell-induced%20inhibition%20of%20dendritic%20cell%20differentiation.%20BMC%20Cancer.%202015;15:1009." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR28">
<span class="label">28.</span><cite>Zhou M, Chen J, Zhou L, Chen W, Ding G, Cao L. Pancreatic cancer derived exosomes regulate the expression of TLR4 in dendritic cells via miR-203. Cell Immunol. 2014;292:65–9.
</cite> [<a href="https://doi.org/10.1016/j.cellimm.2014.09.004" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25290620/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Zhou%20M,%20Chen%20J,%20Zhou%20L,%20Chen%20W,%20Ding%20G,%20Cao%20L.%20Pancreatic%20cancer%20derived%20exosomes%20regulate%20the%20expression%20of%20TLR4%20in%20dendritic%20cells%20via%20miR-203.%20Cell%20Immunol.%202014;292:65%E2%80%939." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR29">
<span class="label">29.</span><cite>Maus RLG, Jakub JW, Nevala WK, Christensen TA, Noble-Orcutt K, Sachs Z, et al. Human melanoma-derived extracellular vesicles regulate dendritic cell maturation. Front Immunol. 2017;8:358.
</cite> [<a href="https://doi.org/10.3389/fimmu.2017.00358" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5372822/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28424693/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Maus%20RLG,%20Jakub%20JW,%20Nevala%20WK,%20Christensen%20TA,%20Noble-Orcutt%20K,%20Sachs%20Z,%20et%20al.%20Human%20melanoma-derived%20extracellular%20vesicles%20regulate%20dendritic%20cell%20maturation.%20Front%20Immunol.%202017;8:358." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR30">
<span class="label">30.</span><cite>Chen Q, Wang J, Jiang R, Qin J. Research progress on immunoediting role of tumor-derived exosomes in the microenvironment of lung cancer. Chin J Clin Oncol. 2024;51:528–33.</cite> [<a href="https://scholar.google.com/scholar_lookup?Chen%20Q,%20Wang%20J,%20Jiang%20R,%20Qin%20J.%20Research%20progress%20on%20immunoediting%20role%20of%20tumor-derived%20exosomes%20in%20the%20microenvironment%20of%20lung%20cancer.%20Chin%20J%20Clin%20Oncol.%202024;51:528%E2%80%9333." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR31">
<span class="label">31.</span><cite>Wang M, Cai Y, Peng Y, Xu B, Hui W, Jiang Y. Exosomal LGALS9 in the cerebrospinal fluid of glioblastoma patients suppressed dendritic cell antigen presentation and cytotoxic T-cell immunity. Cell Death Dis. 2020;11:896.
</cite> [<a href="https://doi.org/10.1038/s41419-020-03042-3" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7582167/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33093453/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Wang%20M,%20Cai%20Y,%20Peng%20Y,%20Xu%20B,%20Hui%20W,%20Jiang%20Y.%20Exosomal%20LGALS9%20in%20the%20cerebrospinal%20fluid%20of%20glioblastoma%20patients%20suppressed%20dendritic%20cell%20antigen%20presentation%20and%20cytotoxic%20T-cell%20immunity.%20Cell%20Death%20Dis.%202020;11:896." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR32">
<span class="label">32.</span><cite>Hosseini R, Sarvnaz H, Arabpour M, Ramshe SM, Asef-Kabiri L, Yousefi H, et al. Cancer exosomes and natural killer cells dysfunction: biological roles, clinical significance and implications for immunotherapy. Mol Cancer. 2022;21:15.
</cite> [<a href="https://doi.org/10.1186/s12943-021-01492-7" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8759167/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35031075/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Hosseini%20R,%20Sarvnaz%20H,%20Arabpour%20M,%20Ramshe%20SM,%20Asef-Kabiri%20L,%20Yousefi%20H,%20et%20al.%20Cancer%20exosomes%20and%20natural%20killer%20cells%20dysfunction:%20biological%20roles,%20clinical%20significance%20and%20implications%20for%20immunotherapy.%20Mol%20Cancer.%202022;21:15." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR33">
<span class="label">33.</span><cite>Zhang P-F, Gao C, Huang X-Y, Lu J-C, Guo X-J, Shi G-M, et al. Cancer cell-derived exosomal circUHRF1 induces natural killer cell exhaustion and may cause resistance to anti-PD1 therapy in hepatocellular carcinoma. Mol Cancer. 2020;19:110.
</cite> [<a href="https://doi.org/10.1186/s12943-020-01222-5" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7320583/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32593303/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Zhang%20P-F,%20Gao%20C,%20Huang%20X-Y,%20Lu%20J-C,%20Guo%20X-J,%20Shi%20G-M,%20et%20al.%20Cancer%20cell-derived%20exosomal%20circUHRF1%20induces%20natural%20killer%20cell%20exhaustion%20and%20may%20cause%20resistance%20to%20anti-PD1%20therapy%20in%20hepatocellular%20carcinoma.%20Mol%20Cancer.%202020;19:110." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR34">
<span class="label">34.</span><cite>Huang Y, Luo Y, Ou W, Wang Y, Dong D, Peng X, et al. Exosomal lncRNA SNHG10 derived from colorectal cancer cells suppresses natural killer cell cytotoxicity by upregulating INHBC. Cancer Cell Int. 2021;21:528.
</cite> [<a href="https://doi.org/10.1186/s12935-021-02221-2" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8507338/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34641864/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Huang%20Y,%20Luo%20Y,%20Ou%20W,%20Wang%20Y,%20Dong%20D,%20Peng%20X,%20et%20al.%20Exosomal%20lncRNA%20SNHG10%20derived%20from%20colorectal%20cancer%20cells%20suppresses%20natural%20killer%20cell%20cytotoxicity%20by%20upregulating%20INHBC.%20Cancer%20Cell%20Int.%202021;21:528." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR35">
<span class="label">35.</span><cite>Zhao J, Schlößer HA, Wang Z, Qin J, Li J, Popp F, et al. Tumor-derived extracellular vesicles inhibit natural killer cell function in pancreatic cancer. Cancers. 2019;11:874.
</cite> [<a href="https://doi.org/10.3390/cancers11060874" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6628179/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31234517/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Zhao%20J,%20Schl%C3%B6%C3%9Fer%20HA,%20Wang%20Z,%20Qin%20J,%20Li%20J,%20Popp%20F,%20et%20al.%20Tumor-derived%20extracellular%20vesicles%20inhibit%20natural%20killer%20cell%20function%20in%20pancreatic%20cancer.%20Cancers.%202019;11:874." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR36">
<span class="label">36.</span><cite>Huyan T, Gao L, Gao N, Wang C, Guo W, Zhou X, et al. miR-221-5p and miR-186-5p are the critical bladder cancer derived exosomal miRNAs in natural killer cell dysfunction. Int J Mol Sci. 2022;23:15177.
</cite> [<a href="https://doi.org/10.3390/ijms232315177" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9740765/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36499501/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Huyan%20T,%20Gao%20L,%20Gao%20N,%20Wang%20C,%20Guo%20W,%20Zhou%20X,%20et%20al.%20miR-221-5p%20and%20miR-186-5p%20are%20the%20critical%20bladder%20cancer%20derived%20exosomal%20miRNAs%20in%20natural%20killer%20cell%20dysfunction.%20Int%20J%20Mol%20Sci.%202022;23:15177." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR37">
<span class="label">37.</span><cite>Huang F, Wan J, Hu W, Hao S. Enhancement of anti-leukemia immunity by leukemia-derived exosomes via downregulation of TGF-β1 expression. Cell Physiol Biochem. 2017;44:240–54.
</cite> [<a href="https://doi.org/10.1159/000484677" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29130994/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Huang%20F,%20Wan%20J,%20Hu%20W,%20Hao%20S.%20Enhancement%20of%20anti-leukemia%20immunity%20by%20leukemia-derived%20exosomes%20via%20downregulation%20of%20TGF-%CE%B21%20expression.%20Cell%20Physiol%20Biochem.%202017;44:240%E2%80%9354." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR38">
<span class="label">38.</span><cite>Hao Y, Chen P, Zhang X, Shao Y, Xu Y, Qian W. The effects of tumor-derived exosomes on T-cell function and efficacy of cancer immunotherapy. ImmunoMedicine. 2021;1: e1029.</cite> [<a href="https://scholar.google.com/scholar_lookup?Hao%20Y,%20Chen%20P,%20Zhang%20X,%20Shao%20Y,%20Xu%20Y,%20Qian%20W.%20The%20effects%20of%20tumor-derived%20exosomes%20on%20T-cell%20function%20and%20efficacy%20of%20cancer%20immunotherapy.%20ImmunoMedicine.%202021;1:%20e1029." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR39">
<span class="label">39.</span><cite>Zhou C, Zhang Y, Yan R, Huang L, Mellor AL, Yang Y, et al. Exosome-derived miR-142-5p remodels lymphatic vessels and induces IDO to promote immune privilege in the tumour microenvironment. Cell Death Differ. 2021;28:715–29.
</cite> [<a href="https://doi.org/10.1038/s41418-020-00618-6" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7862304/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32929219/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Zhou%20C,%20Zhang%20Y,%20Yan%20R,%20Huang%20L,%20Mellor%20AL,%20Yang%20Y,%20et%20al.%20Exosome-derived%20miR-142-5p%20remodels%20lymphatic%20vessels%20and%20induces%20IDO%20to%20promote%20immune%20privilege%20in%20the%20tumour%20microenvironment.%20Cell%20Death%20Differ.%202021;28:715%E2%80%9329." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR40">
<span class="label">40.</span><cite>Chen M, Fu Z, Wu C. Tumor-derived exosomal ICAM1 promotes bone metastasis of triple-negative breast cancer by inducing CD8+ T cell exhaustion. Int J Biochem Cell Biol. 2024;175: 106637.
</cite> [<a href="https://doi.org/10.1016/j.biocel.2024.106637" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39147124/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Chen%20M,%20Fu%20Z,%20Wu%20C.%20Tumor-derived%20exosomal%20ICAM1%20promotes%20bone%20metastasis%20of%20triple-negative%20breast%20cancer%20by%20inducing%20CD8+%20T%20cell%20exhaustion.%20Int%20J%20Biochem%20Cell%20Biol.%202024;175:%20106637." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR41">
<span class="label">41.</span><cite>Salimu J, Webber J, Gurney M, Al-Taei S, Clayton A, Tabi Z. Dominant immunosuppression of dendritic cell function by prostate-cancer-derived exosomes. J Extracell Vesicles. 2017;6:1368823.
</cite> [<a href="https://doi.org/10.1080/20013078.2017.1368823" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5613918/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28959385/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Salimu%20J,%20Webber%20J,%20Gurney%20M,%20Al-Taei%20S,%20Clayton%20A,%20Tabi%20Z.%20Dominant%20immunosuppression%20of%20dendritic%20cell%20function%20by%20prostate-cancer-derived%20exosomes.%20J%20Extracell%20Vesicles.%202017;6:1368823." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR42">
<span class="label">42.</span><cite>Vignard V, Labbé M, Marec N, André-Grégoire G, Jouand N, Fonteneau J-F, et al. MicroRNAs in tumor exosomes drive immune escape in melanoma. Cancer Immunol Res. 2020;8:255–67.
</cite> [<a href="https://doi.org/10.1158/2326-6066.CIR-19-0522" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31857348/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Vignard%20V,%20Labb%C3%A9%20M,%20Marec%20N,%20Andr%C3%A9-Gr%C3%A9goire%20G,%20Jouand%20N,%20Fonteneau%20J-F,%20et%20al.%20MicroRNAs%20in%20tumor%20exosomes%20drive%20immune%20escape%20in%20melanoma.%20Cancer%20Immunol%20Res.%202020;8:255%E2%80%9367." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR43">
<span class="label">43.</span><cite>Li J, Sun L, Chen Y, Zhu J, Shen J, Wang J, et al. Gastric cancer-derived exosomal miR-135b-5p impairs the function of Vγ9Vδ2 T cells by targeting specificity protein 1. Cancer Immunol Immunother. 2022;71:311–25.
</cite> [<a href="https://doi.org/10.1007/s00262-021-02991-8" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10992495/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34159436/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Li%20J,%20Sun%20L,%20Chen%20Y,%20Zhu%20J,%20Shen%20J,%20Wang%20J,%20et%20al.%20Gastric%20cancer-derived%20exosomal%20miR-135b-5p%20impairs%20the%20function%20of%20V%CE%B39V%CE%B42%20T%20cells%20by%20targeting%20specificity%20protein%201.%20Cancer%20Immunol%20Immunother.%202022;71:311%E2%80%9325." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR44">
<span class="label">44.</span><cite>Wang X, Shen H, Zhangyuan G, Huang R, Zhang W, He Q, et al. 14-3-3ζ delivered by hepatocellular carcinoma-derived exosomes impaired anti-tumor function of tumor-infiltrating T lymphocytes. Cell Death Dis. 2018;9:159.
</cite> [<a href="https://doi.org/10.1038/s41419-017-0180-7" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5833352/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29415983/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Wang%20X,%20Shen%20H,%20Zhangyuan%20G,%20Huang%20R,%20Zhang%20W,%20He%20Q,%20et%20al.%2014-3-3%CE%B6%20delivered%20by%20hepatocellular%20carcinoma-derived%20exosomes%20impaired%20anti-tumor%20function%20of%20tumor-infiltrating%20T%20lymphocytes.%20Cell%20Death%20Dis.%202018;9:159." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR45">
<span class="label">45.</span><cite>Rao X, Zhou X, Wang G, Jie X, Xing B, Xu Y, et al. NLRP6 is required for cancer-derived exosome-modified macrophage M2 polarization and promotes metastasis in small cell lung cancer. Cell Death Dis. 2022;13:891.
</cite> [<a href="https://doi.org/10.1038/s41419-022-05336-0" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9587220/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36270983/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Rao%20X,%20Zhou%20X,%20Wang%20G,%20Jie%20X,%20Xing%20B,%20Xu%20Y,%20et%20al.%20NLRP6%20is%20required%20for%20cancer-derived%20exosome-modified%20macrophage%20M2%20polarization%20and%20promotes%20metastasis%20in%20small%20cell%20lung%20cancer.%20Cell%20Death%20Dis.%202022;13:891." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR46">
<span class="label">46.</span><cite>Yu H, Pan J, Zheng S, Cai D, Luo A, Xia Z, et al. Hepatocellular carcinoma cell-derived exosomal miR-21-5p induces macrophage M2 polarization by targeting RhoB. Int J Mol Sci. 2023;24:4593.
</cite> [<a href="https://doi.org/10.3390/ijms24054593" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10003272/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36902024/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Yu%20H,%20Pan%20J,%20Zheng%20S,%20Cai%20D,%20Luo%20A,%20Xia%20Z,%20et%20al.%20Hepatocellular%20carcinoma%20cell-derived%20exosomal%20miR-21-5p%20induces%20macrophage%20M2%20polarization%20by%20targeting%20RhoB.%20Int%20J%20Mol%20Sci.%202023;24:4593." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR47">
<span class="label">47.</span><cite>Lu Q, Wang X, Zhu J, Fei X, Chen H, Li C. Hypoxic tumor-derived exosomal Circ0048117 facilitates M2 macrophage polarization acting as miR-140 sponge in esophageal squamous cell carcinoma. OTT. 2020;13:11883–97.</cite> [<a href="https://doi.org/10.2147/OTT.S284192" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7682796/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33239890/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Lu%20Q,%20Wang%20X,%20Zhu%20J,%20Fei%20X,%20Chen%20H,%20Li%20C.%20Hypoxic%20tumor-derived%20exosomal%20Circ0048117%20facilitates%20M2%20macrophage%20polarization%20acting%20as%20miR-140%20sponge%20in%20esophageal%20squamous%20cell%20carcinoma.%20OTT.%202020;13:11883%E2%80%9397." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR48">
<span class="label">48.</span><cite>Guo J, Duan Z, Zhang C, Wang W, He H, Liu Y, et al. Mouse 4T1 breast cancer cell-derived exosomes induce proinflammatory cytokine production in macrophages via miR-183. J Immunol. 2020;205:2916–25.
</cite> [<a href="https://doi.org/10.4049/jimmunol.1901104" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32989094/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Guo%20J,%20Duan%20Z,%20Zhang%20C,%20Wang%20W,%20He%20H,%20Liu%20Y,%20et%20al.%20Mouse%204T1%20breast%20cancer%20cell-derived%20exosomes%20induce%20proinflammatory%20cytokine%20production%20in%20macrophages%20via%20miR-183.%20J%20Immunol.%202020;205:2916%E2%80%9325." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR49">
<span class="label">49.</span><cite>Jia X, Xi J, Tian B, Zhang Y, Wang Z, Wang F, et al. The tautomerase activity of tumor exosomal MIF promotes pancreatic cancer progression by modulating MDSC differentiation. Cancer Immunol Res. 2024;12:72–90.
</cite> [<a href="https://doi.org/10.1158/2326-6066.CIR-23-0205" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37956411/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Jia%20X,%20Xi%20J,%20Tian%20B,%20Zhang%20Y,%20Wang%20Z,%20Wang%20F,%20et%20al.%20The%20tautomerase%20activity%20of%20tumor%20exosomal%20MIF%20promotes%20pancreatic%20cancer%20progression%20by%20modulating%20MDSC%20differentiation.%20Cancer%20Immunol%20Res.%202024;12:72%E2%80%9390." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR50">
<span class="label">50.</span><cite>Du Z, Feng Y, Zhang H, Liu J, Wang J. Melanoma-derived small extracellular vesicles remodel the systemic onco-immunity via disrupting hematopoietic stem cell proliferation and differentiation. Cancer Lett. 2022;545: 215841.
</cite> [<a href="https://doi.org/10.1016/j.canlet.2022.215841" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35921973/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Du%20Z,%20Feng%20Y,%20Zhang%20H,%20Liu%20J,%20Wang%20J.%20Melanoma-derived%20small%20extracellular%20vesicles%20remodel%20the%20systemic%20onco-immunity%20via%20disrupting%20hematopoietic%20stem%20cell%20proliferation%20and%20differentiation.%20Cancer%20Lett.%202022;545:%20215841." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR51">
<span class="label">51.</span><cite>Yang J, Kang H, Liu Y, Lu S, Wu H, Zhang B, et al. Harnessing tumor cell-derived exosomes for immune rejection management in corneal transplantation. Adv Sci (Weinh). 2024;12:2409207.
</cite> [<a href="https://doi.org/10.1002/advs.202409207" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11727379/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39540242/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Yang%20J,%20Kang%20H,%20Liu%20Y,%20Lu%20S,%20Wu%20H,%20Zhang%20B,%20et%20al.%20Harnessing%20tumor%20cell-derived%20exosomes%20for%20immune%20rejection%20management%20in%20corneal%20transplantation.%20Adv%20Sci%20(Weinh).%202024;12:2409207." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR52">
<span class="label">52.</span><cite>Li H, Chen X, Zheng S, Han B, Zhang X, Zheng X, et al. The expansion of MDSCs induced by exosomal PD-L1 promotes the progression of gastric cancer. J Transl Med. 2024;22:821.
</cite> [<a href="https://doi.org/10.1186/s12967-024-05611-y" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11373121/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39227816/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Li%20H,%20Chen%20X,%20Zheng%20S,%20Han%20B,%20Zhang%20X,%20Zheng%20X,%20et%20al.%20The%20expansion%20of%20MDSCs%20induced%20by%20exosomal%20PD-L1%20promotes%20the%20progression%20of%20gastric%20cancer.%20J%20Transl%20Med.%202024;22:821." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR53">
<span class="label">53.</span><cite>Li J, Zhou C, Gao X, Tan T, Zhang M, Li Y, et al. S100A10 promotes cancer metastasis via recruitment of MDSCs within the lungs. Oncoimmunology. 2024;13:2381803.
</cite> [<a href="https://doi.org/10.1080/2162402X.2024.2381803" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11275524/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39071160/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Li%20J,%20Zhou%20C,%20Gao%20X,%20Tan%20T,%20Zhang%20M,%20Li%20Y,%20et%20al.%20S100A10%20promotes%20cancer%20metastasis%20via%20recruitment%20of%20MDSCs%20within%20the%20lungs.%20Oncoimmunology.%202024;13:2381803." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR54">
<span class="label">54.</span><cite>Gu P, Sun M, Li L, Yang Y, Jiang Z, Ge Y, et al. Breast tumor-derived exosomal MicroRNA-200b-3p promotes specific organ metastasis through regulating CCL2 expression in lung epithelial cells. Front Cell Dev Biol. 2021;9: 657158.
</cite> [<a href="https://doi.org/10.3389/fcell.2021.657158" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8264457/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34249913/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Gu%20P,%20Sun%20M,%20Li%20L,%20Yang%20Y,%20Jiang%20Z,%20Ge%20Y,%20et%20al.%20Breast%20tumor-derived%20exosomal%20MicroRNA-200b-3p%20promotes%20specific%20organ%20metastasis%20through%20regulating%20CCL2%20expression%20in%20lung%20epithelial%20cells.%20Front%20Cell%20Dev%20Biol.%202021;9:%20657158." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR55">
<span class="label">55.</span><cite>Capello M, Vykoukal JV, Katayama H, Bantis LE, Wang H, Kundnani DL, et al. Exosomes harbor B cell targets in pancreatic adenocarcinoma and exert decoy function against complement-mediated cytotoxicity. Nat Commun. 2019;10:254.
</cite> [<a href="https://doi.org/10.1038/s41467-018-08109-6" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6335434/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30651550/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Capello%20M,%20Vykoukal%20JV,%20Katayama%20H,%20Bantis%20LE,%20Wang%20H,%20Kundnani%20DL,%20et%20al.%20Exosomes%20harbor%20B%20cell%20targets%20in%20pancreatic%20adenocarcinoma%20and%20exert%20decoy%20function%20against%20complement-mediated%20cytotoxicity.%20Nat%20Commun.%202019;10:254." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR56">
<span class="label">56.</span><cite>Zhou W, Lovasz D, Zizzo Z, He Q, Coughlan C, Kowalski RG, et al. Phenotype and neuronal cytotoxic function of glioblastoma extracellular vesicles. Biomedicines. 2022;10:2718.
</cite> [<a href="https://doi.org/10.3390/biomedicines10112718" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9688005/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36359238/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Zhou%20W,%20Lovasz%20D,%20Zizzo%20Z,%20He%20Q,%20Coughlan%20C,%20Kowalski%20RG,%20et%20al.%20Phenotype%20and%20neuronal%20cytotoxic%20function%20of%20glioblastoma%20extracellular%20vesicles.%20Biomedicines.%202022;10:2718." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR57">
<span class="label">57.</span><cite>Pucci M, Moschetti M, Urzì O, Loria M, Conigliaro A, Di Bella MA, et al. Colorectal cancer-derived small extracellular vesicles induce TGFβ1-mediated epithelial to mesenchymal transition of hepatocytes. Cancer Cell Int. 2023;23:77.
</cite> [<a href="https://doi.org/10.1186/s12935-023-02916-8" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10114452/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37072829/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Pucci%20M,%20Moschetti%20M,%20Urz%C3%AC%20O,%20Loria%20M,%20Conigliaro%20A,%20Di%20Bella%20MA,%20et%20al.%20Colorectal%20cancer-derived%20small%20extracellular%20vesicles%20induce%20TGF%CE%B21-mediated%20epithelial%20to%20mesenchymal%20transition%20of%20hepatocytes.%20Cancer%20Cell%20Int.%202023;23:77." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR58">
<span class="label">58.</span><cite>Tellez-Gabriel M, Knutsen E, Perander M. Current status of circulating tumor cells, circulating tumor DNA, and exosomes in breast cancer liquid biopsies. Int J Mol Sci. 2020;21:9457.
</cite> [<a href="https://doi.org/10.3390/ijms21249457" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7763984/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33322643/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Tellez-Gabriel%20M,%20Knutsen%20E,%20Perander%20M.%20Current%20status%20of%20circulating%20tumor%20cells,%20circulating%20tumor%20DNA,%20and%20exosomes%20in%20breast%20cancer%20liquid%20biopsies.%20Int%20J%20Mol%20Sci.%202020;21:9457." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR59">
<span class="label">59.</span><cite>Lehuédé C, Li X, Dauvillier S, Vaysse C, Franchet C, Clement E, et al. Adipocytes promote breast cancer resistance to chemotherapy, a process amplified by obesity: role of the major vault protein (MVP). Breast Cancer Res. 2019;21:7.
</cite> [<a href="https://doi.org/10.1186/s13058-018-1088-6" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6337862/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30654824/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Lehu%C3%A9d%C3%A9%20C,%20Li%20X,%20Dauvillier%20S,%20Vaysse%20C,%20Franchet%20C,%20Clement%20E,%20et%20al.%20Adipocytes%20promote%20breast%20cancer%20resistance%20to%20chemotherapy,%20a%20process%20amplified%20by%20obesity:%20role%20of%20the%20major%20vault%20protein%20(MVP).%20Breast%20Cancer%20Res.%202019;21:7." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR60">
<span class="label">60.</span><cite>Mostafazadeh M, Samadi N, Kahroba H, Baradaran B, Haiaty S, Nouri M. Potential roles and prognostic significance of exosomes in cancer drug resistance. Cell Biosci. 2021;11:1.
</cite> [<a href="https://doi.org/10.1186/s13578-020-00515-y" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7789218/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33407894/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Mostafazadeh%20M,%20Samadi%20N,%20Kahroba%20H,%20Baradaran%20B,%20Haiaty%20S,%20Nouri%20M.%20Potential%20roles%20and%20prognostic%20significance%20of%20exosomes%20in%20cancer%20drug%20resistance.%20Cell%20Biosci.%202021;11:1." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR61">
<span class="label">61.</span><cite>Li Z, Meng X, Wu P, Zha C, Han B, Li L, et al. Glioblastoma cell-derived lncRNA-containing exosomes induce microglia to produce complement C5, promoting chemotherapy resistance. Cancer Immunol Res. 2021;9:1383–99.
</cite> [<a href="https://doi.org/10.1158/2326-6066.CIR-21-0258" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34667108/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Li%20Z,%20Meng%20X,%20Wu%20P,%20Zha%20C,%20Han%20B,%20Li%20L,%20et%20al.%20Glioblastoma%20cell-derived%20lncRNA-containing%20exosomes%20induce%20microglia%20to%20produce%20complement%20C5,%20promoting%20chemotherapy%20resistance.%20Cancer%20Immunol%20Res.%202021;9:1383%E2%80%9399." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR62">
<span class="label">62.</span><cite>Meng C, Yang Y, Feng W, Ma P, Bai R. Exosomal miR-331-3p derived from chemoresistant osteosarcoma cells induces chemoresistance through autophagy. J Orthop Surg Res. 2023;18:892.
</cite> [<a href="https://doi.org/10.1186/s13018-023-04338-8" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10666460/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37993925/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Meng%20C,%20Yang%20Y,%20Feng%20W,%20Ma%20P,%20Bai%20R.%20Exosomal%20miR-331-3p%20derived%20from%20chemoresistant%20osteosarcoma%20cells%20induces%20chemoresistance%20through%20autophagy.%20J%20Orthop%20Surg%20Res.%202023;18:892." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR63">
<span class="label">63.</span><cite>Mutschelknaus L, Peters C, Winkler K, Yentrapalli R, Heider T, Atkinson MJ, et al. Exosomes derived from squamous head and neck cancer promote cell survival after ionizing radiation. PLoS ONE. 2016;11: e0152213.
</cite> [<a href="https://doi.org/10.1371/journal.pone.0152213" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4805173/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27006994/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Mutschelknaus%20L,%20Peters%20C,%20Winkler%20K,%20Yentrapalli%20R,%20Heider%20T,%20Atkinson%20MJ,%20et%20al.%20Exosomes%20derived%20from%20squamous%20head%20and%20neck%20cancer%20promote%20cell%20survival%20after%20ionizing%20radiation.%20PLoS%20ONE.%202016;11:%20e0152213." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR64">
<span class="label">64.</span><cite>Affolter A, Liebel K, Tengler L, Seiz E, Tiedtke M, Azhakesan A, et al. Modulation of PD-L1 expression by standard therapy in head and neck cancer cell lines and exosomes. Int J Oncol. 2023;63:1–15.</cite> [<a href="https://doi.org/10.3892/ijo.2023.5550" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10552694/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37503786/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Affolter%20A,%20Liebel%20K,%20Tengler%20L,%20Seiz%20E,%20Tiedtke%20M,%20Azhakesan%20A,%20et%20al.%20Modulation%20of%20PD-L1%20expression%20by%20standard%20therapy%20in%20head%20and%20neck%20cancer%20cell%20lines%20and%20exosomes.%20Int%20J%20Oncol.%202023;63:1%E2%80%9315." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR65">
<span class="label">65.</span><cite>Du X, Zhang X, Dong J, Zou N, Guo D, Yao W, et al. Irradiation-induced exosomal HMGB1 to confer radioresistance via the PI3K/AKT/FOXO3A signaling pathway in ESCC. J Transl Med. 2022;20:507.
</cite> [<a href="https://doi.org/10.1186/s12967-022-03720-0" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9636677/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36335371/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Du%20X,%20Zhang%20X,%20Dong%20J,%20Zou%20N,%20Guo%20D,%20Yao%20W,%20et%20al.%20Irradiation-induced%20exosomal%20HMGB1%20to%20confer%20radioresistance%20via%20the%20PI3K/AKT/FOXO3A%20signaling%20pathway%20in%20ESCC.%20J%20Transl%20Med.%202022;20:507." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR66">
<span class="label">66.</span><cite>Yang L, Wu X-H, Wang D, Luo C-L, Chen L-X. Bladder cancer cell-derived exosomes inhibit tumor cell apoptosis and induce cell proliferation in vitro. Mol Med Rep. 2013;8:1272–8.
</cite> [<a href="https://doi.org/10.3892/mmr.2013.1634" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/23969721/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Yang%20L,%20Wu%20X-H,%20Wang%20D,%20Luo%20C-L,%20Chen%20L-X.%20Bladder%20cancer%20cell-derived%20exosomes%20inhibit%20tumor%20cell%20apoptosis%20and%20induce%20cell%20proliferation%20in%20vitro.%20Mol%20Med%20Rep.%202013;8:1272%E2%80%938." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR67">
<span class="label">67.</span><cite>Dong Y, Tamari K, Kishigami M, Katsuki S, Minami K, Tatekawa S, et al. Irradiated cell-derived exosomes enhance cell proliferation and radioresistance via the MAPK/Erk pathway. Cancer Genomics Proteomics. 2024;21:12–7.
</cite> [<a href="https://doi.org/10.21873/cgp.20425" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10756343/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38151290/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Dong%20Y,%20Tamari%20K,%20Kishigami%20M,%20Katsuki%20S,%20Minami%20K,%20Tatekawa%20S,%20et%20al.%20Irradiated%20cell-derived%20exosomes%20enhance%20cell%20proliferation%20and%20radioresistance%20via%20the%20MAPK/Erk%20pathway.%20Cancer%20Genomics%20Proteomics.%202024;21:12%E2%80%937." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR68">
<span class="label">68.</span><cite>Chen F, Xu B, Li J, Yang X, Gu J, Yao X, et al. Hypoxic tumour cell-derived exosomal miR-340-5p promotes radioresistance of oesophageal squamous cell carcinoma via KLF10. J Exp Clin Cancer Res. 2021;40:38.
</cite> [<a href="https://doi.org/10.1186/s13046-021-01834-9" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7825246/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33485367/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Chen%20F,%20Xu%20B,%20Li%20J,%20Yang%20X,%20Gu%20J,%20Yao%20X,%20et%20al.%20Hypoxic%20tumour%20cell-derived%20exosomal%20miR-340-5p%20promotes%20radioresistance%20of%20oesophageal%20squamous%20cell%20carcinoma%20via%20KLF10.%20J%20Exp%20Clin%20Cancer%20Res.%202021;40:38." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR69">
<span class="label">69.</span><cite>Chen L, Guo P, He Y, Chen Z, Chen L, Luo Y, et al. HCC-derived exosomes elicit HCC progression and recurrence by epithelial-mesenchymal transition through MAPK/ERK signalling pathway. Cell Death Dis. 2018;9:513.
</cite> [<a href="https://doi.org/10.1038/s41419-018-0534-9" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5938707/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29725020/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Chen%20L,%20Guo%20P,%20He%20Y,%20Chen%20Z,%20Chen%20L,%20Luo%20Y,%20et%20al.%20HCC-derived%20exosomes%20elicit%20HCC%20progression%20and%20recurrence%20by%20epithelial-mesenchymal%20transition%20through%20MAPK/ERK%20signalling%20pathway.%20Cell%20Death%20Dis.%202018;9:513." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR70">
<span class="label">70.</span><cite>Qin J, Yang J, Cui H, Feng C, Liu A. Exosomal miR-552-5p regulates the role of NK cells in EMT of gastric cancer via the PD-1/PD-L1 axis. J Cancer. 2025;16:406–16.
</cite> [<a href="https://doi.org/10.7150/jca.102360" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11685699/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39744482/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Qin%20J,%20Yang%20J,%20Cui%20H,%20Feng%20C,%20Liu%20A.%20Exosomal%20miR-552-5p%20regulates%20the%20role%20of%20NK%20cells%20in%20EMT%20of%20gastric%20cancer%20via%20the%20PD-1/PD-L1%20axis.%20J%20Cancer.%202025;16:406%E2%80%9316." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR71">
<span class="label">71.</span><cite>Zhulai G, Oleinik E, Shibaev M, Ignatev K. Adenosine-metabolizing enzymes, adenosine kinase and adenosine deaminase, in cancer. Biomolecules. 2022;12:418.
</cite> [<a href="https://doi.org/10.3390/biom12030418" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8946555/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35327609/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Zhulai%20G,%20Oleinik%20E,%20Shibaev%20M,%20Ignatev%20K.%20Adenosine-metabolizing%20enzymes,%20adenosine%20kinase%20and%20adenosine%20deaminase,%20in%20cancer.%20Biomolecules.%202022;12:418." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR72">
<span class="label">72.</span><cite>Saze Z, Schuler PJ, Hong C-S, Cheng D, Jackson EK, Whiteside TL. Adenosine production by human B cells and B cell–mediated suppression of activated T cells. Blood. 2013;122:9–18.
</cite> [<a href="https://doi.org/10.1182/blood-2013-02-482406" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3701906/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/23678003/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Saze%20Z,%20Schuler%20PJ,%20Hong%20C-S,%20Cheng%20D,%20Jackson%20EK,%20Whiteside%20TL.%20Adenosine%20production%20by%20human%20B%20cells%20and%20B%20cell%E2%80%93mediated%20suppression%20of%20activated%20T%20cells.%20Blood.%202013;122:9%E2%80%9318." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR73">
<span class="label">73.</span><cite>Theodoraki M-N, Laban S, Jackson EK, Lotfi R, Schuler PJ, Brunner C, et al. Changes in circulating exosome molecular profiles following surgery/(chemo)radiotherapy: early detection of response in head and neck cancer patients. Br J Cancer. 2021;125:1677–86.
</cite> [<a href="https://doi.org/10.1038/s41416-021-01567-8" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8651659/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34642463/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Theodoraki%20M-N,%20Laban%20S,%20Jackson%20EK,%20Lotfi%20R,%20Schuler%20PJ,%20Brunner%20C,%20et%20al.%20Changes%20in%20circulating%20exosome%20molecular%20profiles%20following%20surgery/(chemo)radiotherapy:%20early%20detection%20of%20response%20in%20head%20and%20neck%20cancer%20patients.%20Br%20J%20Cancer.%202021;125:1677%E2%80%9386." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR74">
<span class="label">74.</span><cite>Ye Z, Yi J, Jiang X, Shi W, Xu H, Cao H, et al. Gastric cancer-derived exosomal let-7 g-5p mediated by SERPINE1 promotes macrophage M2 polarization and gastric cancer progression. J Exp Clin Cancer Res. 2025;44:2.
</cite> [<a href="https://doi.org/10.1186/s13046-024-03269-4" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11694445/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39748408/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Ye%20Z,%20Yi%20J,%20Jiang%20X,%20Shi%20W,%20Xu%20H,%20Cao%20H,%20et%20al.%20Gastric%20cancer-derived%20exosomal%20let-7%20g-5p%20mediated%20by%20SERPINE1%20promotes%20macrophage%20M2%20polarization%20and%20gastric%20cancer%20progression.%20J%20Exp%20Clin%20Cancer%20Res.%202025;44:2." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR75">
<span class="label">75.</span><cite>Wu L, Ye S, Yao Y, Zhang C, Liu W. Oral cancer stem cell-derived small extracellular vesicles promote M2 macrophage polarization and suppress CD4+ T-cell activity by transferring UCA1 and targeting LAMC2. Stem Cells Int. 2022;2022:5817684.
</cite> [<a href="https://doi.org/10.1155/2022/5817684" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9723417/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36483681/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Wu%20L,%20Ye%20S,%20Yao%20Y,%20Zhang%20C,%20Liu%20W.%20Oral%20cancer%20stem%20cell-derived%20small%20extracellular%20vesicles%20promote%20M2%20macrophage%20polarization%20and%20suppress%20CD4+%20T-cell%20activity%20by%20transferring%20UCA1%20and%20targeting%20LAMC2.%20Stem%20Cells%20Int.%202022;2022:5817684." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR76">
<span class="label">76.</span><cite>Alharbi M, Sharma S, Guanzon D, Lai A, Zuñiga F, Shiddiky MJA, et al. miRNa signature in small extracellular vesicles and their association with platinum resistance and cancer recurrence in ovarian cancer. Nanomed Nanotechnol Biol Med. 2020;28: 102207.</cite> [<a href="https://doi.org/10.1016/j.nano.2020.102207" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32334098/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Alharbi%20M,%20Sharma%20S,%20Guanzon%20D,%20Lai%20A,%20Zu%C3%B1iga%20F,%20Shiddiky%20MJA,%20et%20al.%20miRNa%20signature%20in%20small%20extracellular%20vesicles%20and%20their%20association%20with%20platinum%20resistance%20and%20cancer%20recurrence%20in%20ovarian%20cancer.%20Nanomed%20Nanotechnol%20Biol%20Med.%202020;28:%20102207." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR77">
<span class="label">77.</span><cite>Xu X, Zheng Y, Luo L, You Z, Chen H, Wang J, et al. Glioblastoma stem cells deliver ABCB4 transcribed by ATF3 via exosomes conferring glioblastoma resistance to temozolomide. Cell Death Dis. 2024;15:1–17.
</cite> [<a href="https://doi.org/10.1038/s41419-024-06695-6" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11074105/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38710703/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Xu%20X,%20Zheng%20Y,%20Luo%20L,%20You%20Z,%20Chen%20H,%20Wang%20J,%20et%20al.%20Glioblastoma%20stem%20cells%20deliver%20ABCB4%20transcribed%20by%20ATF3%20via%20exosomes%20conferring%20glioblastoma%20resistance%20to%20temozolomide.%20Cell%20Death%20Dis.%202024;15:1%E2%80%9317." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR78">
<span class="label">78.</span><cite>Wang Z-F, Liao F, Wu H, Dai J. Glioma stem cells-derived exosomal miR-26a promotes angiogenesis of microvessel endothelial cells in glioma. J Exp Clin Cancer Res CR. 2019;38:201.
</cite> [<a href="https://doi.org/10.1186/s13046-019-1181-4" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6525364/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31101062/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Wang%20Z-F,%20Liao%20F,%20Wu%20H,%20Dai%20J.%20Glioma%20stem%20cells-derived%20exosomal%20miR-26a%20promotes%20angiogenesis%20of%20microvessel%20endothelial%20cells%20in%20glioma.%20J%20Exp%20Clin%20Cancer%20Res%20CR.%202019;38:201." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR79">
<span class="label">79.</span><cite>Tang T, Yang T, Xue H, Liu X, Yu J, Liang C, et al. Breast cancer stem cell-derived exosomal lnc-PDGFD induces fibroblast-niche formation and promotes lung metastasis. Oncogene. 2024;44:1–17.
</cite> [<a href="https://doi.org/10.1038/s41388-024-03237-4" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11850284/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39633064/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Tang%20T,%20Yang%20T,%20Xue%20H,%20Liu%20X,%20Yu%20J,%20Liang%20C,%20et%20al.%20Breast%20cancer%20stem%20cell-derived%20exosomal%20lnc-PDGFD%20induces%20fibroblast-niche%20formation%20and%20promotes%20lung%20metastasis.%20Oncogene.%202024;44:1%E2%80%9317." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR80">
<span class="label">80.</span><cite>Wang Y, Chen Q, Song H, Zhang Y, Chen H, Liu P, et al. A triple therapeutic strategy with antiexosomal iron efflux for enhanced ferroptosis therapy and immunotherapy. Small. 2022;18: e2201704.
</cite> [<a href="https://doi.org/10.1002/smll.202201704" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36071027/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Wang%20Y,%20Chen%20Q,%20Song%20H,%20Zhang%20Y,%20Chen%20H,%20Liu%20P,%20et%20al.%20A%20triple%20therapeutic%20strategy%20with%20antiexosomal%20iron%20efflux%20for%20enhanced%20ferroptosis%20therapy%20and%20immunotherapy.%20Small.%202022;18:%20e2201704." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR81">
<span class="label">81.</span><cite>Cai H, Ren Y, Chen S, Wang Y, Chu L. Ferroptosis and tumor immunotherapy: a promising combination therapy for tumors. Front Oncol. 2023;13:1119369.
</cite> [<a href="https://doi.org/10.3389/fonc.2023.1119369" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9945274/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36845720/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Cai%20H,%20Ren%20Y,%20Chen%20S,%20Wang%20Y,%20Chu%20L.%20Ferroptosis%20and%20tumor%20immunotherapy:%20a%20promising%20combination%20therapy%20for%20tumors.%20Front%20Oncol.%202023;13:1119369." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR82">
<span class="label">82.</span><cite>Chen A, Zhang W, Jiang C, Jiang Z, Tang D. The engineered exosomes targeting ferroptosis: a novel approach to reverse immune checkpoint inhibitors resistance. Int J Cancer. 2024;155:7–18.
</cite> [<a href="https://doi.org/10.1002/ijc.34934" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38533694/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Chen%20A,%20Zhang%20W,%20Jiang%20C,%20Jiang%20Z,%20Tang%20D.%20The%20engineered%20exosomes%20targeting%20ferroptosis:%20a%20novel%20approach%20to%20reverse%20immune%20checkpoint%20inhibitors%20resistance.%20Int%20J%20Cancer.%202024;155:7%E2%80%9318." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR83">
<span class="label">83.</span><cite>Efimova I, Catanzaro E, Van der Meeren L, Turubanova VD, Hammad H, Mishchenko TA, et al. Vaccination with early ferroptotic cancer cells induces efficient antitumor immunity. J Immunother Cancer. 2020;8: e001369.
</cite> [<a href="https://doi.org/10.1136/jitc-2020-001369" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7668384/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33188036/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Efimova%20I,%20Catanzaro%20E,%20Van%20der%20Meeren%20L,%20Turubanova%20VD,%20Hammad%20H,%20Mishchenko%20TA,%20et%20al.%20Vaccination%20with%20early%20ferroptotic%20cancer%20cells%20induces%20efficient%20antitumor%20immunity.%20J%20Immunother%20Cancer.%202020;8:%20e001369." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR84">
<span class="label">84.</span><cite>Song Z, Jia G, Ma P, Cang S. Exosomal miR-4443 promotes cisplatin resistance in non-small cell lung carcinoma by regulating FSP1 m6A modification-mediated ferroptosis. Life Sci. 2021;276: 119399.
</cite> [<a href="https://doi.org/10.1016/j.lfs.2021.119399" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33781830/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Song%20Z,%20Jia%20G,%20Ma%20P,%20Cang%20S.%20Exosomal%20miR-4443%20promotes%20cisplatin%20resistance%20in%20non-small%20cell%20lung%20carcinoma%20by%20regulating%20FSP1%20m6A%20modification-mediated%20ferroptosis.%20Life%20Sci.%202021;276:%20119399." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR85">
<span class="label">85.</span><cite>Zhang H, Wang M, He Y, Deng T, Liu R, Wang W, et al. Chemotoxicity-induced exosomal lncFERO regulates ferroptosis and stemness in gastric cancer stem cells. Cell Death Dis. 2021;12:1116.
</cite> [<a href="https://doi.org/10.1038/s41419-021-04406-z" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8629982/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34845198/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Zhang%20H,%20Wang%20M,%20He%20Y,%20Deng%20T,%20Liu%20R,%20Wang%20W,%20et%20al.%20Chemotoxicity-induced%20exosomal%20lncFERO%20regulates%20ferroptosis%20and%20stemness%20in%20gastric%20cancer%20stem%20cells.%20Cell%20Death%20Dis.%202021;12:1116." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR86">
<span class="label">86.</span><cite>Wang X, Tian L, Lu J, Ng IOL. Exosomes and cancer—Diagnostic and prognostic biomarkers and therapeutic vehicle. Oncogenesis. 2022;11:1–12.
</cite> [<a href="https://doi.org/10.1038/s41389-022-00431-5" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9477829/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36109501/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Wang%20X,%20Tian%20L,%20Lu%20J,%20Ng%20IOL.%20Exosomes%20and%20cancer%E2%80%94Diagnostic%20and%20prognostic%20biomarkers%20and%20therapeutic%20vehicle.%20Oncogenesis.%202022;11:1%E2%80%9312." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR87">
<span class="label">87.</span><cite>Castillo J, Bernard V, San Lucas FA, Allenson K, Capello M, Kim DU, et al. Surfaceome profiling enables isolation of cancer-specific exosomal cargo in liquid biopsies from pancreatic cancer patients. Ann Oncol. 2018;29:223–9.
</cite> [<a href="https://doi.org/10.1093/annonc/mdx542" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6248757/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29045505/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Castillo%20J,%20Bernard%20V,%20San%20Lucas%20FA,%20Allenson%20K,%20Capello%20M,%20Kim%20DU,%20et%20al.%20Surfaceome%20profiling%20enables%20isolation%20of%20cancer-specific%20exosomal%20cargo%20in%20liquid%20biopsies%20from%20pancreatic%20cancer%20patients.%20Ann%20Oncol.%202018;29:223%E2%80%939." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR88">
<span class="label">88.</span><cite>Shi H, Liu L, Deng X, Xing X, Zhang Y, Djouda Rebecca Y, et al. Exosomal biomarkers in the differential diagnosis of ovarian tumors: the emerging roles of CA125, HE4, and C5a. J Ovar Res. 2024;17:4.</cite> [<a href="https://doi.org/10.1186/s13048-023-01336-6" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10768525/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38178252/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Shi%20H,%20Liu%20L,%20Deng%20X,%20Xing%20X,%20Zhang%20Y,%20Djouda%20Rebecca%20Y,%20et%20al.%20Exosomal%20biomarkers%20in%20the%20differential%20diagnosis%20of%20ovarian%20tumors:%20the%20emerging%20roles%20of%20CA125,%20HE4,%20and%20C5a.%20J%20Ovar%20Res.%202024;17:4." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR89">
<span class="label">89.</span><cite>Fanale D, Corsini LR, Bono M, Randazzo U, Barraco N, Brando C, et al. Clinical relevance of exosome-derived microRNAs in Ovarian Cancer: looking for new tumor biological fingerprints. Crit Rev Oncol Hematol. 2024;193: 104220.
</cite> [<a href="https://doi.org/10.1016/j.critrevonc.2023.104220" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38036154/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Fanale%20D,%20Corsini%20LR,%20Bono%20M,%20Randazzo%20U,%20Barraco%20N,%20Brando%20C,%20et%20al.%20Clinical%20relevance%20of%20exosome-derived%20microRNAs%20in%20Ovarian%20Cancer:%20looking%20for%20new%20tumor%20biological%20fingerprints.%20Crit%20Rev%20Oncol%20Hematol.%202024;193:%20104220." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR90">
<span class="label">90.</span><cite>Horie K, Nanashima N, Yokoyama Y, Yoshioka H, Watanabe J. Exosomal MicroRNA as Biomarkers for diagnosing or monitoring the progression of ovarian clear cell carcinoma: a pilot study. Molecules. 2022;27:3953.
</cite> [<a href="https://doi.org/10.3390/molecules27123953" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9228939/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35745075/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Horie%20K,%20Nanashima%20N,%20Yokoyama%20Y,%20Yoshioka%20H,%20Watanabe%20J.%20Exosomal%20MicroRNA%20as%20Biomarkers%20for%20diagnosing%20or%20monitoring%20the%20progression%20of%20ovarian%20clear%20cell%20carcinoma:%20a%20pilot%20study.%20Molecules.%202022;27:3953." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR91">
<span class="label">91.</span><cite>Liu M, Mo F, Song X, He Y, Yuan Y, Yan J, et al. Exosomal hsa-miR-21-5p is a biomarker for breast cancer diagnosis. PeerJ. 2021;9: e12147.
</cite> [<a href="https://doi.org/10.7717/peerj.12147" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8451442/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34616615/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Liu%20M,%20Mo%20F,%20Song%20X,%20He%20Y,%20Yuan%20Y,%20Yan%20J,%20et%20al.%20Exosomal%20hsa-miR-21-5p%20is%20a%20biomarker%20for%20breast%20cancer%20diagnosis.%20PeerJ.%202021;9:%20e12147." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR92">
<span class="label">92.</span><cite>Lei Y, Fei X, Ding Y, Zhang J, Zhang G, Dong L, et al. Simultaneous subset tracing and miRNA profiling of tumor-derived exosomes via dual-surface-protein orthogonal barcoding. Sci Adv. 2023;9:eadi1556.
</cite> [<a href="https://doi.org/10.1126/sciadv.adi1556" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10550235/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37792944/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Lei%20Y,%20Fei%20X,%20Ding%20Y,%20Zhang%20J,%20Zhang%20G,%20Dong%20L,%20et%20al.%20Simultaneous%20subset%20tracing%20and%20miRNA%20profiling%20of%20tumor-derived%20exosomes%20via%20dual-surface-protein%20orthogonal%20barcoding.%20Sci%20Adv.%202023;9:eadi1556." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR93">
<span class="label">93.</span><cite>Cao Y, Yu X, Zeng T, Fu Z, Zhao Y, Nie B, et al. Molecular characterization of exosomes for subtype-based diagnosis of breast cancer. J Am Chem Soc. 2022;144:13475–86.
</cite> [<a href="https://doi.org/10.1021/jacs.2c00119" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35802880/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Cao%20Y,%20Yu%20X,%20Zeng%20T,%20Fu%20Z,%20Zhao%20Y,%20Nie%20B,%20et%20al.%20Molecular%20characterization%20of%20exosomes%20for%20subtype-based%20diagnosis%20of%20breast%20cancer.%20J%20Am%20Chem%20Soc.%202022;144:13475%E2%80%9386." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR94">
<span class="label">94.</span><cite>Deng C, Huo M, Chu H, Zhuang X, Deng G, Li W, et al. Exosome circATP8A1 induces macrophage M2 polarization by regulating the miR-1-3p/STAT6 axis to promote gastric cancer progression. Mol Cancer. 2024;23:49.
</cite> [<a href="https://doi.org/10.1186/s12943-024-01966-4" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10921793/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38459596/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Deng%20C,%20Huo%20M,%20Chu%20H,%20Zhuang%20X,%20Deng%20G,%20Li%20W,%20et%20al.%20Exosome%20circATP8A1%20induces%20macrophage%20M2%20polarization%20by%20regulating%20the%20miR-1-3p/STAT6%20axis%20to%20promote%20gastric%20cancer%20progression.%20Mol%20Cancer.%202024;23:49." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR95">
<span class="label">95.</span><cite>Dorado E, Doria ML, Nagelkerke A, McKenzie JS, Maneta-Stavrakaki S, Whittaker TE, et al. Extracellular vesicles as a promising source of lipid biomarkers for breast cancer detection in blood plasma. J Extracell Vesicles. 2024;13: e12419.
</cite> [<a href="https://doi.org/10.1002/jev2.12419" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10914699/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38443328/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Dorado%20E,%20Doria%20ML,%20Nagelkerke%20A,%20McKenzie%20JS,%20Maneta-Stavrakaki%20S,%20Whittaker%20TE,%20et%20al.%20Extracellular%20vesicles%20as%20a%20promising%20source%20of%20lipid%20biomarkers%20for%20breast%20cancer%20detection%20in%20blood%20plasma.%20J%20Extracell%20Vesicles.%202024;13:%20e12419." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR96">
<span class="label">96.</span><cite>Sun X, Chen B, Shan Y, Jian M, Wang Z. Lectin microarray based glycan profiling of exosomes for dynamic monitoring of colorectal cancer progression. Anal Chim Acta. 2024;1316: 342819.
</cite> [<a href="https://doi.org/10.1016/j.aca.2024.342819" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38969421/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Sun%20X,%20Chen%20B,%20Shan%20Y,%20Jian%20M,%20Wang%20Z.%20Lectin%20microarray%20based%20glycan%20profiling%20of%20exosomes%20for%20dynamic%20monitoring%20of%20colorectal%20cancer%20progression.%20Anal%20Chim%20Acta.%202024;1316:%20342819." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR97">
<span class="label">97.</span><cite>Dong X, Bai X, Ni J, Zhang H, Duan W, Graham P, et al. Exosomes and breast cancer drug resistance. Cell Death Dis. 2020;11:987.
</cite> [<a href="https://doi.org/10.1038/s41419-020-03189-z" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7673022/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33203834/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Dong%20X,%20Bai%20X,%20Ni%20J,%20Zhang%20H,%20Duan%20W,%20Graham%20P,%20et%20al.%20Exosomes%20and%20breast%20cancer%20drug%20resistance.%20Cell%20Death%20Dis.%202020;11:987." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR98">
<span class="label">98.</span><cite>Szajnik M, Derbis M, Lach M, Patalas P, Michalak M, Drzewiecka H, et al. Exosomes in plasma of patients with ovarian carcinoma: potential biomarkers of tumor progression and response to therapy. Gynecol Obstet (Sunnyvale). 2013. 
</cite> [<a href="https://doi.org/10.4172/2161-0932.S4-003" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3899646/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24466501/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Szajnik%20M,%20Derbis%20M,%20Lach%20M,%20Patalas%20P,%20Michalak%20M,%20Drzewiecka%20H,%20et%20al.%20Exosomes%20in%20plasma%20of%20patients%20with%20ovarian%20carcinoma:%20potential%20biomarkers%20of%20tumor%20progression%20and%20response%20to%20therapy.%20Gynecol%20Obstet%20(Sunnyvale).%202013.%C2%A0" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR99">
<span class="label">99.</span><cite>Yang Q, Zhao S, Shi Z, Cao L, Liu GG, Pan T, et al. Chemotherapy-elicited exosomal miR-378a-3p and miR-378d promote breast cancer stemness and chemoresistance via the activation of EZH2/STAT3 signaling. J Exp Clin Cancer Res. 2021;40:1–18.
</cite> [<a href="https://doi.org/10.1186/s13046-021-01901-1" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8022546/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33823894/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Yang%20Q,%20Zhao%20S,%20Shi%20Z,%20Cao%20L,%20Liu%20GG,%20Pan%20T,%20et%20al.%20Chemotherapy-elicited%20exosomal%20miR-378a-3p%20and%20miR-378d%20promote%20breast%20cancer%20stemness%20and%20chemoresistance%20via%20the%20activation%20of%20EZH2/STAT3%20signaling.%20J%20Exp%20Clin%20Cancer%20Res.%202021;40:1%E2%80%9318." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR100">
<span class="label">100.</span><cite>Feng Y, Zhong M, Zeng S, Wang L, Liu P, Xiao X, et al. Exosome-derived miRNAs as predictive biomarkers for diffuse large B-cell lymphoma chemotherapy resistance. Epigenomics. 2019;11:35–51.
</cite> [<a href="https://doi.org/10.2217/epi-2018-0123" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30211623/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Feng%20Y,%20Zhong%20M,%20Zeng%20S,%20Wang%20L,%20Liu%20P,%20Xiao%20X,%20et%20al.%20Exosome-derived%20miRNAs%20as%20predictive%20biomarkers%20for%20diffuse%20large%20B-cell%20lymphoma%20chemotherapy%20resistance.%20Epigenomics.%202019;11:35%E2%80%9351." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR101">
<span class="label">101.</span><cite>Yang C, Kim HS, Park SJ, Lee EJ, Kim SI, Song G, et al. Inhibition of miR-214-3p aids in preventing epithelial ovarian cancer malignancy by increasing the expression of LHX6. Cancers (Basel). 2019;11:1917.
</cite> [<a href="https://doi.org/10.3390/cancers11121917" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6966693/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31810245/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Yang%20C,%20Kim%20HS,%20Park%20SJ,%20Lee%20EJ,%20Kim%20SI,%20Song%20G,%20et%20al.%20Inhibition%20of%20miR-214-3p%20aids%20in%20preventing%20epithelial%20ovarian%20cancer%20malignancy%20by%20increasing%20the%20expression%20of%20LHX6.%20Cancers%20(Basel).%202019;11:1917." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR102">
<span class="label">102.</span><cite>Tian W, Lei N, Zhou J, Chen M, Guo R, Qin B, et al. Extracellular vesicles in ovarian cancer chemoresistance, metastasis, and immune evasion. Cell Death Dis. 2022;13:1–12.</cite> [<a href="https://doi.org/10.1038/s41419-022-04510-8" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8766448/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35042862/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Tian%20W,%20Lei%20N,%20Zhou%20J,%20Chen%20M,%20Guo%20R,%20Qin%20B,%20et%20al.%20Extracellular%20vesicles%20in%20ovarian%20cancer%20chemoresistance,%20metastasis,%20and%20immune%20evasion.%20Cell%20Death%20Dis.%202022;13:1%E2%80%9312." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR103">
<span class="label">103.</span><cite>Zou Y, Zhao Z, Wang J, Ma L, Liu Y, Sun L, et al. Extracellular vesicles carrying miR-6836 derived from resistant tumor cells transfer cisplatin resistance of epithelial ovarian cancer via DLG2-YAP1 signaling pathway. Int J Biol Sci. 2023;19:3099–114.
</cite> [<a href="https://doi.org/10.7150/ijbs.83264" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10321283/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37416779/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Zou%20Y,%20Zhao%20Z,%20Wang%20J,%20Ma%20L,%20Liu%20Y,%20Sun%20L,%20et%20al.%20Extracellular%20vesicles%20carrying%20miR-6836%20derived%20from%20resistant%20tumor%20cells%20transfer%20cisplatin%20resistance%20of%20epithelial%20ovarian%20cancer%20via%20DLG2-YAP1%20signaling%20pathway.%20Int%20J%20Biol%20Sci.%202023;19:3099%E2%80%93114." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR104">
<span class="label">104.</span><cite>Zhu X, Long L, Xiao H, He X. Cancer-derived exosomal miR-651 as a diagnostic marker restrains cisplatin resistance and directly targets ATG3 for cervical cancer. Dis Markers. 2021;2021:1544784.
</cite> [<a href="https://doi.org/10.1155/2021/1544784" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8460390/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34567283/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Zhu%20X,%20Long%20L,%20Xiao%20H,%20He%20X.%20Cancer-derived%20exosomal%20miR-651%20as%20a%20diagnostic%20marker%20restrains%20cisplatin%20resistance%20and%20directly%20targets%20ATG3%20for%20cervical%20cancer.%20Dis%20Markers.%202021;2021:1544784." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR105">
<span class="label">105.</span><cite>Wan X, Xie B, Sun H, Gu W, Wang C, Deng Q, et al. Exosomes derived from M2 type tumor-associated macrophages promote osimertinib resistance in non-small cell lung cancer through MSTRG.292666.16-miR-6836-5p-MAPK8IP3 axis. Cancer Cell Int. 2022;22:83.
</cite> [<a href="https://doi.org/10.1186/s12935-022-02509-x" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8845243/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35168607/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Wan%20X,%20Xie%20B,%20Sun%20H,%20Gu%20W,%20Wang%20C,%20Deng%20Q,%20et%20al.%20Exosomes%20derived%20from%20M2%20type%20tumor-associated%20macrophages%20promote%20osimertinib%20resistance%20in%20non-small%20cell%20lung%20cancer%20through%20MSTRG.292666.16-miR-6836-5p-MAPK8IP3%20axis.%20Cancer%20Cell%20Int.%202022;22:83." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR106">
<span class="label">106.</span><cite>Yang B, Teng F, Chang L, Wang J, Liu D-L, Cui Y-S, et al. Tumor-derived exosomal circRNA_102481 contributes to EGFR-TKIs resistance via the miR-30a-5p/ROR1 axis in non-small cell lung cancer. Aging (Albany NY). 2021;13:13264–86.
</cite> [<a href="https://doi.org/10.18632/aging.203011" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8148492/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33952725/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Yang%20B,%20Teng%20F,%20Chang%20L,%20Wang%20J,%20Liu%20D-L,%20Cui%20Y-S,%20et%20al.%20Tumor-derived%20exosomal%20circRNA_102481%20contributes%20to%20EGFR-TKIs%20resistance%20via%20the%20miR-30a-5p/ROR1%20axis%20in%20non-small%20cell%20lung%20cancer.%20Aging%20(Albany%20NY).%202021;13:13264%E2%80%9386." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR107">
<span class="label">107.</span><cite>Su Y-Y, Chao C-H, Hsu H-Y, Li H-K, Wang Y-L, Wu Lee Y-H, et al. DDX3 suppresses hepatocellular carcinoma progression through modulating the secretion and composition of exosome. Am J Cancer Res. 2023;13:1744–65.
</cite> [<a href="/articles/PMC10244113/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37293175/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Su%20Y-Y,%20Chao%20C-H,%20Hsu%20H-Y,%20Li%20H-K,%20Wang%20Y-L,%20Wu%20Lee%20Y-H,%20et%20al.%20DDX3%20suppresses%20hepatocellular%20carcinoma%20progression%20through%20modulating%20the%20secretion%20and%20composition%20of%20exosome.%20Am%20J%20Cancer%20Res.%202023;13:1744%E2%80%9365." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR108">
<span class="label">108.</span><cite>Yuan F, Zhou Z-F. Exosomes derived from Taxol-resistant nasopharyngeal carcinoma (NPC) cells transferred DDX53 to NPC cells and promoted cancer resistance to Taxol. Eur Rev Med Pharmacol Sci. 2021;25:127–38.
</cite> [<a href="https://doi.org/10.26355/eurrev_202101_24375" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33506900/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Yuan%20F,%20Zhou%20Z-F.%20Exosomes%20derived%20from%20Taxol-resistant%20nasopharyngeal%20carcinoma%20(NPC)%20cells%20transferred%20DDX53%20to%20NPC%20cells%20and%20promoted%20cancer%20resistance%20to%20Taxol.%20Eur%20Rev%20Med%20Pharmacol%20Sci.%202021;25:127%E2%80%9338." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR109">
<span class="label">109.</span><cite>Wang J, Li T, Wang B. Exosomal transfer of miR-25-3p promotes the proliferation and temozolomide resistance of glioblastoma cells by targeting FBXW7. Int J Oncol. 2021;59:64.
</cite> [<a href="https://doi.org/10.3892/ijo.2021.5244" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8295027/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34278448/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Wang%20J,%20Li%20T,%20Wang%20B.%20Exosomal%20transfer%20of%20miR-25-3p%20promotes%20the%20proliferation%20and%20temozolomide%20resistance%20of%20glioblastoma%20cells%20by%20targeting%20FBXW7.%20Int%20J%20Oncol.%202021;59:64." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR110">
<span class="label">110.</span><cite>Tang S, Zheng K, Tang Y, Li Z, Zou T, Liu D. Overexpression of serum exosomal HOTAIR is correlated with poor survival and poor response to chemotherapy in breast cancer patients. J Biosci. 2019;44:1–8.
</cite> [<a href="https://pubmed.ncbi.nlm.nih.gov/31180050/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Tang%20S,%20Zheng%20K,%20Tang%20Y,%20Li%20Z,%20Zou%20T,%20Liu%20D.%20Overexpression%20of%20serum%20exosomal%20HOTAIR%20is%20correlated%20with%20poor%20survival%20and%20poor%20response%20to%20chemotherapy%20in%20breast%20cancer%20patients.%20J%20Biosci.%202019;44:1%E2%80%938." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR111">
<span class="label">111.</span><cite>Ning T, Li J, He Y, Zhang H, Wang X, Deng T, et al. Exosomal miR-208b related with oxaliplatin resistance promotes Treg expansion in colorectal cancer. Mol Ther. 2021;29:2723–36.
</cite> [<a href="https://doi.org/10.1016/j.ymthe.2021.04.028" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8417448/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33905821/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Ning%20T,%20Li%20J,%20He%20Y,%20Zhang%20H,%20Wang%20X,%20Deng%20T,%20et%20al.%20Exosomal%20miR-208b%20related%20with%20oxaliplatin%20resistance%20promotes%20Treg%20expansion%20in%20colorectal%20cancer.%20Mol%20Ther.%202021;29:2723%E2%80%9336." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR112">
<span class="label">112.</span><cite>Hu J, Liu W-F, Zhang X-Y, Shi G-M, Yang X-R, Zhou K-Q, et al. Synthetic miR-26a mimics delivered by tumor exosomes repress hepatocellular carcinoma through downregulating lymphoid enhancer factor 1. Hepatol Int. 2023;17:1265–78.
</cite> [<a href="https://doi.org/10.1007/s12072-023-10527-8" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37115456/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Hu%20J,%20Liu%20W-F,%20Zhang%20X-Y,%20Shi%20G-M,%20Yang%20X-R,%20Zhou%20K-Q,%20et%20al.%20Synthetic%20miR-26a%20mimics%20delivered%20by%20tumor%20exosomes%20repress%20hepatocellular%20carcinoma%20through%20downregulating%20lymphoid%20enhancer%20factor%201.%20Hepatol%20Int.%202023;17:1265%E2%80%9378." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR113">
<span class="label">113.</span><cite>Zhou Q, Wang J, Zhang H, Sun L, Liu J, Meng L, et al. Tumor-derived exosomes RNA expression profiling identifies the prognosis, immune characteristics, and treatment in HR+/HER2-breast cancer. Aging (Albany NY). 2023;15:8471–86.
</cite> [<a href="https://doi.org/10.18632/aging.204986" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10497011/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37647033/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Zhou%20Q,%20Wang%20J,%20Zhang%20H,%20Sun%20L,%20Liu%20J,%20Meng%20L,%20et%20al.%20Tumor-derived%20exosomes%20RNA%20expression%20profiling%20identifies%20the%20prognosis,%20immune%20characteristics,%20and%20treatment%20in%20HR+/HER2-breast%20cancer.%20Aging%20(Albany%20NY).%202023;15:8471%E2%80%9386." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR114">
<span class="label">114.</span><cite>Liu Y, Tang Y, Jiang H, Zhang X, Chen X, Guo J, et al. Exosome-related FTCD facilitates M1 macrophage polarization and impacts the prognosis of hepatocellular carcinoma. Biomolecules. 2024;14:41.</cite> [<a href="https://doi.org/10.3390/biom14010041" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10813691/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38254641/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Liu%20Y,%20Tang%20Y,%20Jiang%20H,%20Zhang%20X,%20Chen%20X,%20Guo%20J,%20et%20al.%20Exosome-related%20FTCD%20facilitates%20M1%20macrophage%20polarization%20and%20impacts%20the%20prognosis%20of%20hepatocellular%20carcinoma.%20Biomolecules.%202024;14:41." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR115">
<span class="label">115.</span><cite>Cui Y, Zhang W, Lu W, Feng Y, Wu X, Zhuo Z, et al. An exosome-derived lncRNA signature identified by machine learning associated with prognosis and biomarkers for immunotherapy in ovarian cancer. Front Immunol. 2024;15:1228235.
</cite> [<a href="https://doi.org/10.3389/fimmu.2024.1228235" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10884316/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38404588/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Cui%20Y,%20Zhang%20W,%20Lu%20W,%20Feng%20Y,%20Wu%20X,%20Zhuo%20Z,%20et%20al.%20An%20exosome-derived%20lncRNA%20signature%20identified%20by%20machine%20learning%20associated%20with%20prognosis%20and%20biomarkers%20for%20immunotherapy%20in%20ovarian%20cancer.%20Front%20Immunol.%202024;15:1228235." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR116">
<span class="label">116.</span><cite>Liu X, Ma R, Wei F, Wang M, Jiang Y, Zheng P, et al. Tumor-derived exosomal lncRNA-MIR193BHG promotes bone metastasis of breast cancer by targeting the miR-489-3p/DNMT3A signaling axis in osteoclasts. J Transl Med. 2025;23:142.
</cite> [<a href="https://doi.org/10.1186/s12967-025-06156-4" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11786480/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39891171/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Liu%20X,%20Ma%20R,%20Wei%20F,%20Wang%20M,%20Jiang%20Y,%20Zheng%20P,%20et%20al.%20Tumor-derived%20exosomal%20lncRNA-MIR193BHG%20promotes%20bone%20metastasis%20of%20breast%20cancer%20by%20targeting%20the%20miR-489-3p/DNMT3A%20signaling%20axis%20in%20osteoclasts.%20J%20Transl%20Med.%202025;23:142." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR117">
<span class="label">117.</span><cite>Cheng K, Pan J, Liu Q, Ji Y, Liu L, Guo X, et al. Exosomal lncRNA XIST promotes perineural invasion of pancreatic cancer cells via miR-211–5p/GDNF. Oncogene. 2024;43:1–12.
</cite> [<a href="https://doi.org/10.1038/s41388-024-02994-6" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38454138/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Cheng%20K,%20Pan%20J,%20Liu%20Q,%20Ji%20Y,%20Liu%20L,%20Guo%20X,%20et%20al.%20Exosomal%20lncRNA%20XIST%20promotes%20perineural%20invasion%20of%20pancreatic%20cancer%20cells%20via%20miR-211%E2%80%935p/GDNF.%20Oncogene.%202024;43:1%E2%80%9312." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR118">
<span class="label">118.</span><cite>Hu Y, Hu Y, Zhang S, Guo Y, Wang F, Du Y, et al. Tumor-derived miR-203a-3p potentiates muscle wasting by inducing muscle ferroptosis in pancreatic cancer. Cancer Lett. 2025;614: 217523.
</cite> [<a href="https://doi.org/10.1016/j.canlet.2025.217523" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39921083/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Hu%20Y,%20Hu%20Y,%20Zhang%20S,%20Guo%20Y,%20Wang%20F,%20Du%20Y,%20et%20al.%20Tumor-derived%20miR-203a-3p%20potentiates%20muscle%20wasting%20by%20inducing%20muscle%20ferroptosis%20in%20pancreatic%20cancer.%20Cancer%20Lett.%202025;614:%20217523." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR119">
<span class="label">119.</span><cite>Theodoraki M-N, Yerneni S, Gooding WE, Ohr J, Clump DA, Bauman JE, et al. Circulating exosomes measure responses to therapy in head and neck cancer patients treated with cetuximab, ipilimumab, and IMRT. Oncoimmunology. 2019;8:1593805.
</cite> [<a href="https://doi.org/10.1080/2162402X.2019.1593805" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6527269/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31143513/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Theodoraki%20M-N,%20Yerneni%20S,%20Gooding%20WE,%20Ohr%20J,%20Clump%20DA,%20Bauman%20JE,%20et%20al.%20Circulating%20exosomes%20measure%20responses%20to%20therapy%20in%20head%20and%20neck%20cancer%20patients%20treated%20with%20cetuximab,%20ipilimumab,%20and%20IMRT.%20Oncoimmunology.%202019;8:1593805." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR120">
<span class="label">120.</span><cite>Whiteside TL, Diergaarde B, Hong C-S. Tumor-derived exosomes (TEX) and their role in immuno-oncology. Int J Mol Sci. 2021;22:6234.
</cite> [<a href="https://doi.org/10.3390/ijms22126234" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8229953/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34207762/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Whiteside%20TL,%20Diergaarde%20B,%20Hong%20C-S.%20Tumor-derived%20exosomes%20(TEX)%20and%20their%20role%20in%20immuno-oncology.%20Int%20J%20Mol%20Sci.%202021;22:6234." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR121">
<span class="label">121.</span><cite>Romanò S, Di Giacinto F, Primiano A, Gervasoni J, Mazzini A, Papi M, et al. Label-free spectroscopic characterization of exosomes reveals cancer cell differentiation. Anal Chim Acta. 2022;1192: 339359.
</cite> [<a href="https://doi.org/10.1016/j.aca.2021.339359" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35057944/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Roman%C3%B2%20S,%20Di%20Giacinto%20F,%20Primiano%20A,%20Gervasoni%20J,%20Mazzini%20A,%20Papi%20M,%20et%20al.%20Label-free%20spectroscopic%20characterization%20of%20exosomes%20reveals%20cancer%20cell%20differentiation.%20Anal%20Chim%20Acta.%202022;1192:%20339359." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR122">
<span class="label">122.</span><cite>Wang J, Guo W, Wang X, Tang X, Sun X, Ren T. Circulating exosomal PD-L1 at initial diagnosis predicts outcome and survival of patients with osteosarcoma. Clin Cancer Res. 2023;29:659–66.
</cite> [<a href="https://doi.org/10.1158/1078-0432.CCR-22-2682" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36374561/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Wang%20J,%20Guo%20W,%20Wang%20X,%20Tang%20X,%20Sun%20X,%20Ren%20T.%20Circulating%20exosomal%20PD-L1%20at%20initial%20diagnosis%20predicts%20outcome%20and%20survival%20of%20patients%20with%20osteosarcoma.%20Clin%20Cancer%20Res.%202023;29:659%E2%80%9366." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR123">
<span class="label">123.</span><cite>Tian Y, Shi W, Wang J, Zhang W, Xia L, Gao L, et al. Exosomal PD-L1 and lactate versus tissue PD-L1 as biomarkers for clinical outcomes of PD-1 Blockade plus chemotherapy in metastatic esophagogastric signet ring cell carcinoma. Exp Hematol Oncol. 2025;14:34.
</cite> [<a href="https://doi.org/10.1186/s40164-025-00615-w" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11905711/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/40075410/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Tian%20Y,%20Shi%20W,%20Wang%20J,%20Zhang%20W,%20Xia%20L,%20Gao%20L,%20et%20al.%20Exosomal%20PD-L1%20and%20lactate%20versus%20tissue%20PD-L1%20as%20biomarkers%20for%20clinical%20outcomes%20of%20PD-1%20Blockade%20plus%20chemotherapy%20in%20metastatic%20esophagogastric%20signet%20ring%20cell%20carcinoma.%20Exp%20Hematol%20Oncol.%202025;14:34." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR124">
<span class="label">124.</span><cite>de Miguel-Perez D, Russo A, Arrieta O, Ak M, Barron F, Gunasekaran M, et al. Extracellular vesicle PD-L1 dynamics predict durable response to immune-checkpoint inhibitors and survival in patients with non-small cell lung cancer. J Exp Clin Cancer Res. 2022;41:186.
</cite> [<a href="https://doi.org/10.1186/s13046-022-02379-1" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9161571/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35650597/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?de%20Miguel-Perez%20D,%20Russo%20A,%20Arrieta%20O,%20Ak%20M,%20Barron%20F,%20Gunasekaran%20M,%20et%20al.%20Extracellular%20vesicle%20PD-L1%20dynamics%20predict%20durable%20response%20to%20immune-checkpoint%20inhibitors%20and%20survival%20in%20patients%20with%20non-small%20cell%20lung%20cancer.%20J%20Exp%20Clin%20Cancer%20Res.%202022;41:186." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR125">
<span class="label">125.</span><cite>Wang Y, Sun Y, Liu M, Wang C, Huang M, Qiu J, et al. In situ and dynamic screening of extracellular vesicles as predictive biomarkers in immune-checkpoint inhibitor therapies. J Nanobiotechnol. 2025;23:411.</cite> [<a href="https://doi.org/10.1186/s12951-025-03467-y" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC12131400/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/40457452/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Wang%20Y,%20Sun%20Y,%20Liu%20M,%20Wang%20C,%20Huang%20M,%20Qiu%20J,%20et%20al.%20In%20situ%20and%20dynamic%20screening%20of%20extracellular%20vesicles%20as%20predictive%20biomarkers%20in%20immune-checkpoint%20inhibitor%20therapies.%20J%20Nanobiotechnol.%202025;23:411." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR126">
<span class="label">126.</span><cite>de Miguel-Perez D, Ak M, Mamindla P, Russo A, Zenkin S, Ak N, et al. Validation of a multiomic model of plasma extracellular vesicle PD-L1 and radiomics for prediction of response to immunotherapy in NSCLC. J Exp Clin Cancer Res. 2024;43:81.
</cite> [<a href="https://doi.org/10.1186/s13046-024-02997-x" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10941547/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38486328/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?de%20Miguel-Perez%20D,%20Ak%20M,%20Mamindla%20P,%20Russo%20A,%20Zenkin%20S,%20Ak%20N,%20et%20al.%20Validation%20of%20a%20multiomic%20model%20of%20plasma%20extracellular%20vesicle%20PD-L1%20and%20radiomics%20for%20prediction%20of%20response%20to%20immunotherapy%20in%20NSCLC.%20J%20Exp%20Clin%20Cancer%20Res.%202024;43:81." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR127">
<span class="label">127.</span><cite>Ochiai R, Hayashi K, Yamamoto H, Fujii R, Saichi N, Shinchi H, et al. Plasma exosomal DOK3 reflects immunological states in lung tumor and predicts prognosis of gefitinib treatment. Cancer Sci. 2022;113:3960–71.
</cite> [<a href="https://doi.org/10.1111/cas.15512" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9633313/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36028467/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Ochiai%20R,%20Hayashi%20K,%20Yamamoto%20H,%20Fujii%20R,%20Saichi%20N,%20Shinchi%20H,%20et%20al.%20Plasma%20exosomal%20DOK3%20reflects%20immunological%20states%20in%20lung%20tumor%20and%20predicts%20prognosis%20of%20gefitinib%20treatment.%20Cancer%20Sci.%202022;113:3960%E2%80%9371." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR128">
<span class="label">128.</span><cite>Jia Y, Li Y, Bai X, Liu L, Shan Y, Wang F, et al. Raman spectroscopy and exosome-based machine learning predicts the efficacy of neoadjuvant therapy for HER2-positive breast cancer. Anal Chem. 2025. 
</cite> [<a href="https://doi.org/10.1021/acs.analchem.4c05833" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39780544/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Jia%20Y,%20Li%20Y,%20Bai%20X,%20Liu%20L,%20Shan%20Y,%20Wang%20F,%20et%20al.%20Raman%20spectroscopy%20and%20exosome-based%20machine%20learning%20predicts%20the%20efficacy%20of%20neoadjuvant%20therapy%20for%20HER2-positive%20breast%20cancer.%20Anal%20Chem.%202025.%C2%A0" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR129">
<span class="label">129.</span><cite>Chen H, Chengalvala V, Hu H, Sun D. Tumor-derived exosomes: Nanovesicles made by cancer cells to promote cancer metastasis. Acta Pharm Sin B. 2021;11:2136–49.
</cite> [<a href="https://doi.org/10.1016/j.apsb.2021.04.012" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8424275/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34522581/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Chen%20H,%20Chengalvala%20V,%20Hu%20H,%20Sun%20D.%20Tumor-derived%20exosomes:%20Nanovesicles%20made%20by%20cancer%20cells%20to%20promote%20cancer%20metastasis.%20Acta%20Pharm%20Sin%20B.%202021;11:2136%E2%80%9349." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR130">
<span class="label">130.</span><cite>To KKW. Abstract 5875: upregulation of the RNA binding protein HuR by cancer-secreted exosome to mediate multidrug resistance. Can Res. 2024;84:5875.</cite> [<a href="https://scholar.google.com/scholar_lookup?To%20KKW.%20Abstract%205875:%20upregulation%20of%20the%20RNA%20binding%20protein%20HuR%20by%20cancer-secreted%20exosome%20to%20mediate%20multidrug%20resistance.%20Can%20Res.%202024;84:5875." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR131">
<span class="label">131.</span><cite>Deng J, Pan T, Lv C, Cao L, Li L, Zhou X, et al. Exosomal transfer leads to chemoresistance through oxidative phosphorylation-mediated stemness phenotype in colorectal cancer. Theranostics. 2023;13:5057–74.
</cite> [<a href="https://doi.org/10.7150/thno.84937" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10526671/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37771767/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Deng%20J,%20Pan%20T,%20Lv%20C,%20Cao%20L,%20Li%20L,%20Zhou%20X,%20et%20al.%20Exosomal%20transfer%20leads%20to%20chemoresistance%20through%20oxidative%20phosphorylation-mediated%20stemness%20phenotype%20in%20colorectal%20cancer.%20Theranostics.%202023;13:5057%E2%80%9374." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR132">
<span class="label">132.</span><cite>Tao L, Xu C, Shen W, Tan J, Li L, Fan M, et al. HIPK3 inhibition by exosomal hsa-miR-101-3p is related to metabolic reprogramming in colorectal cancer. Front Oncol. 2022;11: 758336.
</cite> [<a href="https://doi.org/10.3389/fonc.2021.758336" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8792385/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35096570/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Tao%20L,%20Xu%20C,%20Shen%20W,%20Tan%20J,%20Li%20L,%20Fan%20M,%20et%20al.%20HIPK3%20inhibition%20by%20exosomal%20hsa-miR-101-3p%20is%20related%20to%20metabolic%20reprogramming%20in%20colorectal%20cancer.%20Front%20Oncol.%202022;11:%20758336." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR133">
<span class="label">133.</span><cite>Tian XP, Wang CY, Jin XH, Li M, Wang FW, Huang WJ, et al. Acidic microenvironment up-regulates exosomal miR-21 and miR-10b in early-stage hepatocellular carcinoma to promote cancer cell proliferation and metastasis. Theranostics. 2019;9:1965.
</cite> [<a href="https://doi.org/10.7150/thno.30958" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6485281/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31037150/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Tian%20XP,%20Wang%20CY,%20Jin%20XH,%20Li%20M,%20Wang%20FW,%20Huang%20WJ,%20et%20al.%20Acidic%20microenvironment%20up-regulates%20exosomal%20miR-21%20and%20miR-10b%20in%20early-stage%20hepatocellular%20carcinoma%20to%20promote%20cancer%20cell%20proliferation%20and%20metastasis.%20Theranostics.%202019;9:1965." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR134">
<span class="label">134.</span><cite>Lin H, Zhang R, Wu W, Lei L. miR-4454 promotes hepatic carcinoma progression by targeting Vps4A and Rab27A. Oxid Med Cell Longev. 2021;2021:9230435.
</cite> [<a href="https://doi.org/10.1155/2021/9230435" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8580624/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34777698/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Lin%20H,%20Zhang%20R,%20Wu%20W,%20Lei%20L.%20miR-4454%20promotes%20hepatic%20carcinoma%20progression%20by%20targeting%20Vps4A%20and%20Rab27A.%20Oxid%20Med%20Cell%20Longev.%202021;2021:9230435." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR135">
<span class="label">135.</span><cite>Zhao S, Pan T, Deng J, Cao L, Vicencio JM, Liu J, et al. Exosomal transfer of miR-181b-5p confers senescence-mediated doxorubicin resistance via modulating BCLAF1 in breast cancer. Br J Cancer. 2023;128:665–77.
</cite> [<a href="https://doi.org/10.1038/s41416-022-02077-x" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9938221/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36522479/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Zhao%20S,%20Pan%20T,%20Deng%20J,%20Cao%20L,%20Vicencio%20JM,%20Liu%20J,%20et%20al.%20Exosomal%20transfer%20of%20miR-181b-5p%20confers%20senescence-mediated%20doxorubicin%20resistance%20via%20modulating%20BCLAF1%20in%20breast%20cancer.%20Br%20J%20Cancer.%202023;128:665%E2%80%9377." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR136">
<span class="label">136.</span><cite>Li W, Han G, Li F, Bu P, Hao Y, Huang L, et al. Cancer cell-derived exosomal miR-20a-5p inhibits CD8+ T-cell function and confers anti-programmed cell death 1 therapy resistance in triple-negative breast cancer. Cancer Sci. 2024;115:347–56.
</cite> [<a href="https://doi.org/10.1111/cas.16036" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10859600/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38129137/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Li%20W,%20Han%20G,%20Li%20F,%20Bu%20P,%20Hao%20Y,%20Huang%20L,%20et%20al.%20Cancer%20cell-derived%20exosomal%20miR-20a-5p%20inhibits%20CD8+%20T-cell%20function%20and%20confers%20anti-programmed%20cell%20death%201%20therapy%20resistance%20in%20triple-negative%20breast%20cancer.%20Cancer%20Sci.%202024;115:347%E2%80%9356." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR137">
<span class="label">137.</span><cite>Li T, Li X, Han G, Liang M, Yang Z, Zhang C, et al. The therapeutic potential and clinical significance of exosomes as carriers of drug delivery system. Pharmaceutics. 2022;15:21.
</cite> [<a href="https://doi.org/10.3390/pharmaceutics15010021" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9865231/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36678650/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Li%20T,%20Li%20X,%20Han%20G,%20Liang%20M,%20Yang%20Z,%20Zhang%20C,%20et%20al.%20The%20therapeutic%20potential%20and%20clinical%20significance%20of%20exosomes%20as%20carriers%20of%20drug%20delivery%20system.%20Pharmaceutics.%202022;15:21." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR138">
<span class="label">138.</span><cite>Liu M, Lai Z, Yuan X, Jin Q, Shen H, Rao D, et al. Role of exosomes in the development, diagnosis, prognosis and treatment of hepatocellular carcinoma. Mol Med. 2023;29:136.
</cite> [<a href="https://doi.org/10.1186/s10020-023-00731-5" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10580543/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37848835/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Liu%20M,%20Lai%20Z,%20Yuan%20X,%20Jin%20Q,%20Shen%20H,%20Rao%20D,%20et%20al.%20Role%20of%20exosomes%20in%20the%20development,%20diagnosis,%20prognosis%20and%20treatment%20of%20hepatocellular%20carcinoma.%20Mol%20Med.%202023;29:136." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR139">
<span class="label">139.</span><cite>Koh HB, Kim HJ, Kang S-W, Yoo T-H. Exosome-based drug delivery: translation from bench to clinic. Pharmaceutics. 2023;15:2042.
</cite> [<a href="https://doi.org/10.3390/pharmaceutics15082042" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10459753/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37631256/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Koh%20HB,%20Kim%20HJ,%20Kang%20S-W,%20Yoo%20T-H.%20Exosome-based%20drug%20delivery:%20translation%20from%20bench%20to%20clinic.%20Pharmaceutics.%202023;15:2042." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR140">
<span class="label">140.</span><cite>Qiao L, Hu S, Huang K, Su T, Li Z, Vandergriff A, et al. Tumor cell-derived exosomes home to their cells of origin and can be used as Trojan horses to deliver cancer drugs. Theranostics. 2020;10:3474–87.
</cite> [<a href="https://doi.org/10.7150/thno.39434" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7069079/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32206102/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Qiao%20L,%20Hu%20S,%20Huang%20K,%20Su%20T,%20Li%20Z,%20Vandergriff%20A,%20et%20al.%20Tumor%20cell-derived%20exosomes%20home%20to%20their%20cells%20of%20origin%20and%20can%20be%20used%20as%20Trojan%20horses%20to%20deliver%20cancer%20drugs.%20Theranostics.%202020;10:3474%E2%80%9387." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR141">
<span class="label">141.</span><cite>Wang Y, Guo M, Lin D, Liang D, Zhao L, Zhao R, et al. Docetaxel-loaded exosomes for targeting non-small cell lung cancer: preparation and evaluation in vitro and in vivo. Drug Deliv. 2021;28:1510–23.
</cite> [<a href="https://doi.org/10.1080/10717544.2021.1951894" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8284156/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34263685/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Wang%20Y,%20Guo%20M,%20Lin%20D,%20Liang%20D,%20Zhao%20L,%20Zhao%20R,%20et%20al.%20Docetaxel-loaded%20exosomes%20for%20targeting%20non-small%20cell%20lung%20cancer:%20preparation%20and%20evaluation%20in%20vitro%20and%20in%20vivo.%20Drug%20Deliv.%202021;28:1510%E2%80%9323." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR142">
<span class="label">142.</span><cite>Yu F, Chen Y, Yi W, Guan M, Lin N, Zhuo Y, et al. Lung-specific exosomes for doxorubicin delivery in lung adenocarcinoma therapy. Biotechnol J. 2024;19:2300296.</cite> [<a href="https://doi.org/10.1002/biot.202300296" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38403456/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Yu%20F,%20Chen%20Y,%20Yi%20W,%20Guan%20M,%20Lin%20N,%20Zhuo%20Y,%20et%20al.%20Lung-specific%20exosomes%20for%20doxorubicin%20delivery%20in%20lung%20adenocarcinoma%20therapy.%20Biotechnol%20J.%202024;19:2300296." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR143">
<span class="label">143.</span><cite>Wang J, Zhu X, Jiang H, Ji M, Wu Y, Chen J. Cancer cell-derived exosome based dual-targeted drug delivery system for non-small cell lung cancer therapy. Colloids Surf, B. 2024;244: 114141.</cite> [<a href="https://doi.org/10.1016/j.colsurfb.2024.114141" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39216444/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Wang%20J,%20Zhu%20X,%20Jiang%20H,%20Ji%20M,%20Wu%20Y,%20Chen%20J.%20Cancer%20cell-derived%20exosome%20based%20dual-targeted%20drug%20delivery%20system%20for%20non-small%20cell%20lung%20cancer%20therapy.%20Colloids%20Surf,%20B.%202024;244:%20114141." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR144">
<span class="label">144.</span><cite>Wang R, Liang Q, Zhang X, Di Z, Wang X, Di L. Tumor-derived exosomes reversing TMZ resistance by synergistic drug delivery for glioma-targeting treatment. Colloids Surf, B. 2022;215: 112505.</cite> [<a href="https://doi.org/10.1016/j.colsurfb.2022.112505" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35487070/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Wang%20R,%20Liang%20Q,%20Zhang%20X,%20Di%20Z,%20Wang%20X,%20Di%20L.%20Tumor-derived%20exosomes%20reversing%20TMZ%20resistance%20by%20synergistic%20drug%20delivery%20for%20glioma-targeting%20treatment.%20Colloids%20Surf,%20B.%202022;215:%20112505." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR145">
<span class="label">145.</span><cite>Chu L, Sun Y, Tang X, Duan X, Zhao Y, Xia H, et al. The tumor-derived exosomes enhanced bevacizumab across the blood-brain barrier for antiangiogenesis therapy against glioblastoma. Mol Pharmaceutics. 2025;22:972–83.</cite> [<a href="https://doi.org/10.1021/acs.molpharmaceut.4c01227" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39895311/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Chu%20L,%20Sun%20Y,%20Tang%20X,%20Duan%20X,%20Zhao%20Y,%20Xia%20H,%20et%20al.%20The%20tumor-derived%20exosomes%20enhanced%20bevacizumab%20across%20the%20blood-brain%20barrier%20for%20antiangiogenesis%20therapy%20against%20glioblastoma.%20Mol%20Pharmaceutics.%202025;22:972%E2%80%9383." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR146">
<span class="label">146.</span><cite>Qiu X, Li Z, Han X, Zhen L, Luo C, Liu M, et al. Tumor-derived nanovesicles promote lung distribution of the therapeutic nanovector through repression of Kupffer cell-mediated phagocytosis. Theranostics. 2019;9:2618–36.
</cite> [<a href="https://doi.org/10.7150/thno.32363" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6525995/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31131057/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Qiu%20X,%20Li%20Z,%20Han%20X,%20Zhen%20L,%20Luo%20C,%20Liu%20M,%20et%20al.%20Tumor-derived%20nanovesicles%20promote%20lung%20distribution%20of%20the%20therapeutic%20nanovector%20through%20repression%20of%20Kupffer%20cell-mediated%20phagocytosis.%20Theranostics.%202019;9:2618%E2%80%9336." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR147">
<span class="label">147.</span><cite>Huang C, Zhou Y, Feng X, Wang J, Li Y, Yao X. Delivery of engineered primary tumor-derived exosomes effectively suppressed the colorectal cancer chemoresistance and liver metastasis. ACS Nano. 2023;17:10313–26.
</cite> [<a href="https://doi.org/10.1021/acsnano.3c00668" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37141393/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Huang%20C,%20Zhou%20Y,%20Feng%20X,%20Wang%20J,%20Li%20Y,%20Yao%20X.%20Delivery%20of%20engineered%20primary%20tumor-derived%20exosomes%20effectively%20suppressed%20the%20colorectal%20cancer%20chemoresistance%20and%20liver%20metastasis.%20ACS%20Nano.%202023;17:10313%E2%80%9326." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR148">
<span class="label">148.</span><cite>Qian R, Jing B, Jiang D, Gai Y, Zhu Z, Huang X, et al. Multi-antitumor therapy and synchronous imaging monitoring based on exosome. Eur J Nucl Med Mol Imaging. 2022;49:2668–81.
</cite> [<a href="https://doi.org/10.1007/s00259-022-05696-x" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35091755/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Qian%20R,%20Jing%20B,%20Jiang%20D,%20Gai%20Y,%20Zhu%20Z,%20Huang%20X,%20et%20al.%20Multi-antitumor%20therapy%20and%20synchronous%20imaging%20monitoring%20based%20on%20exosome.%20Eur%20J%20Nucl%20Med%20Mol%20Imaging.%202022;49:2668%E2%80%9381." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR149">
<span class="label">149.</span><cite>Li L, He D, Guo Q, Zhang Z, Ru D, Wang L, et al. Exosome-liposome hybrid nanoparticle codelivery of TP and miR497 conspicuously overcomes chemoresistant ovarian cancer. J Nanobiotechnol. 2022;20:50.</cite> [<a href="https://doi.org/10.1186/s12951-022-01264-5" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8787930/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35078498/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Li%20L,%20He%20D,%20Guo%20Q,%20Zhang%20Z,%20Ru%20D,%20Wang%20L,%20et%20al.%20Exosome-liposome%20hybrid%20nanoparticle%20codelivery%20of%20TP%20and%20miR497%20conspicuously%20overcomes%20chemoresistant%20ovarian%20cancer.%20J%20Nanobiotechnol.%202022;20:50." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR150">
<span class="label">150.</span><cite>Moholkar DN, Kandimalla R, Gupta RC, Aqil F. Advances in lipid-based carriers for cancer therapeutics: liposomes, exosomes and hybrid exosomes. Cancer Lett. 2023;565: 216220.
</cite> [<a href="https://doi.org/10.1016/j.canlet.2023.216220" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10325927/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37209944/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Moholkar%20DN,%20Kandimalla%20R,%20Gupta%20RC,%20Aqil%20F.%20Advances%20in%20lipid-based%20carriers%20for%20cancer%20therapeutics:%20liposomes,%20exosomes%20and%20hybrid%20exosomes.%20Cancer%20Lett.%202023;565:%20216220." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR151">
<span class="label">151.</span><cite>Zhou X, Zhuang Y, Liu X, Gu Y, Wang J, Shi Y, et al. Study on tumour cell-derived hybrid exosomes as dasatinib nanocarriers for pancreatic cancer therapy. Artif Cells Nanomed Biotechnol. 2023;51:532–46.
</cite> [<a href="https://doi.org/10.1080/21691401.2023.2264358" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37948136/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Zhou%20X,%20Zhuang%20Y,%20Liu%20X,%20Gu%20Y,%20Wang%20J,%20Shi%20Y,%20et%20al.%20Study%20on%20tumour%20cell-derived%20hybrid%20exosomes%20as%20dasatinib%20nanocarriers%20for%20pancreatic%20cancer%20therapy.%20Artif%20Cells%20Nanomed%20Biotechnol.%202023;51:532%E2%80%9346." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR152">
<span class="label">152.</span><cite>Gomes ER, Souza FR, Cassali GD, de Sabino AP, de Barros ALB, Oliveira MC. Investigation of the antitumor activity and toxicity of tumor-derived exosomes fused with long-circulating and pH-sensitive liposomes containing doxorubicin. Pharmaceutics. 2022;14:2256.
</cite> [<a href="https://doi.org/10.3390/pharmaceutics14112256" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9696811/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36365075/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Gomes%20ER,%20Souza%20FR,%20Cassali%20GD,%20de%20Sabino%20AP,%20de%20Barros%20ALB,%20Oliveira%20MC.%20Investigation%20of%20the%20antitumor%20activity%20and%20toxicity%20of%20tumor-derived%20exosomes%20fused%20with%20long-circulating%20and%20pH-sensitive%20liposomes%20containing%20doxorubicin.%20Pharmaceutics.%202022;14:2256." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR153">
<span class="label">153.</span><cite>Yang Y, Wang Q, Zou H, Chou C-K, Chen X. Exosome-modified liposomes targeted delivery of thalidomide to regulate Treg cells for antitumor immunotherapy. Pharmaceutics. 2023;15:1074.
</cite> [<a href="https://doi.org/10.3390/pharmaceutics15041074" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10142880/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37111560/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Yang%20Y,%20Wang%20Q,%20Zou%20H,%20Chou%20C-K,%20Chen%20X.%20Exosome-modified%20liposomes%20targeted%20delivery%20of%20thalidomide%20to%20regulate%20Treg%20cells%20for%20antitumor%20immunotherapy.%20Pharmaceutics.%202023;15:1074." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR154">
<span class="label">154.</span><cite>Zhao J, Cui X, Zhan Q, Zhang K, Su D, Yang S, et al. CRISPR-Cas9 library screening combined with an exosome-targeted delivery system addresses tumorigenesis/TMZ resistance in the mesenchymal subtype of glioblastoma. Theranostics. 2024;14:2835–55.
</cite> [<a href="https://doi.org/10.7150/thno.92703" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11103500/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38773970/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Zhao%20J,%20Cui%20X,%20Zhan%20Q,%20Zhang%20K,%20Su%20D,%20Yang%20S,%20et%20al.%20CRISPR-Cas9%20library%20screening%20combined%20with%20an%20exosome-targeted%20delivery%20system%20addresses%20tumorigenesis/TMZ%20resistance%20in%20the%20mesenchymal%20subtype%20of%20glioblastoma.%20Theranostics.%202024;14:2835%E2%80%9355." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR155">
<span class="label">155.</span><cite>Hosseini M, Baghaei K, Amani D, Ebtekar M. Tumor-derived exosomes encapsulating miR-34a promote apoptosis and inhibit migration and tumor progression of colorectal cancer cells under in vitro condition. DARU J Pharm Sci. 2021;29:267–78.</cite> [<a href="https://doi.org/10.1007/s40199-021-00400-0" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8602593/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34405380/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Hosseini%20M,%20Baghaei%20K,%20Amani%20D,%20Ebtekar%20M.%20Tumor-derived%20exosomes%20encapsulating%20miR-34a%20promote%20apoptosis%20and%20inhibit%20migration%20and%20tumor%20progression%20of%20colorectal%20cancer%20cells%20under%20in%20vitro%20condition.%20DARU%20J%20Pharm%20Sci.%202021;29:267%E2%80%9378." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR156">
<span class="label">156.</span><cite>Sun W, Huang S, Sun Z, Zhao Q, Li J, Wen B, et al. Exosome platform with three-in-one functionality of mRNA therapy, immune checkpoint blockade, and mild photothermal therapy for the treatment of triple-negative breast cancer. ACS Appl Mater Interfaces. 2025;17:10328–41.
</cite> [<a href="https://doi.org/10.1021/acsami.4c17804" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39905637/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Sun%20W,%20Huang%20S,%20Sun%20Z,%20Zhao%20Q,%20Li%20J,%20Wen%20B,%20et%20al.%20Exosome%20platform%20with%20three-in-one%20functionality%20of%20mRNA%20therapy,%20immune%20checkpoint%20blockade,%20and%20mild%20photothermal%20therapy%20for%20the%20treatment%20of%20triple-negative%20breast%20cancer.%20ACS%20Appl%20Mater%20Interfaces.%202025;17:10328%E2%80%9341." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR157">
<span class="label">157.</span><cite>Kitai Y, Kawasaki T, Sueyoshi T, Kobiyama K, Ishii KJ, Zou J, et al. DNA-containing exosomes derived from cancer cells treated with topotecan activate a STING-dependent pathway and reinforce antitumor immunity. J Immunol. 2017;198:1649–59.
</cite> [<a href="https://doi.org/10.4049/jimmunol.1601694" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28069806/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Kitai%20Y,%20Kawasaki%20T,%20Sueyoshi%20T,%20Kobiyama%20K,%20Ishii%20KJ,%20Zou%20J,%20et%20al.%20DNA-containing%20exosomes%20derived%20from%20cancer%20cells%20treated%20with%20topotecan%20activate%20a%20STING-dependent%20pathway%20and%20reinforce%20antitumor%20immunity.%20J%20Immunol.%202017;198:1649%E2%80%9359." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR158">
<span class="label">158.</span><cite>Huang X, Wu W, Jing D, Yang L, Guo H, Wang L, et al. Engineered exosome as targeted lncRNA MEG3 delivery vehicles for osteosarcoma therapy. J Control Release. 2022;343:107–17.
</cite> [<a href="https://doi.org/10.1016/j.jconrel.2022.01.026" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35077741/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Huang%20X,%20Wu%20W,%20Jing%20D,%20Yang%20L,%20Guo%20H,%20Wang%20L,%20et%20al.%20Engineered%20exosome%20as%20targeted%20lncRNA%20MEG3%20delivery%20vehicles%20for%20osteosarcoma%20therapy.%20J%20Control%20Release.%202022;343:107%E2%80%9317." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR159">
<span class="label">159.</span><cite>Lin W, Chen L, Zhang H, Qiu X, Huang Q, Wan F, et al. Tumor-intrinsic YTHDF1 drives immune evasion and resistance to immune checkpoint inhibitors via promoting MHC-I degradation. Nat Commun. 2023;14:265.
</cite> [<a href="https://doi.org/10.1038/s41467-022-35710-7" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9845301/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36650153/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Lin%20W,%20Chen%20L,%20Zhang%20H,%20Qiu%20X,%20Huang%20Q,%20Wan%20F,%20et%20al.%20Tumor-intrinsic%20YTHDF1%20drives%20immune%20evasion%20and%20resistance%20to%20immune%20checkpoint%20inhibitors%20via%20promoting%20MHC-I%20degradation.%20Nat%20Commun.%202023;14:265." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR160">
<span class="label">160.</span><cite>Kim SM, Yang Y, Oh SJ, Hong Y, Seo M, Jang M. Cancer-derived exosomes as a delivery platform of CRISPR/Cas9 confer cancer cell tropism-dependent targeting. J Control Release. 2017;266:8–16.
</cite> [<a href="https://doi.org/10.1016/j.jconrel.2017.09.013" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28916446/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Kim%20SM,%20Yang%20Y,%20Oh%20SJ,%20Hong%20Y,%20Seo%20M,%20Jang%20M.%20Cancer-derived%20exosomes%20as%20a%20delivery%20platform%20of%20CRISPR/Cas9%20confer%20cancer%20cell%20tropism-dependent%20targeting.%20J%20Control%20Release.%202017;266:8%E2%80%9316." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR161">
<span class="label">161.</span><cite>Wang C, Huang X, Wu Y, Wang J, Li F, Guo G. Tumor cell-associated exosomes robustly elicit anti-tumor immune responses through modulating dendritic cell vaccines in lung tumor. Int J Biol Sci. 2020;16:633–43.
</cite> [<a href="https://doi.org/10.7150/ijbs.38414" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6990923/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32025211/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Wang%20C,%20Huang%20X,%20Wu%20Y,%20Wang%20J,%20Li%20F,%20Guo%20G.%20Tumor%20cell-associated%20exosomes%20robustly%20elicit%20anti-tumor%20immune%20responses%20through%20modulating%20dendritic%20cell%20vaccines%20in%20lung%20tumor.%20Int%20J%20Biol%20Sci.%202020;16:633%E2%80%9343." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR162">
<span class="label">162.</span><cite>Gao D, Jiang L. Exosomes in cancer therapy: a novel experimental strategy. Am J Cancer Res. 2018;8:2165.
</cite> [<a href="/articles/PMC6291654/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30555736/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Gao%20D,%20Jiang%20L.%20Exosomes%20in%20cancer%20therapy:%20a%20novel%20experimental%20strategy.%20Am%20J%20Cancer%20Res.%202018;8:2165." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR163">
<span class="label">163.</span><cite>Yao Y, Wang C, Wei W, Shen C, Deng X, Chen L, et al. Dendritic cells pulsed with leukemia cell-derived exosomes more efficiently induce antileukemic immunities. PLoS ONE. 2014;9: e91463.
</cite> [<a href="https://doi.org/10.1371/journal.pone.0091463" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3951359/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24622345/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Yao%20Y,%20Wang%20C,%20Wei%20W,%20Shen%20C,%20Deng%20X,%20Chen%20L,%20et%20al.%20Dendritic%20cells%20pulsed%20with%20leukemia%20cell-derived%20exosomes%20more%20efficiently%20induce%20antileukemic%20immunities.%20PLoS%20ONE.%202014;9:%20e91463." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR164">
<span class="label">164.</span><cite>Zhang F, Wang Y, Yang F, Zhang Y, Jiang M, Zhang X. The efficacy and safety of PD-1 inhibitors combined with nab-paclitaxel plus gemcitabine versus nab-paclitaxel plus gemcitabine in the first-line treatment of advanced pancreatic cancer: a retrospective monocentric study. Cancer Manag Res. 2022;14:535.
</cite> [<a href="https://doi.org/10.2147/CMAR.S349442" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8841313/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35173487/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Zhang%20F,%20Wang%20Y,%20Yang%20F,%20Zhang%20Y,%20Jiang%20M,%20Zhang%20X.%20The%20efficacy%20and%20safety%20of%20PD-1%20inhibitors%20combined%20with%20nab-paclitaxel%20plus%20gemcitabine%20versus%20nab-paclitaxel%20plus%20gemcitabine%20in%20the%20first-line%20treatment%20of%20advanced%20pancreatic%20cancer:%20a%20retrospective%20monocentric%20study.%20Cancer%20Manag%20Res.%202022;14:535." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR165">
<span class="label">165.</span><cite>Rezaei R, Baghaei K, Hashemi SM, Zali MR, Ghanbarian H, Amani D. Tumor-derived exosomes enriched by miRNA-124 promote anti-tumor immune response in CT-26 tumor-bearing mice. Front Med (Lausanne). 2021;8: 619939.
</cite> [<a href="https://doi.org/10.3389/fmed.2021.619939" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8110712/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33987190/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Rezaei%20R,%20Baghaei%20K,%20Hashemi%20SM,%20Zali%20MR,%20Ghanbarian%20H,%20Amani%20D.%20Tumor-derived%20exosomes%20enriched%20by%20miRNA-124%20promote%20anti-tumor%20immune%20response%20in%20CT-26%20tumor-bearing%20mice.%20Front%20Med%20(Lausanne).%202021;8:%20619939." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR166">
<span class="label">166.</span><cite>Naseri M, Bozorgmehr M, Zöller M, Ranaei Pirmardan E, Madjd Z. Tumor-derived exosomes: the next generation of promising cell-free vaccines in cancer immunotherapy. OncoImmunology. 2020;9:1779991.
</cite> [<a href="https://doi.org/10.1080/2162402X.2020.1779991" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7466856/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32934883/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Naseri%20M,%20Bozorgmehr%20M,%20Z%C3%B6ller%20M,%20Ranaei%20Pirmardan%20E,%20Madjd%20Z.%20Tumor-derived%20exosomes:%20the%20next%20generation%20of%20promising%20cell-free%20vaccines%20in%20cancer%20immunotherapy.%20OncoImmunology.%202020;9:1779991." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR167">
<span class="label">167.</span><cite>Alia Moosavian S, Hashemi M, Etemad L, Daneshmand S, Salmasi Z. Melanoma-derived exosomes: versatile extracellular vesicles for diagnosis, metastasis, immune modulation, and treatment of melanoma. Int Immunopharmacol. 2022;113: 109320.
</cite> [<a href="https://doi.org/10.1016/j.intimp.2022.109320" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36274482/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Alia%20Moosavian%20S,%20Hashemi%20M,%20Etemad%20L,%20Daneshmand%20S,%20Salmasi%20Z.%20Melanoma-derived%20exosomes:%20versatile%20extracellular%20vesicles%20for%20diagnosis,%20metastasis,%20immune%20modulation,%20and%20treatment%20of%20melanoma.%20Int%20Immunopharmacol.%202022;113:%20109320." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR168">
<span class="label">168.</span><cite>Huang L, Rong Y, Tang X, Yi K, Qi P, Hou J, et al. Engineered exosomes as an in situ DC-primed vaccine to boost antitumor immunity in breast cancer. Mol Cancer. 2022;21:45.
</cite> [<a href="https://doi.org/10.1186/s12943-022-01515-x" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8831689/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35148751/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Huang%20L,%20Rong%20Y,%20Tang%20X,%20Yi%20K,%20Qi%20P,%20Hou%20J,%20et%20al.%20Engineered%20exosomes%20as%20an%20in%20situ%20DC-primed%20vaccine%20to%20boost%20antitumor%20immunity%20in%20breast%20cancer.%20Mol%20Cancer.%202022;21:45." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR169">
<span class="label">169.</span><cite>Yildirim M, Yildirim TC, Turay N, Bildik T, Ibibik B, Evcili I, et al. TLR ligand loaded exosome mediated immunotherapy of established mammary tumor in mice. Immunol Lett. 2021;239:32–41.
</cite> [<a href="https://doi.org/10.1016/j.imlet.2021.08.004" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34418488/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Yildirim%20M,%20Yildirim%20TC,%20Turay%20N,%20Bildik%20T,%20Ibibik%20B,%20Evcili%20I,%20et%20al.%20TLR%20ligand%20loaded%20exosome%20mediated%20immunotherapy%20of%20established%20mammary%20tumor%20in%20mice.%20Immunol%20Lett.%202021;239:32%E2%80%9341." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR170">
<span class="label">170.</span><cite>Shi X, Sun J, Li H, Lin H, Xie W, Li J, et al. Antitumor efficacy of interferon-γ-modified exosomal vaccine in prostate cancer. Prostate. 2020;80:811–23.
</cite> [<a href="https://doi.org/10.1002/pros.23996" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32427375/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Shi%20X,%20Sun%20J,%20Li%20H,%20Lin%20H,%20Xie%20W,%20Li%20J,%20et%20al.%20Antitumor%20efficacy%20of%20interferon-%CE%B3-modified%20exosomal%20vaccine%20in%20prostate%20cancer.%20Prostate.%202020;80:811%E2%80%9323." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR171">
<span class="label">171.</span><cite>Xu H-Y, Li N, Yao N, Xu X-F, Wang H-X, Liu X-Y, et al. CD8+ T cells stimulated by exosomes derived from RenCa cells mediate specific immune responses through the FasL/Fas signaling pathway and combined with GM-CSF and IL-12, enhance the anti-renal cortical adenocarcinoma effect. Oncol Rep. 2019;42:866–79.
</cite> [<a href="https://doi.org/10.3892/or.2019.7208" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31233203/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Xu%20H-Y,%20Li%20N,%20Yao%20N,%20Xu%20X-F,%20Wang%20H-X,%20Liu%20X-Y,%20et%20al.%20CD8+%20T%20cells%20stimulated%20by%20exosomes%20derived%20from%20RenCa%20cells%20mediate%20specific%20immune%20responses%20through%20the%20FasL/Fas%20signaling%20pathway%20and%20combined%20with%20GM-CSF%20and%20IL-12,%20enhance%20the%20anti-renal%20cortical%20adenocarcinoma%20effect.%20Oncol%20Rep.%202019;42:866%E2%80%9379." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR172">
<span class="label">172.</span><cite>Tong Q, Li K, Huang F, Dai Y, Zhang T, Muaibati M, et al. Extracellular vesicles hybrid plasmid-loaded lipid nanovesicles for synergistic cancer immunotherapy. Mater Today Bio. 2023;23: 100845.
</cite> [<a href="https://doi.org/10.1016/j.mtbio.2023.100845" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10628780/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37942423/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Tong%20Q,%20Li%20K,%20Huang%20F,%20Dai%20Y,%20Zhang%20T,%20Muaibati%20M,%20et%20al.%20Extracellular%20vesicles%20hybrid%20plasmid-loaded%20lipid%20nanovesicles%20for%20synergistic%20cancer%20immunotherapy.%20Mater%20Today%20Bio.%202023;23:%20100845." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR173">
<span class="label">173.</span><cite>Xu J, Liu H, Wang T, Wen Z, Chen H, Yang Z, et al. CCR7 mediated mimetic dendritic cell vaccine homing in lymph node for head and neck squamous cell carcinoma therapy. Adv Sci (Weinh). 2023;10:2207017.
</cite> [<a href="https://doi.org/10.1002/advs.202207017" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10265089/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37092579/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Xu%20J,%20Liu%20H,%20Wang%20T,%20Wen%20Z,%20Chen%20H,%20Yang%20Z,%20et%20al.%20CCR7%20mediated%20mimetic%20dendritic%20cell%20vaccine%20homing%20in%20lymph%20node%20for%20head%20and%20neck%20squamous%20cell%20carcinoma%20therapy.%20Adv%20Sci%20(Weinh).%202023;10:2207017." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR174">
<span class="label">174.</span><cite>Ji P, Sun W, Zhang S, Xing Y, Wang C, Wei M, et al. Modular hydrogel vaccine for programmable and coordinate elicitation of cancer immunotherapy. Adv Sci (Weinh). 2023;10:2301789.
</cite> [<a href="https://doi.org/10.1002/advs.202301789" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10401092/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37222047/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Ji%20P,%20Sun%20W,%20Zhang%20S,%20Xing%20Y,%20Wang%20C,%20Wei%20M,%20et%20al.%20Modular%20hydrogel%20vaccine%20for%20programmable%20and%20coordinate%20elicitation%20of%20cancer%20immunotherapy.%20Adv%20Sci%20(Weinh).%202023;10:2301789." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR175">
<span class="label">175.</span><cite>Li J, Lin W, Huang T, Chen M, Lin Q. IL-12 improves the anti-HCC efficacy of dendritic cells loaded with exosomes from overexpressing Rab27a tumor cells. Exp Cell Res. 2024;439: 114073.
</cite> [<a href="https://doi.org/10.1016/j.yexcr.2024.114073" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38704079/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Li%20J,%20Lin%20W,%20Huang%20T,%20Chen%20M,%20Lin%20Q.%20IL-12%20improves%20the%20anti-HCC%20efficacy%20of%20dendritic%20cells%20loaded%20with%20exosomes%20from%20overexpressing%20Rab27a%20tumor%20cells.%20Exp%20Cell%20Res.%202024;439:%20114073." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR176">
<span class="label">176.</span><cite>Morishita M, Takahashi Y, Matsumoto A, Nishikawa M, Takakura Y. Exosome-based tumor antigens–adjuvant co-delivery utilizing genetically engineered tumor cell-derived exosomes with immunostimulatory CpG DNA. Biomaterials. 2016;111:55–65.
</cite> [<a href="https://doi.org/10.1016/j.biomaterials.2016.09.031" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27723556/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Morishita%20M,%20Takahashi%20Y,%20Matsumoto%20A,%20Nishikawa%20M,%20Takakura%20Y.%20Exosome-based%20tumor%20antigens%E2%80%93adjuvant%20co-delivery%20utilizing%20genetically%20engineered%20tumor%20cell-derived%20exosomes%20with%20immunostimulatory%20CpG%20DNA.%20Biomaterials.%202016;111:55%E2%80%9365." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
</ul></section></section><section id="_ad93_" lang="en" class="associated-data"><h2 class="pmc_sec_title">Associated Data</h2>
<p class="font-secondary"><em>This section collects any data citations, data availability statements, or supplementary materials included in this article.</em></p>
<section id="_adda93_" lang="en" class="data-availability-statement"><h3 class="pmc_sec_title">Data Availability Statement</h3>
<p>Not applicable.</p></section></section></section><footer class="p courtesy-note font-secondary font-sm text-center"><hr class="headless">
<p>Articles from Journal of Translational Medicine are provided here courtesy of <strong>BMC</strong></p></footer></section></article>

                      

                    </main>
                </div>
            </div>
        </div>

        



<!-- Secondary navigation placeholder -->
<div class="pmc-sidenav desktop:grid-col-4 display-flex">
    <section class="pmc-sidenav__container" aria-label="Article resources and navigation">
        <button type="button" class="usa-button pmc-sidenav__container__close usa-button--unstyled">
            <img src="/static/img/usa-icons/close.svg" role="img" alt="Close" />
        </button>
    <div class="display-none desktop:display-block">
       <section class="margin-top-4 desktop:margin-top-0">
              <h2 class="margin-top-0">ACTIONS</h2>
           <ul class="usa-list usa-list--unstyled usa-list--actions">
               
               <li>
                     <a
                             href="https://doi.org/10.1186/s12967-025-06883-8"
                             class="usa-button usa-button--outline width-24 font-xs display-inline-flex flex-align-center flex-justify-start padding-left-1"
                             target="_blank"
                             rel="noreferrer noopener"
                             data-ga-category="actions"
                             data-ga-action="click"
                             data-ga-label="publisher_link_desktop"
                     >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#launch"></use>
                         </svg>
                         <span class="display-inline-flex flex-justify-center flex-1 padding-right-2">View on publisher site</span>
                     </a>
               </li>
               
               
               <li>
                    <a
                            href="pdf/12967_2025_Article_6883.pdf"
                            class="usa-button usa-button--outline width-24 display-inline-flex flex-align-center flex-justify-start padding-left-1"
                            data-ga-category="actions"
                            data-ga-action="click"
                            data-ga-label="pdf_download_desktop"
                    >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#file_download"></use>
                        </svg>
                        <span class="display-inline-flex flex-justify-center flex-1">PDF (6.5 MB)</span>
                    </a>
               </li>
               
                
               <li>
                   <button role="button" class="usa-button width-24 citation-dialog-trigger display-inline-flex flex-align-center flex-justify-start padding-left-1"
                        aria-label="Open dialog with citation text in different styles"
                        data-ga-category="actions"
                        data-ga-action="open"
                        data-ga-label="cite_desktop"
                        data-all-citations-url="/resources/citations/12362945/"
                        data-citation-style="nlm"
                        data-download-format-link="/resources/citations/12362945/export/"
                    >
                        <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#format_quote"></use>
                        </svg>
                       <span class="display-inline-flex flex-justify-center flex-1 button-label">Cite</span>
                    </button>
               </li>
                
               <li>

                        <button class="usa-button width-24 collections-dialog-trigger collections-button display-inline-flex flex-align-center flex-justify-start padding-left-1 collections-button-empty"
                              aria-label="Save article in MyNCBI collections."
                              data-ga-category="actions"
                              data-ga-action="click"
                              data-ga-label="collections_button_desktop"
                              data-collections-open-dialog-enabled="false"
                              data-collections-open-dialog-url="https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC12362945%2F%3Freport%3Dclassic%23open-collections-dialog"
                              data-in-collections="false">
                            <svg class="usa-icon width-3 height-3 usa-icon--bookmark-full" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-full.svg#icon"></use>
                            </svg>
                            <svg class="usa-icon width-3 height-3 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-empty.svg#icon"></use>
                            </svg>
                            <span class="display-inline-flex flex-justify-center flex-1">Collections</span>
                       </button>
               </li>
               <li class="pmc-permalink">
                    <button
                            type="button"
                            class="usa-button width-24 display-inline-flex flex-align-center flex-justify padding-left-1 shadow-none"
                            aria-label="Show article permalink"
                            aria-expanded="false"
                            aria-haspopup="true"
                            data-ga-category="actions"
                            data-ga-action="open"
                            data-ga-label="permalink_desktop"
                    >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#share"></use>
                        </svg>
                        <span class="display-inline-flex flex-justify-center flex-1 button-label">Permalink</span>
                    </button>
                   

<div class="pmc-permalink__dropdown" hidden>
    <div class="pmc-permalink__dropdown__container">
          <h2 class="usa-modal__heading margin-top-0 margin-bottom-2 text-uppercase font-sans-xs">PERMALINK</h2>
          <div class="pmc-permalink__dropdown__content">
              <input type="text" class="usa-input" value="https://pmc.ncbi.nlm.nih.gov/articles/PMC12362945/" aria-label="Article permalink">
              <button class="usa-button display-inline-flex pmc-permalink__dropdown__copy__btn margin-right-0" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                  <svg class="usa-icon" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#content_copy"></use>
                  </svg>
                  <span class="margin-left-1">Copy</span>
              </button>
          </div>
    </div>
</div>
               </li>
           </ul>
       </section>
     </div>

        <section class="pmc-resources margin-top-6 desktop:margin-top-4" data-page-path="/articles/PMC12362945/">
            <h2 class="margin-top-0">RESOURCES</h2>
            
                <div class="usa-accordion usa-accordion--multiselectable" data-allow-multiple>
                    <h3 class="usa-accordion__heading">
                        <button
                        type="button"
                        class="usa-accordion__button"
                        aria-expanded="false"
                        aria-controls="resources-similar-articles"
                        data-ga-category="resources_accordion"
                        data-ga-action="open_similar_articles"
                        data-ga-label="/articles/PMC12362945/"
                        data-action-open="open_similar_articles"
                        data-action-close="close_similar_articles"
                        >
                            Similar articles
                        </button>
                    </h3>
                    <div
                            id="resources-similar-articles"
                            class="usa-accordion__content usa-prose"
                            
                                data-source-url="/resources/similar-article-links/40826466/"
                            
                    >
                        
                    </div>
                    <h3 class="usa-accordion__heading">
                        <button
                        type="button"
                        class="usa-accordion__button"
                        aria-expanded="false"
                        aria-controls="resources-cited-by-other-articles"
                        data-ga-category="resources_accordion"
                        data-ga-action="open_cited_by"
                        data-ga-label="/articles/PMC12362945/"
                        data-action-open="open_cited_by"
                        data-action-close="close_cited_by"
                        >
                             Cited by other articles
                        </button>
                    </h3>
                    <div
                            id="resources-cited-by-other-articles"
                            class="usa-accordion__content usa-prose"
                            
                                data-source-url="/resources/cited-by-links/40826466/"
                            
                    >
                          
                    </div>
                    
                        <h3 class="usa-accordion__heading">
                            <button
                            type="button"
                            class="usa-accordion__button"
                            aria-expanded="false"
                            aria-controls="resources-links-to-ncbi-databases"
                            data-ga-category="resources_accordion"
                            data-ga-action="open_NCBI_links"
                            data-ga-label="/articles/PMC12362945/"
                            data-action-open="open_NCBI_links"
                            data-action-close="close_NCBI_link"
                            >
                                 Links to NCBI Databases
                            </button>
                        </h3>
                        <div
                                id="resources-links-to-ncbi-databases"
                                class="usa-accordion__content usa-prose"
                                data-source-url="/resources/db-links/12362945/"
                        >
                        </div>
                    
                    
                </div>
            
        </section>


        <section
        class="usa-in-page-nav usa-in-page-nav--wide margin-top-6 desktop:margin-top-4"
        data-title-text="On this page"
        data-title-heading-level="h2"
        data-scroll-offset="0"
        data-root-margin="-10% 0px -80% 0px"
        data-main-content-selector="main"
        data-threshold="1"
        hidden
        ></section>
    </section>
</div>


        

<div class="overlay" role="dialog" aria-label="Citation Dialog" hidden>
    <div class="dialog citation-dialog" aria-hidden="true">
        <div class="display-inline-flex flex-align-center flex-justify width-full margin-bottom-2">
            <h2 class="usa-modal__heading margin-0">Cite</h2>
             <button type="button" class="usa-button usa-button--unstyled close-overlay text-black width-auto"  tabindex="1">
                <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#close"></use>
                </svg>
             </button>
        </div>

        

<div class="citation-text-block">
  <div class="citation-text margin-bottom-2"></div>
  <ul class="usa-list usa-list--unstyled display-inline-flex flex-justify width-full flex-align-center">
      <li>
        <button
          class="usa-button usa-button--unstyled text-no-underline display-flex flex-align-center copy-button dialog-focus"
          data-ga-category="save_share"
          data-ga-action="cite"
          data-ga-label="copy"
          tabindex="2">
            <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                <use xlink:href="/static/img/sprite.svg#content_copy"></use>
            </svg>
            <span>Copy</span>
        </button>
      </li>
      <li>
          <a
              href="#"
              role="button"
              class="usa-button usa-button--unstyled text-no-underline display-flex flex-align-center export-button"
              data-ga-category="save_share"
              data-ga-action="cite"
              data-ga-label="download"
              title="Download a file for external citation management software"
              tabindex="3">
                <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#file_download"></use>
                </svg>
                <span class="display-none mobile-lg:display-inline">Download .nbib</span>
                <span class="display-inline mobile-lg:display-none">.nbib</span>
            </a>
      </li>
      <li>
          

<div class="display-inline-flex flex-align-center">
  <label class="usa-label margin-top-0">Format:</label>
  <select aria-label="Format" class="usa-select citation-style-selector padding-1 margin-top-0 border-0 padding-right-4" tabindex="4" >
    
      <option data-style-url-name="ama"
              value="AMA"
              >
        AMA
      </option>
    
      <option data-style-url-name="apa"
              value="APA"
              >
        APA
      </option>
    
      <option data-style-url-name="mla"
              value="MLA"
              >
        MLA
      </option>
    
      <option data-style-url-name="nlm"
              value="NLM"
              selected="selected">
        NLM
      </option>
    
  </select>
</div>
      </li>
  </ul>
</div>
    </div>
</div>

        <div class="overlay" role="dialog" hidden>
  <div id="collections-action-dialog" class="dialog collections-dialog" aria-hidden="true">
   <div class="display-inline-flex flex-align-center flex-justify width-full margin-bottom-2">
        <h2 class="usa-modal__heading margin-0">Add to Collections</h2>
    </div>
    <div class="collections-action-panel action-panel">
      


<form id="collections-action-dialog-form"
      class="usa-form maxw-full collections-action-panel-form action-panel-content action-form action-panel-smaller-selectors"
      data-existing-collections-url="/list-existing-collections/"
      data-add-to-existing-collection-url="/add-to-existing-collection/"
      data-create-and-add-to-new-collection-url="/create-and-add-to-new-collection/"
      data-myncbi-max-collection-name-length="100"
      data-collections-root-url="https://www.ncbi.nlm.nih.gov/myncbi/collections/">

    <input type="hidden" name="csrfmiddlewaretoken" value="BVIIeKMEOL3M1lmxb0sPOTQE62YRnXRVwzsOEdp3THbhiI2KjkOFdYDXZ4NZXTtX">

    <fieldset class="usa-fieldset margin-bottom-2">
        <div class="usa-radio">
            <input type="radio"
            id="collections-action-dialog-new"
            class="usa-radio__input usa-radio__input--tile collections-new  margin-top-0"
            name="collections"
            value="new"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="collections_radio_new" />
            <label class="usa-radio__label" for="collections-action-dialog-new">Create a new collection</label>
        </div>
        <div class="usa-radio">
            <input type="radio"
            id="collections-action-dialog-existing"
            class="usa-radio__input usa-radio__input--tile collections-existing"
            name="collections"
            value="existing"
            checked="true"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="collections_radio_existing" />
            <label class="usa-radio__label" for="collections-action-dialog-existing">Add to an existing collection</label>
        </div>
    </fieldset>

    <fieldset class="usa-fieldset margin-bottom-2">
        <div class="action-panel-control-wrap new-collections-controls">
           <label for="collections-action-dialog-add-to-new" class="usa-label margin-top-0">
                Name your collection
               <abbr title="required" class="usa-hint usa-hint--required text-no-underline">*</abbr>
          </label>
          <input
            type="text"
            name="add-to-new-collection"
            id="collections-action-dialog-add-to-new"
            class="usa-input collections-action-add-to-new"
            pattern="[^&quot;&amp;=&lt;&gt;/]*" title="The following characters are not allowed in the Name field: &quot;&amp;=&lt;&gt;/"
            maxlength=""
            data-ga-category="collections_button"
            data-ga-action="create_collection"
            data-ga-label="non_favorties_collection"
            required
          />
        </div>
        <div class="action-panel-control-wrap existing-collections-controls">
             <label for="collections-action-dialog-add-to-existing" class="usa-label margin-top-0">
                Choose a collection
              </label>
              <select id="collections-action-dialog-add-to-existing"
                      class="usa-select collections-action-add-to-existing"
                      data-ga-category="collections_button"
                      data-ga-action="select_collection"
                      data-ga-label="($('.collections-action-add-to-existing').val() === 'Favorites') ? 'Favorites' : 'non_favorites_collection'">
              </select>
              <div class="collections-retry-load-on-error usa-input-error-message selection-validation-message">
                Unable to load your collection due to an error<br>
                <a href="#">Please try again</a>
              </div>
        </div>
    </fieldset>

    <div class="display-inline-flex">
        <button class="usa-button margin-top-0 action-panel-submit"
            type="submit"
            data-loading-label="Adding..."
            data-pinger-ignore
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="add">
          Add
        </button>
        <button class="usa-button usa-button--outline margin-top-0 action-panel-cancel"
                aria-label="Close 'Add to Collections' panel"
                ref="linksrc=close_collections_panel"
                data-ga-category="collections_button"
                data-ga-action="click"
                data-ga-label="cancel">
          Cancel
        </button>
    </div>
</form>
    </div>
  </div>
</div>

        

      </div>
    </div>
  </div>



        
    
    

<footer class="ncbi-footer ncbi-dark-background " >
    
        <div class="ncbi-footer__icon-section">
            <div class="ncbi-footer__social-header">
                Follow NCBI
            </div>

            <div class="grid-container ncbi-footer__ncbi-social-icons-container">
                
                    <a href="https://twitter.com/ncbi"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="40"
                             height="40"
                             viewBox="0 0 40 40"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="m6.067 8 10.81 13.9L6 33.2h4.2l8.4-9.1 7.068 9.1H34L22.8 18.5 31.9 8h-3.5l-7.7 8.4L14.401 8H6.067Zm3.6 1.734h3.266l16.8 21.732H26.57L9.668 9.734Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on X (formerly known as Twitter)</span>
                    </a>
                

                
                    <a href="https://www.facebook.com/ncbi.nlm"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="16"
                             height="29"
                             focusable="false"
                             aria-hidden="true"
                             viewBox="0 0 16 29"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg">
                            <path d="M3.8809 21.4002C3.8809 19.0932 3.8809 16.7876 3.8809 14.478C3.8809 14.2117 3.80103 14.1452 3.54278 14.1492C2.53372 14.1638 1.52334 14.1492 0.514288 14.1598C0.302626 14.1598 0.248047 14.0972 0.248047 13.8936C0.256034 12.4585 0.256034 11.0239 0.248047 9.58978C0.248047 9.37013 0.302626 9.30224 0.528931 9.3049C1.53798 9.31688 2.54837 9.3049 3.55742 9.31555C3.80103 9.31555 3.8809 9.26097 3.87957 9.00272C3.87158 8.00565 3.85428 7.00592 3.90753 6.00884C3.97142 4.83339 4.31487 3.73115 5.04437 2.78467C5.93095 1.63318 7.15699 1.09005 8.56141 0.967577C10.5582 0.79319 12.555 0.982221 14.5518 0.927641C14.7102 0.927641 14.7462 0.99287 14.7449 1.13664C14.7449 2.581 14.7449 4.02668 14.7449 5.47104C14.7449 5.67604 14.6517 5.68669 14.4946 5.68669C13.4523 5.68669 12.4113 5.68669 11.3703 5.68669C10.3506 5.68669 9.92057 6.10868 9.90593 7.13904C9.89661 7.7647 9.91525 8.39303 9.89794 9.01869C9.88995 9.26364 9.96583 9.31822 10.2015 9.31688C11.7204 9.30623 13.2393 9.31688 14.7595 9.3049C15.0257 9.3049 15.0723 9.3728 15.0444 9.62439C14.89 10.9849 14.7515 12.3467 14.6144 13.7085C14.5691 14.1571 14.5785 14.1585 14.1458 14.1585C12.8386 14.1585 11.5313 14.1665 10.2254 14.1518C9.95119 14.1518 9.89794 14.2317 9.89794 14.4899C9.90593 19.0799 9.89794 23.6752 9.91125 28.2612C9.91125 28.5674 9.8407 28.646 9.53186 28.6433C7.77866 28.6273 6.02414 28.6366 4.27094 28.634C3.82499 28.634 3.87158 28.6992 3.87158 28.22C3.87602 25.9472 3.87913 23.6739 3.8809 21.4002Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on Facebook</span>
                    </a>
                

                
                    <a href="https://www.linkedin.com/company/ncbinlm"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="25"
                             height="23"
                             viewBox="0 0 26 24"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M14.6983 9.98423C15.6302 9.24808 16.5926 8.74754 17.6762 8.51991C19.673 8.09126 21.554 8.30824 23.1262 9.7526C24.2351 10.7723 24.7529 12.1115 25.0165 13.5612C25.1486 14.3363 25.2105 15.1218 25.2015 15.9081C25.2015 18.3043 25.2015 20.6898 25.2082 23.0806C25.2082 23.3468 25.1549 23.444 24.8621 23.4414C23.1297 23.4272 21.3992 23.4272 19.6704 23.4414C19.4041 23.4414 19.3429 23.3588 19.3442 23.1019C19.3535 20.5194 19.3442 17.9368 19.3442 15.3543C19.3442 14.0005 18.3258 12.9448 17.0266 12.9488C15.7273 12.9528 14.6983 14.0071 14.6983 15.361C14.6983 17.9328 14.6917 20.5047 14.6983 23.0753C14.6983 23.3708 14.6198 23.444 14.3296 23.4427C12.6185 23.4294 10.9079 23.4294 9.19779 23.4427C8.93155 23.4427 8.86099 23.3735 8.86232 23.1086C8.8783 19.7619 8.88628 16.4144 8.88628 13.066C8.88628 11.5688 8.87874 10.0708 8.86365 8.57182C8.86365 8.3575 8.90758 8.27896 9.14054 8.28029C10.9048 8.29094 12.6687 8.29094 14.4321 8.28029C14.6464 8.28029 14.6983 8.34818 14.6983 8.54653C14.6903 9.00047 14.6983 9.45441 14.6983 9.98423Z">
                            </path>
                            <path d="M6.55316 15.8443C6.55316 18.2564 6.55316 20.6699 6.55316 23.082C6.55316 23.3629 6.48127 23.4388 6.19906 23.4374C4.47737 23.4241 2.75568 23.4241 1.03399 23.4374C0.767751 23.4374 0.69986 23.3629 0.701191 23.1006C0.709178 18.2648 0.709178 13.4281 0.701191 8.59053C0.701191 8.34026 0.765089 8.27237 1.01669 8.2737C2.74991 8.28435 4.48048 8.28435 6.20838 8.2737C6.47462 8.2737 6.5465 8.33627 6.54517 8.6065C6.54783 11.0186 6.55316 13.4308 6.55316 15.8443Z">
                            </path>
                            <path d="M3.65878 0.243898C5.36804 0.243898 6.58743 1.45529 6.58743 3.1406C6.58743 4.75801 5.32145 5.95742 3.60819 5.96807C3.22177 5.97614 2.83768 5.90639 2.47877 5.76299C2.11985 5.61959 1.79344 5.40546 1.51897 5.13334C1.24449 4.86123 1.02755 4.53668 0.881058 4.17902C0.734563 3.82136 0.661505 3.43788 0.666231 3.05141C0.67555 1.42601 1.9362 0.242566 3.65878 0.243898Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on LinkedIn</span>
                    </a>
                

                
                    <a href="https://github.com/ncbi"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="28"
                             height="27"
                             viewBox="0 0 28 28"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M16.7228 20.6334C17.5057 20.5527 18.2786 20.3944 19.0301 20.1608C21.3108 19.4193 22.5822 17.8259 22.963 15.4909C23.1228 14.5112 23.1814 13.5287 22.9883 12.5437C22.8106 11.6423 22.4013 10.8028 21.8007 10.1076C21.7526 10.0605 21.7197 10 21.7064 9.934C21.6931 9.86799 21.7 9.79952 21.7262 9.73748C22.0856 8.6206 21.9711 7.51969 21.601 6.42677C21.582 6.3497 21.5345 6.2827 21.468 6.23923C21.4016 6.19577 21.3211 6.17906 21.2429 6.19248C20.7329 6.21649 20.2313 6.33051 19.7611 6.52928C19.1103 6.7908 18.4899 7.12198 17.9104 7.51703C17.84 7.56996 17.7581 7.60551 17.6713 7.62078C17.5846 7.63605 17.4954 7.6306 17.4112 7.60489C15.2596 7.05882 13.0054 7.06203 10.8554 7.61421C10.7806 7.63586 10.7018 7.63967 10.6253 7.62534C10.5487 7.611 10.4766 7.57892 10.4148 7.53167C9.64788 7.03247 8.85171 6.58918 7.96368 6.33359C7.65781 6.24338 7.34123 6.19458 7.02239 6.18849C6.94879 6.17986 6.87462 6.19893 6.81432 6.242C6.75402 6.28507 6.71191 6.34904 6.69621 6.42145C6.32342 7.51437 6.2209 8.61527 6.56307 9.73348C6.59635 9.84264 6.64694 9.93316 6.54177 10.0516C5.47666 11.2604 5.09988 12.6834 5.19574 14.2676C5.2663 15.4244 5.46201 16.5466 6.01454 17.5769C6.84399 19.1171 8.21664 19.9119 9.85158 20.3352C10.3938 20.4706 10.9444 20.5698 11.4998 20.632C11.5384 20.7492 11.4506 20.7798 11.408 20.8291C11.1734 21.1179 10.9894 21.4441 10.8634 21.7942C10.7622 22.0458 10.8315 22.4039 10.6065 22.5516C10.263 22.7766 9.83827 22.8485 9.42421 22.8871C8.17936 23.0056 7.26471 22.4877 6.6283 21.4348C6.25552 20.8184 5.76956 20.3325 5.08523 20.0663C4.76981 19.9325 4.42139 19.8967 4.08537 19.9638C3.7898 20.029 3.73788 20.1901 3.93891 20.4111C4.03639 20.5234 4.14989 20.6207 4.27575 20.6999C4.9796 21.1318 5.51717 21.7884 5.80152 22.5636C6.37002 23.9973 7.48039 24.5697 8.93825 24.6323C9.43741 24.6575 9.93768 24.615 10.4254 24.5058C10.5892 24.4672 10.6531 24.4872 10.6517 24.6762C10.6451 25.4936 10.6637 26.3123 10.6517 27.131C10.6517 27.6635 10.1684 27.9297 9.58663 27.7393C8.17396 27.2671 6.84977 26.5631 5.66838 25.656C2.59555 23.2891 0.720966 20.1861 0.217704 16.3376C-0.357453 11.9127 0.911353 8.00824 3.98551 4.73881C6.11909 2.42656 8.99932 0.939975 12.1203 0.540191C16.5351 -0.0601815 20.4347 1.14323 23.7232 4.16373C26.2449 6.47869 27.724 9.37672 28.1048 12.7726C28.5828 17.0325 27.3686 20.7945 24.4768 23.9827C22.9762 25.6323 21.0956 26.8908 18.9982 27.6488C18.8783 27.6927 18.7585 27.738 18.636 27.7726C18.0356 27.9404 17.6189 27.6395 17.6189 27.0098C17.6189 25.7452 17.6308 24.4806 17.6295 23.2159C17.6329 22.9506 17.6128 22.6856 17.5696 22.4238C17.4325 21.6664 17.3419 21.484 16.7228 20.6334Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on GitHub</span>
                    </a>
                

                
                    <a href="https://ncbiinsights.ncbi.nlm.nih.gov/"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="26"
                             height="26"
                             viewBox="0 0 27 27"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M23.7778 26.4574C23.1354 26.3913 22.0856 26.8024 21.636 26.3087C21.212 25.8444 21.4359 24.8111 21.324 24.0347C19.9933 14.8323 14.8727 8.80132 6.09057 5.85008C4.37689 5.28406 2.58381 4.99533 0.779072 4.99481C0.202773 4.99481 -0.0229751 4.83146 0.00455514 4.21479C0.0660406 3.08627 0.0660406 1.95525 0.00455514 0.826734C-0.0413285 0.0815827 0.259669 -0.0193618 0.896534 0.00266238C6.96236 0.222904 12.3693 2.24179 16.9889 6.16209C22.9794 11.2478 26.1271 17.7688 26.4372 25.648C26.4629 26.294 26.3179 26.5271 25.6609 26.4684C25.0827 26.417 24.4991 26.4574 23.7778 26.4574Z">
                            </path>
                            <path d="M14.8265 26.441C14.0924 26.441 13.2371 26.6795 12.6626 26.3786C12.0092 26.0372 12.3781 25.0644 12.246 24.378C11.1154 18.5324 6.6849 14.5497 0.74755 14.1001C0.217135 14.0615 -0.0104482 13.9422 0.0134113 13.3659C0.0519536 12.1454 0.0482829 10.9213 0.0134113 9.69524C-0.00127145 9.14464 0.196946 9.03268 0.703502 9.04736C9.21217 9.27128 16.5994 16.2511 17.2804 24.7231C17.418 26.4446 17.418 26.4446 15.6579 26.4446H14.832L14.8265 26.441Z">
                            </path>
                            <path d="M3.58928 26.4555C2.64447 26.4618 1.73584 26.0925 1.06329 25.4289C0.39073 24.7653 0.00933763 23.8617 0.0030097 22.9169C-0.00331824 21.9721 0.365937 21.0635 1.02954 20.3909C1.69315 19.7184 2.59675 19.337 3.54156 19.3306C4.48637 19.3243 5.39499 19.6936 6.06755 20.3572C6.7401 21.0208 7.1215 21.9244 7.12782 22.8692C7.13415 23.814 6.7649 24.7226 6.10129 25.3952C5.43768 26.0677 4.53409 26.4491 3.58928 26.4555Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI RSS feed</span>
                    </a>
                
            </div>
        </div>
    

    <div data-testid="gridContainer"
         class="grid-container ncbi-footer__container">
        <div class="grid-row ncbi-footer__main-content-container"
             data-testid="grid">
            
                <div class="ncbi-footer__column">
                    
                        <p class="ncbi-footer__circled-icons-heading">
                            Connect with NLM
                        </p>
                    

                    <div class="ncbi-footer__circled-icons-list">
                        
                            <a href=https://twitter.com/nlm_nih class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="32"
                                     height="32"
                                     viewBox="0 0 40 40"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="m6.067 8 10.81 13.9L6 33.2h4.2l8.4-9.1 7.068 9.1H34L22.8 18.5 31.9 8h-3.5l-7.7 8.4L14.401 8H6.067Zm3.6 1.734h3.266l16.8 21.732H26.57L9.668 9.734Z">
                                    </path>
                                </svg>
                                <span class="usa-sr-only">NLM on X (formerly known as Twitter)</span>
                            </a>
                        

                        
                            <a href=https://www.facebook.com/nationallibraryofmedicine class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="13"
                                     height="24"
                                     viewBox="0 0 13 24"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="M4.11371 23.1369C4.11371 23.082 4.11371 23.0294 4.11371 22.9745V12.9411H0.817305C0.6709 12.9411 0.670898 12.9411 0.670898 12.8016C0.670898 11.564 0.670898 10.3287 0.670898 9.09341C0.670898 8.97903 0.705213 8.95158 0.815017 8.95158C1.8673 8.95158 2.91959 8.95158 3.97417 8.95158H4.12057V8.83263C4.12057 7.8055 4.12057 6.7738 4.12057 5.74897C4.1264 4.92595 4.31387 4.11437 4.66959 3.37217C5.12916 2.38246 5.94651 1.60353 6.95717 1.1921C7.64827 0.905008 8.3913 0.764035 9.13953 0.778051C10.0019 0.791777 10.8644 0.830666 11.7268 0.860404C11.8869 0.860404 12.047 0.894717 12.2072 0.90158C12.2964 0.90158 12.3261 0.940469 12.3261 1.02968C12.3261 1.5421 12.3261 2.05452 12.3261 2.56465C12.3261 3.16857 12.3261 3.7725 12.3261 4.37642C12.3261 4.48165 12.2964 4.51367 12.1912 4.51138C11.5369 4.51138 10.8804 4.51138 10.2261 4.51138C9.92772 4.51814 9.63058 4.5526 9.33855 4.61433C9.08125 4.6617 8.84537 4.78881 8.66431 4.97766C8.48326 5.16652 8.3662 5.40755 8.32972 5.66661C8.28476 5.89271 8.26027 6.1224 8.25652 6.35289C8.25652 7.19014 8.25652 8.02969 8.25652 8.86923C8.25652 8.89439 8.25652 8.91955 8.25652 8.95615H12.0219C12.1797 8.95615 12.182 8.95616 12.1614 9.10714C12.0768 9.76596 11.9876 10.4248 11.9029 11.0813C11.8312 11.6319 11.7626 12.1824 11.697 12.733C11.6719 12.9434 11.6787 12.9434 11.4683 12.9434H8.26338V22.899C8.26338 22.979 8.26338 23.0591 8.26338 23.1392L4.11371 23.1369Z">
                                    </path>
                                </svg>
                                <span class="usa-sr-only">NLM on Facebook</span>
                            </a>
                        

                        
                            <a href=https://www.youtube.com/user/NLMNIH class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="21"
                                     height="15"
                                     viewBox="0 0 21 15"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="M19.2561 1.47914C18.9016 1.15888 18.5699 0.957569 17.2271 0.834039C15.5503 0.678484 13.2787 0.655608 11.563 0.65332H9.43556C7.71987 0.65332 5.4483 0.678484 3.77151 0.834039C2.43098 0.957569 2.097 1.15888 1.74242 1.47914C0.813665 2.32097 0.619221 4.62685 0.598633 6.89384C0.598633 7.31781 0.598633 7.74101 0.598633 8.16345C0.626084 10.4121 0.827391 12.686 1.74242 13.521C2.097 13.8412 2.4287 14.0425 3.77151 14.1661C5.4483 14.3216 7.71987 14.3445 9.43556 14.3468H11.563C13.2787 14.3468 15.5503 14.3216 17.2271 14.1661C18.5676 14.0425 18.9016 13.8412 19.2561 13.521C20.1712 12.6929 20.3725 10.451 20.3999 8.22064C20.3999 7.74025 20.3999 7.25986 20.3999 6.77946C20.3725 4.54907 20.1689 2.30724 19.2561 1.47914ZM8.55942 10.5311V4.65201L13.5601 7.50005L8.55942 10.5311Z"
                                          fill="white" />
                                </svg>
                                <span class="usa-sr-only">NLM on YouTube</span>
                            </a>
                        
                    </div>
                </div>
            

            
                <address class="ncbi-footer__address ncbi-footer__column">
                    
        <p>
            <a class="usa-link usa-link--external"
            href="https://www.google.com/maps/place/8600+Rockville+Pike,+Bethesda,+MD+20894/%4038.9959508,
            -77.101021,17z/data%3D!3m1!4b1!4m5!3m4!1s0x89b7c95e25765ddb%3A0x19156f88b27635b8!8m2!3d38.9959508!
            4d-77.0988323"
            rel="noopener noreferrer" target="_blank">National Library of Medicine
            <br/> 8600 Rockville Pike<br/> Bethesda, MD 20894</a>
        </p>
    
                </address>
            

            
                <ul class="usa-list usa-list--unstyled ncbi-footer__vertical-list ncbi-footer__column">
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/web_policies.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Web Policies
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nih.gov/institutes-nih/nih-office-director/office-communications-public-liaison/freedom-information-act-office" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            FOIA
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.hhs.gov/vulnerability-disclosure-policy/index.html" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            HHS Vulnerability Disclosure
        

        
    </a>


                        </li>
                    
                </ul>
            

            
                <ul class="usa-list usa-list--unstyled ncbi-footer__vertical-list ncbi-footer__column">
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://support.nlm.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Help
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/accessibility.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Accessibility
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/careers/careers.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Careers
        

        
    </a>


                        </li>
                    
                </ul>
            
        </div>

        
            <div class="grid-row grid-col-12" data-testid="grid">
                <ul class="ncbi-footer__bottom-links-list">
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.nlm.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            NLM
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            NIH
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.hhs.gov/" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            HHS
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.usa.gov/" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            USA.gov
        

        
    </a>


                        </li>
                    
                </ul>
            </div>
        
    </div>
</footer>

    


        
        
    
  <script  type="text/javascript" src="https://cdn.ncbi.nlm.nih.gov/core/pinger/pinger.js"> </script>


    
        

<button class="back-to-top" data-ga-category="pagination" data-ga-action="back_to_top">
    <label>Back to Top</label>
    <svg class="usa-icon order-0" aria-hidden="true" focusable="false" role="img">
        <use xlink:href="/static/img/sprite.svg#arrow_upward"></use>
    </svg>
</button>
    


        
    
    
    
        
    <script type="application/javascript">
    window.ncbi = window.ncbi || {};
    window.ncbi.pmc = window.ncbi.pmc || {};
    window.ncbi.pmc.options = {
        logLevel: 'INFO',
        
        staticEndpoint: '/static/',
        
        citeCookieName: 'pmc-cf',
    };
</script>
    <script type="module" crossorigin="" src="/static/assets/base-133c6271.js"></script>
    
    <script type="text/javascript" src="https://cdn.ncbi.nlm.nih.gov/core/jquery/jquery-3.6.0.min.js">&#xA0;</script>
    <script type="text/javascript">
        jQuery.getScript("https://cdn.ncbi.nlm.nih.gov/core/alerts/alerts.js", function () {
            galert(['div.nav_and_browser', 'div.header', '#universal_header', '.usa-banner', 'body > *:nth-child(1)'])
        });
    </script>


    <script type="text/javascript">var exports = {};</script>
     <script src="/static/CACHE/js/output.13b077bc3ffd.js"></script>

    <script type="module" crossorigin="" src="/static/assets/article-44d04358.js"></script>
    
    

    </body>
</html>
